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1.1 Maedi-Visna Virus: an Ovine Lentivirus
Maedi-visna virus (MVV) was initially isolated and characterised following outbreaks of
progressive paralysis (visna) and progressive pneumonia (maedi) in Icelandic sheep flocks
between 1939 and 1952. Transmission of the disease to healthy animals using tissue
preparations from infected animals was demonstrated (Sigurdsson 1954a, Sigurdsson eta/.,
1957) and in 1967 a single virus was shown to be responsible for both symptoms (Gudnadottir
& Ralsson 1967). The long interval between MVV infection and onset of MVV mediated
disease was used to define a new form of virally induced disease defined as 'slow' (Sigurdsson
1954b). This was to distinguish the disease process from acute viral infection.
MVV is thus the prototypic member of the Lentivirinae subfamily of the Retroviridae
family of viruses. The Lentivirinae subfamily includes, in addition to MVV, caprine arthritis-
encephalitis virus (CAEV, Crawford et al., 1980), equine infectious anaemia virus (EIAV,
Dreguss & Lombard 1954), feline immunodeficiency virus (FIV, Pedersen efa/.,1987), bovine
immunodeficiency virus (BIV, Gonda etal., 1987), simian immunodeficiency virus (SIV, Letvin
et al., 1985) and Human Immunodeficiency Virus types 1 and 2 (HIV-1 and HIV-2). With the
exception of EIAV which causes cyclical disease episodes, the lentiviruses cause
progressively debilitating disease, usually with slow onset.
Phylogenetic comparisons of the lentiviruses differ in fine detail dependent on the
gene and viral strains studied. These studies do, however, provide a reasonable consensus
that MVV is more closely related to the non-primate lentiviruses than to the primate species
(Olmsted etal., 1986, McClure et al., 1988, Olmsted etal., 1989). Like all members of the
retroviridae, MVV possesses a positive sense single stranded RNA genome (ssRNA) (Brahic
etal., 1977), an RNA dependent DNA polymerase (Lin & Thormar 1970) and replicates via a
DNA intermediate, the provirus (Haase & Varmus 1973). Although possessing a ssRNA
genome the retroviruses package two copies of the genome per virion. Thus MVV, like all
lentiviruses, is described as being diploid. This packaging of two genomes is one of the
features which allows the retroviruses to achieve high mutation rates (reviewed by Coffin
1979, Katz & Skalka 1990). Recombination between the two genomes during reverse
transcription allows sequences within 10s of bases to behave as if they were unlinked.
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1.2 Genomic Organisation of MVV
The lentiviruses possess a complex genome structure which, in addition to the gag,
pol and env genes, contains a number of small open reading frames (orfs). These orfs
encode auxiliary proteins involved in the control of viral replication.
Seven MVV isolates have been sequenced to date. Four of these are variants of the
1514 strain (Sonigo efa/., 1985, Braun etal., 1987, Staskus etal., 1991, Andresson et al.,
1992) while the others are South African-Ovine Maedi Visna Virus (SA-OMVV, Querat et al.,
1990) and the British isolate EV-1 (Sargan efa/., 1991). These sequences were all derived
from molecular clones with the exception of the EV-1 sequence which is from a biological
clone. The viruses of these 3 strains possess a similar genomic structure with only minor
differences. A basic outline of the MVV genome is shown in Fig 1.1. The DNA genome of the
lentiviruses is flanked by two long terminal repeats (LTRs). The LTR sequence is composed of
the U3, R and U5 regions. This sequence contains a primer binding site complementary to that
fortRNA|V's1 2 (Sonigo efa/., 1985) and a polypurine tract which acts as the initiation site for
positive strand DNA synthesis. The LTR also contains the target sequences which are
responsible for regulating transcription of the viral genome (Section 1.6).
The MVV viruses appear to have a less complex pattern of orfs than HIV-1, the most
extensively studied lentivirus. In this thesis, the HIV orf nomencluture will be used. Potential
homologues to the HIV orf proteins Tat (Gourdou efa/., 1989) , Rev (Tiley etal., 1990) and Vif
(Strebel etal., 1987, Audoly et al., 1992) have been described in MVV. In addition to these
three orfs, which are known to produce functional proteins, SA-OMVV contains a novel orf
termed W (Querat et al., 1990). There is, however, no evidence for translation of this
sequence. It should be made clear that although some of the MVV orf products are
functionally homologous to the HIV proteins (Rev and Vif) others may be acting in a quite
distinct manner (Tat). MVV does not appear to encode homologues for the HIV-1 orfs vpr
(Ogawa etal., 1989), vpu (Strebel etal., 1988), fev(Benko etal., 1990) or net (Ahmed &




An outline of the MVVgenome is illustrated. The locations of the 6 translated open reading
frames are indicated. All sequenced isolates of MVV have a size of between 9 and 9.3kB. The
LTR is divided into U3, R and U5 regions. The promoter sequences controlling transcription

















1.3 Pathology of MVV infection
During the original outbreak of MW in Iceland, an incubation period of between one
to three years was described, although in some cases the incubation period was longer
(Sigurdsson etal., 1954a). This prolonged asymptomatic period was followed by the onset of
clinical disease. This was characterised by a gradual progression of symptoms, with little
regresssion, until death occurred. A number of organ systems were affected most notably the
lung, mammary gland and central nervous system (CNS). The lesions were characterised by
their inflammatory nature and lymphocytic infiltrate.
The lung disease causes dyspnoea (Maedi). At post-mortem the lungs may be two to
four times their normal weight with decreased elasticity and a degree of fibrosis (Sigurdsson
etal., 1954a). Accumulation of plasma cells, mononuclear phagocytes and lymphocytes leads
to a thickening of the alveolar septa (Georgsson & Palsson 1971). In severe disease this
infiltrate generates lymphoid follicles with active germinal centres (Lairmore etal., 1986). The
regional lymph nodes become enlarged.
Neurological infection affects gait with paralysis of the hindquarters progressing until
paraplegia develops (Visna). Infection of the CNS leads to demyelination and destruction of
the white matter in the brain, cerebellum and spinal chord (Sigurdsson et ai, 1957). Primary
inflammatory lesions appear to be focused on the glia with little neuronal destruction
(Sigurdsson & Palsson 1958, Stowring etal. 1985). Infection of oligodendrocytes and
astrocytes by MVV has been observed in vivo (Stowring etal., 1985). In the mammary gland,
MVV generates a chronic indurative mastitis (Van der Molen et at., 1985) which is again
characterised by marked lymphoid hyperplasia and slight fibrosis as occurs in the lung. One
additional site of pathology in some animals is the joint. Swelling and calcification of soft tissue,
fibrosis of the joint capsule and synovium and perivascular lymphocytic infiltration leads to
arthritis (Oliver etal., 1981). This pathology is similar to that seen with CAEV (Crawford etal.,
1980). In all these sites of pathology only very few cells are seen to be expressing viral
proteins. The mechanisms controlling viral pathogenesis are poorly understood and the
events which lead to the initiation of the viral lesions and pathology are unknown. The lifecycle
of MVV has been analysed with regard to identifying steps which are linked to the observed
pathology. This can be simplified to two major questions; firstly, how does MVV evade the
immune response during the long incubation period and secondly, how does the virus
3
dysregulate normal homeostasis and induce these massive cellular infiltrates? There is as yet
no firm answer to either of these two questions, but in vitro and in vivo studies on the viral
lifecycle and regulatory genes have begun to provide clues as to possible mechanisms.
1 .4 The MVV Lifecycle
In vivo, MVV appears to infect preferentially cells of the monocyte and macrophage
lineage (Gendelman etal., 1985, Peluso etal., 1985) although numerous other tissues have
been shown to be susceptible to infection in vivo. These include choroid plexus cells (Brahic
etal., 1981), lung epithelia (Geballe etal., 1985) and both oligodendrocytes and astrocytes in
the CNS (Stowring et al., 1985). The nature of the MVV receptor remains to be fully
characterised (Crane etal., 1991, Dalziel etal., 1991). Given the range of cells apparently
susceptible to infection it appears to be widely distributed.
After binding the cellular receptor the MVV particle fuses with the cell. The virus then
enters and the virion is uncoated. Reverse transcription of the viral nucleic acid then
proceeds, primed off the cellular tRNA'ys bound to the LTR. The viral Pol protein then
generates a linear dsDNA copy of the genome which is then circularised. This circularised form
is thought to be topological^ preferred for integration into the host cell's DNA (Panganiban &
Temein 1984).
1.4.1 Integration
The confirmation of integration as a critical step in the MVV lifecycle still awaits a full
experimental demonstration. However, integration has been shown in a variety of systems to
be a critical step in the lifecycle of the retroviruses (reviewed by Coffin 1990). The importance
of integration during in vitro MVV infection has been questioned (Harris etal., 1985). These
workers found no evidence for integrated genomes during lytic infection of sheep choroid
plexus cells. However, using different permissive cells, Vigne et al. (1985) observed
integration in a minority of cells. This reported failure to observe large numbers of integrated
genomes does not appear to be due to a defect in the MVV integrase protein. Studies using
purified recombinant MVV integrase have demonstrated that it is competent to perform the full
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repertoire of in vitro functions characteristic of retroviral integrases (Katzman & Sudol 1994).
Recent experiments with integrase deficient molecular clones suggest that these viruses are
non-infectious (G.Querat personal communication). Thus, while during lytic in vitro infection
there may only be a small number of integrated genomes these may be vital for the viral
lifecycle.
In HIV, where integrase deficient viruses have been functionally tested, there is some
disagreement as to the consequences of integrase deletion. Several studies have suggested
that the integrase activity is an absolute requirement for productive infection (Stevenson et
a!., 1990a, LaFemina etal., 1992, Sakai etal., 1993). These studies do, however, disagree as
to the mechanism by which the integrase mutation blocks the infectious process. The data of
Stevenson etal. appears to suggest a late action of the defect, as expression of viral proteins
was unimpaired. This would suggest a novel function for the Integrase as mutants appear to
generate a phenotype similar to Vif mutants (Section 1.5.2); perhaps affecting virion assembly
or some other late process. In contrast, the data of Sakai etal. is consistent with observations
in other retroviruses such as murine leukemia virus (Donehower & Varmus 1984, Roth etal.,
1990) and Rous Sarcoma Virus (Hippenmeyer & Grandgenett 1984) where mutation of the
integrase blocked viral gene expression. One problem of studies on the integrase protein is
that it is produced as a precursor polyprotein which is cleaved to generate the mature Pol and
Gag proteins. As the Pol protein contains a number of distinct enzymatic activities any
mutation within the integrase domain may interfere with the activity of these other sites (Roth
etal., 1990, Stevenson etal.. 1990). Using the HIV-1 integrase Shin etal. (1994) identified a
number of single point mutations within the integrase active site which failed to block
integration but which did affect virion assembly and infectivity. Additional studies by this group
identified single amino acid substitutions which blocked the production of virus but these
viruses were not integration defective (Taddeo etal., 1994). Further it was possible to identify
mutants which blocked integration but did not block replication. Using a similar single amino
acid substitution approach Wiskerchen & Muesing (1995) failed to observe replication of
integrase mutants. These workers tested the producer cell lines for proper expression and
processing of the Pol and Gag proteins. From this work it was concluded that integration was
essential for viral replication in primary cell lines.
The integrase activity of the Pol gene has been accepted as playing a central role in
the retroviral lifecycle. The studies described above suggest that mutations within the
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integrase domain can block the activity of other domains within the Pol protein so blocking
replication. This may account for the some of discrepencies described in previous studies on
the phenoytype generated by the deletion of integrase activity in HIV-1 (Stevenson etal.,
1990, Sakai et al., 1993).
The reason for the dependence of viral gene expression on integration is unclear. On
balance it is accepted that retroviral replication is dependent on integration, and linearization,
within the host genome. This dependency on integration for gene expression is not due
solely to the topology of the genome as circularized DNA is transcribed as efficiently, if not
more so, than the linear form (Harland etal., 1983). Thus the failure of unintegrated retrovirus
genomes to replicate would appear to be a property of the genome, or the nucleoprotein
complex which forms on it. The role of viral integration in the lifecycle is also of importance
when it comes to analysing LTR function. Jeang et al. (1993) have reported that integrated
HIV LTRs show a distinct activity and Tat responsiveness when compared to unintegrated
genomes. One interesting result of these studies was that transient co-transfection assays
had suggested that exon 1 of Tat was as active as proteins containing both exons. Jeang etal.
have demonstrated that this effect was due to the non-integrated nature of the target vectors.
When integrated LTRs are studied the two exon form of Tat was up to 10 fold more active than
the single (1st) exon protein. This highlights possible complications, and the danger of over
interpretation, of model systems.
The provirus possesses an LTR, and hence promoter sequences, at both ends of the
genome. In the integrated HIV genome the 5' LTR directs initiation of transcription and
sequences in the 3' LTR control cleavage and polyadenylation. The basis for this promoter
selection is unclear as both LTRs share a common nucleotide sequence (Ju & Culllen 1985).
Studies on this asymmetry in HIV have shown that both LTRs are transcriptionally active and
Tat inducible. However, the 5' LTR drives a much higher level of transcription than the 3' LTR
(Klaver & Berkhout 1994). These studies showed that both LTRs are functioning suboptimally.
Transcription from the 5' LTR can be elevated by deletion of the 3' LTR and likewise deletion of
the 5' LTR activates the 3' LTR. The basis for this promoter suppression is unknown.
It appears that while HIV can infect and persist in unactivated T cells, activation of the
cells is required for integration and the triggering of efficient gene transcription (Stevenson
etal., 1990b). These resting cells were able to maintain extrachromosomal HIV genomes for 2
weeks In vitro. The maximum period that these unintegrated genomes can remain in resting
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cells has not been determined. Integration may thus represent a potential block in the normal
HIV lifecycle in vivo. Rather than integrating and becoming latent, the virus remains in a
unintegrated state, which may be blocked for transcription and replication, until cell activation.
This provides a novel mechanism to prevent premature gene expression which may reveal the
infected cell to immune surviellance. The relevance of these observations to MVV has yet to
be determined but they do provide a possible insight as to the sequence of early events in
lentiviral infection and their possible significance to the processess of viral replication and
latency.
Studies on cell lines non-productively infected with HIV have led to the proposition
that integration site selection may affect viral gene transcription and play a role in latency
(Winslow etal., 1993). These non-productively infected cell lines appear blocked at the early
non-productive stage of infection and multiply spliced RNAs (encoding Tat, Rev and Nef)
predominate over singly or unspliced RNAs (Pomerantz etal., 1990). These cell lines can be
induced to produce virus following activation with phorbol esters or lipopolysaccharide. The
endogenous virus produced from these cells is infectious showing that the lack of efficient
replication is not due to a defective genome. The cell lines which show this blocking of
endogenous virus can support the replication of exogenous virus under the same conditions
where production of virions by the endogenous virus is blocked (Winslow etal., 1994). This
superinfection with a second HIV virus leads to production of virus derived from both the
exogenous and endogenous viruses. This activation of the endogenous virus is believed to
occur in trans via Rev produced from the exogenous virus. Winslow et at. concluded from
these observations that the integration site of the endogenous virus was preventing efficient
transcription and blocking the accumulation of Rev and other products of the multiply spliced
RNAs which control the switch to virus production. Thus the location of the integration site in
the host genome may affect the outcome of viral infection for a given cell.
The integration site within the host genome is selected in a non-random manner, with
structure of the host genome affecting integration apparently more than the presence of an
integration target sequence (reviewed by Craige 1992). Retroviral integration does not appear
to be sequence specific in vitro or in vivo. However, in vivo, integration of retroviruses appears
to be preferentially directed to sites where the chromatin is sensitive to nuclease digestion
(Shih etal., 1988). There is also other evidence that retroviruses integrate preferentially into
transcriptionally active regions of the host genome. Hwang & Gilboa (1985) compared the
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efficiency of transfection and retroviruses for the transfer, and expression, of a foreign gene in
tissue culture cells. The retroviral transfer gave levels of transcripts 10-50 fold higher than the
levels acheived with calcium phosphate transfection. These workers concluded that their
results were consistent with an elevated integration of the retroviral vector, when compared to
the transfected vector, into transcribed regions.
There is evidence that DNA bending results in the generation of favoured sites for
retrovirus integration (Pruss et al., 1994, Muller & Varmus 1994). One consequence of
nucleosome formation is DNA bending thus creating optimal sites for retrovirus integration. It is
important to note that this insertion is triggered by DNA bending itself and not the
DNA/nucleosome interaction (Muller & Varmus 1994). This and other and other evidence
(reviewed in Sandmeyer et al., 1990) suggests preferential integration into transcribed
regions of the host genome. This makes sense as the integration of the virus in regions where
transcription is inactive is likely to lead to silencing of the genome, due to chromatin
condensation, and failure of the virus to propagate itself.
These early steps in the retroviral lifecycle i.e. the generation of the DNA genome and
integration, are critical for later steps of the lifecycle. The failure to integrate or integration at a
heterochromatic locus will block all further stages of the lifecycle. However, it does appear that
lentiviruses may be able to take advantage of the transcriptionally silent state of unintegrated
genomes and use this as a mechanism for generating latent infection.
1.4.2 Viral Replication
After these early events in the infection process, reverse transcription generating the
dsDNA genome and integration, the process of viral replication follows distinct patterns in
vivo and in vitro. In vitro MVV infection of permissive cells, such as sheep choroid plexus,
gives rapid viral replication with a pronounced cytopathic effect (CPE) and the release of free
infectious virus into the culture medium. In vivo there appears to be a block to rapid replication
and this state has been referred to as restricted replication (Haase et al., 1977, Brahic et al.,
1981). The nature of this in vivo block of viral replication is poorly understood and it is unclear
what the relative contribution of viral and cellular products is in this process. Some form of




Through this thesis the concept of 'restricted replication' will be referred to on a
number of occasions. This concept is based on the idea that the viral genome can direct
expression of only the small spliced transcripts (Tat and Rev in MW) without the expression of
structural genes. Restricted replication is thus proposed as a possible mechanism of lentivirus
persistance where viral protein expression is kept below levels which the immune system can
detect (Haase etal., 1977, Haase etal., 1994). The ideas of 'restricted replication' and 'latency'
are therefore distinct. However, if a state of restricted replication does exist, it is possible that
the viral genome may move from a latent state to a restricted state and then either back to
latency or on to a fully activated state. The actual definition of restricted replication is unclear,
as the term is often used to cover any situation in vivo where the infected cell is expressing
the viral genome at levels below that seen in permissive infection in vitro (Geballe etal., 1985).
The most meaningful definition is probably that only those cells expressing the small spliced
transcripts (i.e. Tat & Rev) and no structural proteins are in a state of restricted replication. Any
cell producing detectable quantities of structural proteins can no longer be said to possess
the viral genome in a truly restricted state and is likely to be producing infectious virus. Such
cells are more likely to be subject to immune surwi. lance due to the expression of the viral
structural proteins as these appear to be the prime targets of the both the antibody and
cytotoxic T cell response in MVV and other lentiviral i -ection (Clerici et al., 1989, Schrier et
at., 1989, Knight etal., 1992, Nixon 1992, Blacklaws etal., 1994). It is probable that there will
be a population of T cells recognising the antigens derived from the small multiply spliced
RNAs in MVV infected animals but the prevelance of these cells remains to be determined. In
MVV there is some indirect evidence to support the idea of a small population of infected cells
being in a state of restricted replication; that is viral gene expression with no expression of
structural proteins (Brahic et al., 1981). However, when more sensitive PCR techniques are
used then it becomes clear that the major population of virally infected cells, in both MVV and
HIV, have viral genomes present in a truly latent state (Embretson et al., 1993, Haase et al.,
1994). One potential problem of the earlier combined in situ /immunocytochemistry studies is
that the sensitivity difference between the two techniques meant that many infected cells
producing viral RNA may in fact have been expressing viral structural protein.
Studies using lymphoid tissue from HIV infected individuals found that message for
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the gag structural gene was expressed throughout infection (Pantaleo etal., 1993). The
conclusion of these workers was that, although replication of the virus was site dependent,
with the lymphoid tissues showing higher replication than blood at all stages except late in
disease, throughout the latent period HIV infection is active and productive. This study did not
claim the absence of a restricted or latent state but rather during that period of infection termed
'latent' when there is no discernable disease lentiviral replication is proceeding at a steady and
detectable rate.
These various studies suggest that the majority of infected cells are not in a state of
restricted replication but rather, are tru ly latent with no detectable gene expression. There
may be a pool of cells in a 'restricted state' (Embretson etal., 1993). However, it is likely that
this represents a short transition phase between latency (or initial infection as there may be no
requirement for a latent phase in the viral lifecycle) and production of viral particles. Thus it may
be more accurate to refer to the situation where low level expression is observed as 'leaky' or
'incomplete' latency in a subpopulation of infected cells rather than as a distinct restricted
state. To be consistent with the literature the term 'restricted replication' will be used in this
thesis to refer to the state of vi replication where there is gene expression but at levels
below those seen in vitro; ie detectable viral RNA transcripts but no directly detectable viral
protein.
The possible trigger for initiating the transition from latency to active gene expression
is unknown. It is critical to elucidate the exact regulation of lentiviral gene expression during
infection as this will have an impact on possible theraputic stratagies. If the restricted state is
prevalent then vaccination against the products of the early spliced transcripts may allow
elimination of cells prior to the generation of infectious virus. On the other hand if there is a
rapid transition from a latent state, which cannot be controlled by the immune system, to active
replication and the release of infectious virus then it is possible that vaccination strategies will
not protect against infection. This second model sits well with the 'Trojan horse' mechanism for
lentivirus dissemination through the host (Peluso etal., 1985). Virus produced from an
infected cell infects surrounding cells which can then spread through the body, or be
transmitted to another host, while carrying the latent viral genome.
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1.4.4 Viral Transcription
While little is known about the lentiviral replicative process in vivo it has been
extensively studied in vitro. The dsDNA genome serves as the template for transcription of
viral genes and for the full length viral genomic RNA which will be packaged into virions at the
end of the lytic cycle. In vitro MVV infection leads to the formation of syncytia and cell lysis.
Viral transcripts are first detected six to eight hours post infection (Davis etal., 1987, Vigne et
at., 1987, Sargan & Bennet 1989). These three studies examining the temporal expression of
viral transcripts differ on the exact timing of the appearence of the various RNA species. They
do all, however, demonstrate a temporal regulation of spliced and unspliced viral RNAs. The
RNAs which accumulate up to 24 hours represent small multiply spliced transcripts which
contain sequences from both the 5' and 3' regions of the genome. After the accumulation of
these small RNA species, larger singly spliced and unspliced transcripts are generated. These
larger forms code for the structural Gag, Pol and Env proteins. The fully spliced, early
transcripts, are believed to encode the Tat (Gourdou etal., 1989) and Rev (Tiley etal., 1990)
proteins. These regulatory proteins are then capable of modulating viral and cellular gene
expression (Tat) and splicing of viral RNAs (Rev).
The lytic, in vitro, infection leads to a rapid accumulation of viral genomes within the
cell. Up to 4000 copies of the RNA genome have been reported (Brahic etal., 1977). At the
end of the lytic cycle the viral genomic RNA, polymerase and structural proteins are assembled
into virions. The particles form by budding from either the cell membrane or, in the case of
macrophages, into cytoplasmic vacuoles (Georgsson etal., 19$^).
A number of distinctions should be made between the viral replicative process in
vitro and in vivo. While virus replication is rapid in vitro, it is not usually possible to recover virus
directly from the tissues of infected animals. Infected cells can be identified either by growing
tissue explants in culture or by culturing the tissues with a permissive cell line. The
requirement for in vitro cultivation, which leads to cell activation, for the generation of virus is
consisitent with a block on viral replication in vivo. Neither of these cultivation techniques is
totally reliable, which highlights the rarity of permissively infected cells in vivo.
Studies to determine the degree of viral replication in vivo do differ in the number of
infected cells and proportion of these cells which express viral proteins. Examination of
choroid plexus cells of experimentally infected lambs (Haase et al., 1977) using in situ
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hybridisation detected viral DNA in 18% of ceils. Viral protein, as measured by p30 staining,
was only detectable in 0.1% of the ceils containing viral DNA. Consequent studies (Brahic et
at., 1981) reported only 1 to 3 % of choroid plexus cells to be infected. These infected cells
contained 60-70 copies of virai DNA , with viral RNA present at levels two orders of magnitude
below those found in vitro. Contrasting with these studies, experiments examining the degree
of alveolar macrophage infection in experimentally infected lambs (Gendelman et al., 1985)
showed 15% of these cells to contain greater than 1000 copies of viral RNA. These authors
estimated that only 1% of these cells were producing virus and so proposed a post
transcriptional block on viral replication. No experiments were performed to immunostain the
cells used for the in situ analysis to look at the expression of viral proteins. It is thus unclear
what relationship there was between the quantity of RNA expressed (which varied from 50 to
over 1000 copies per cell) and viral protein synthesis.
In the two studies referred to in the preceding paragraph a massive forced infection
was used; either to the brain or to the lung. Following this infection these workers studied only
the early stages of infection. This will lead to a number of discrepencies between the
observations made in these systems and what is seen in natural infection. What is striking is
that even with a forcing of the system viral replication appears to be limited and not all available
cells are productively infected.
In vivo restricted replication can be observed in monocytes taken from a variety of
anatomical locations. Monocytes obtained from blood, lateral ventricles (Peluso et al., 1985)
and bone marrow (Gendelman et al., 1985) show viral RNA expression. The observation of
infected cells within the bone marrow highlights a possible mechanism for viral persistance and
dissemination throughout the body without the need to generate a viremia. The bone marrow
cells which harboured viral RNA were not phenotyped so it is not known whether they were
mature, resident, monocyte/macrophages or monocyte precursors. Infection of precursors
would lead to all progeny monocytes carrying the MVV genome. Even if the infected cells
were not precursors but tissue macrophages then these cells would be in a position to infect
newly matured monocytes prior to their migration from the bone marrow and seeding to the
periphery. One explanation for the variation in detection of cells containing viral RNA and
proteins is the dependency of viral gene expression on monocyte maturation. This has been
shown in vitro where monocyte to macrophage differentiation leads to increased viral gene
expression (Gendelman etal., 1986). In vivo studies, using transgenes under the control of
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the MVV LTR, show that while expression is not limited to the monocyte/macrophage lineage
in these cells expression is dependent on differentiation into macrophages (Small etal., 1989
Clements etal., 1994). Thus alveolar macrophages, which are fully differentiated and are likely
to be activated, may be capable of supporting greater levels of viral replication than monocytes
and macrophages in other tissues. Monocytes and macrophages resident in other sites are
likely to be in a lower activation state, unless activated by changes in the cellular environment,
e.g. infection with a second virus or cellular activation by cytokines. This dependence on host
cell factors may explain the discrepancy between cells containing viral DNA and those
producing infectious virus.
1.5 Viral Regulatory Proteins
Three viral regulatory orfs are known to be expressed by MVV (Davis & Clements
1989, Audoly etal., 1992). Using the nomenclature for the HIV orfs these are known as Rev,
Vif and Tat. These proteins can be described as functional analogues of the HIV proteins
bearing the same names. The Rev and Vif proteins appear to function via similar pathways in
both HIV and MVV but the MVV Tat protein appears to functions by a distinct mechanism in the
two viruses.
1.5.1 Rev
The MVV Rev protein is translated from two exons within the env gene (Fig. 1.1). The
first exon is in the same reading frame as that which encodes the Env protein. This gives the
two proteins a common 48 amino acids at the amino terminus. The second exon of Rev is out
of frame with the env gene and encodes a unique 119 amino acids (Davis & Clements 1989).
Within the various MVV isolates sequenced to date the Rev protein is the least well conserved
with between 30 and 35% divergence between isolates (Sargan et al., 1991). As in HIV,
deletion of the Rev gene products gives rise to replication incompetent virus (Toohey & Haase
1994). The Rev proteins of HIV and MVV show little sequence homology. The only areas
where there is any conservation of amino acids are the basic and leucine rich domains of HIV
Rev (Tiley et al., 1991). These domains have, in HIV, been been shown to mediate RNA
binding and interaction with cellular factors respectively (Malim etal., 1989, Hope etal., 1990,
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Malim etal., 1991). There is evidence to suggest that these two domains are functioning in the
same way in the MVV protein (Tiley etal., 1991). In vitro analysis of MVV Rev function shows
that like the HIV protein it interacts with an RNA sequence present within the env gene. This
sequence is capable of forming a complex stem-loop structure (Tiley & Cullen 1992). Both the
Rev protein and the Rev Responsive Element (RRE) are required for the generation of
unspliced and singly spliced transcripts, and the expression of structural genes (Tiley et al.,
1990, Tiley & Cullen 1992).
While both HIV and MVV depend upon a Rev/RRE interaction to express structural
genes there is no cross recognition between the two systems (Tiley et al., 1990). This is in
contrast to what is observed with the HIV Rev and HTLV (Human T-Lymphotropic Virus) Rex
proteins. Like the lentiviruses, HTLV-I encodes a protein, Rex, which controls the splicing of
full length RNA and export of unspliced RNA from the nucleus (Hidaka etal., 1988). The Rex
protein is capable of replacing HIV-1 Rev in trans so rescueing Rev mutant viruses and allowing
the production of virions (Rimsky etal., 1988). While the MVV Rev protein will not act on the
HIV RRE if an MVV RRE is introduced into a Rev defective HIV genome then the expression
of MVV Rev will rescue the chimeric HIV virus. There is, however, complete or partial functional
reciprocity between the Rev proteins of the MVV strains EV-1 and 1514 and the Rev protein
of CAEV (Cork strain)(M. Fotheringham personal communication).
1.5.2 Vif
The vif orf, previously described as Q, encodes a 29kD protein of 230 amino acids.
This protein is expressed late in the lytic life cycle in tissue culture cells (Audoly et al., 1992).
The MVV Vif protein shows 80% homology between isolates (Querat et al., 1990, Sargan et
al., 1991). The HIV and MVV Vif proteins show no sequence homology but as in HIV deletion
of Vif results in the production of virions with a reduced infectivity (G. Querat personal
communication). HIV Vif has been described as a regulator of virion infectivity (Fisher et al.,
1987, Strebel etal., 1987). Mutation of vif gives rise to virions which are up to 1000 fold less
infectious than wild type virus. As there is no detectable Vif protein within the mature virion it
appears that it is involved in the assembly of virus; mutation of v/7appears to interfere with virus
assembly. These vif defective viruses can be complemented by the expression of vif in the
producer but not the target cell (Schwedler etal., 1993). These vif mutant viruses appeared
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defective in their ability to synthesise proviral DNA, even though they contained normal
amounts of reverse transcriptase and integrase activities. The MVV protein is similarity
distributed to HIV Vif; no detectable protein within the mature virus released from infected
ceils and a cytosolic localisation within infected cells. The MVV Vif protein is the least well
understood of the three orfs known to expressed in MVV.
1.5.3 Tat
Like Rev, the MVV Tat protein is expressed early in infection from a small multiply
spliced RNA. Unlike the Rev and Vif proteins there is experimental evidence to suggest that
the mechanism of transactivation is distinct to that seen with the HIV Tat protein. This is borne
out by evidence which suggests that for in vitro growth MVV does not require the Tat protein.
(A. Harmache personal communication).
In HIV the Tat protein acts primarily via the TAR (Tat Activated Region) which is present
within the R region of the LTR (Dayton etal., 1986, Fisher etai., 1986). The TAR sequence
forms a stable stem-loop structure following its transcription. This Tat/TAR interaction is an
absolute requirement HIV replication. The TAR region forms a hairpin structure which binds Tat
and a number of cellular factors (reviewed byAntoni etal., 1994). In MVV there is no evidence
of a sequence within the R/U5 region capable of forming an RNA hairpin structure (TAR) in any
of the isolates sequenced to date. Deletion analysis of the R region of the LTR (Hess et al.,
1989) identified no sequences in this region which were Tat responsive. Further the Tat
proteins of HIV and MVV show no extended homology and have distinct domain structures
(Carruth etal., 1994). The absence of a TAR region is not unique to MVV. Both FIV and CAEV
show no evidence of TAR regions (Olmstead et al., 1989b, Saltarelli etal., 1990). In the
absence of a Tat/TAR interaction the mode of MVV Tat action is unclear. There is no evidence
to support direct binding of the Tat protein to the viral LTR sequences (Gdovin et al., 1992,
Neuveut et al., 1993). Both of these studies did, however, report transactivation by the Tat
protein. The transactivation potential of the MVV Tat protein is much reduced when compared
to the HIV protein. MVV Tat can elevate LTR activity by between 5 and 30 fold; with the lowest
transactivation observed using monocyte/macrophage cell lines (Neuveut et al., 1993). The
transactivation appears to occur primarily at the transcriptional level but there is also some
evidence for a post transcriptional effect (Gdovin et al., 1992).
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One feature of the MVV LTR which distinguishes it from the HIV LTR is its high level of
activity in the absence of Tat (Twu et at., 1989). In comparison with the HIV U3 promoter the
MVV sequences show a much greater activity. This difference is probably not due to the MVV
LTR being a better initiator of pol II complexes. Rather it is probable that the complexes
generated are more processive and do not require stabilisation. The HIV LTR has been
described as an 'attenuated' promoter (reviewed by Jones & Peterlin 1994). The poor
transcription from the HIV LTR is demonstrated when exogenous Tat is introduced into cells
carrying endogenous Tat defective virus (Feinberg etal., 1991). Only very low levels of virus
could be detected from these cells in the absence of Tat. When exogenous Tat is introduced
production of virus increases >30,000 fold. This effect is mediated via an increased efficiency
of elongation of nascent transcripts, rather than effects on pol II initiation which is determined
by U3 promoter sequences. The RNA pol II complexes formed on the HIV LTR are poorly
processive and generate predominantly small RNA species that terminate shortly after
initiation (Laspia etal., 1989). The poor processivity of pol II complexes formed on the HIV LTR
appears to be the cause of this accumulation of short transcripts rather than termination sites
within the viral genome (Kessler & Mattews 1992). The Tat protein of HIV thus appears to be
acting on pol II complexes formed by the LTR promoter sequences to elevate their efficiency
or processivity of elongation. The sequence responsible for this targeting is the TAR
sequence in the nascent RNA. As stated before deletion of tat or TAR abolishes viral
replication. However, this action of Tat is not TAR dependent as deletion of the TAR in
conjunction with targeting of the Tat protein directly to the HIV LTR using chimeric DNA
binding constructs allows full Tat induction (Berkhout et at., 1990, Kamine et a/., 1991,
Southgate & Green 1991).
The HIV LTR can then be said to possess to distinct activities; a basal activity which
initiates poorly processive pol II complexes at a high rate and a second Tat dependent activity
which is required to generate fully processive complexes. The second, Tat dependent activity,
relieves the block on elongation and processivity and allows the generation of high levels of
full length transcripts. Both these activities, basal and Tat induced, are required for the viral
lifecycle to proceed. Deletion of elements required for the basal activity of the LTR also
prevents or attenuates viral replication (Leonard etal., 1989, Ross etal., 1991).
In MVV it appears that the LTR is capable of forming fully processive pol II complexes.
Thus, together with the apparent absence of a TAR region it would appear that the MVV Tat
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protein transactivates by a distinct mechanism to that seen with the HIV Tat protein. If MVV Tat
is not binding to the promoter directly, as observed with a number of viral transactivators, or to
an RNA TAR structure, how is it functioning? There are several examples of viral transactivators
which function via interactions with cellular proteins rather than directly with sequences in the
viral genome. Two of the better characterised examples are the HTLV Tax protein and the X
protein (pX) of Hepatitis B virus (HBV). Like the MVV Tat protein neither of these transactivitors
binds directly to the viral promoter or to any identified sequence in cellular genes. Thus they
may represent better model systems than HIV Tat for asking how MW Tat may be functioning.
The pX protein of HBV is capable of transactivating both viral and cellular genes (Twu
& Robinson 1989, Hu etal., 1990). Transactivation of MHC class I (Hu etal., 1990) and class II
(Zhou et al., 1990) genes is observed together with the B interferon promoter (Twu &
Schloemer 1987). Viral promoters transactivated include HIV-1, SV-40 enhancer but not the
MVV or HTLV-I LTRs (Twu & Robinson 1989). The pX protein has been shown to bind directly
the cellular bZIP transcription factors CREB and ATF-2. This interaction alters the sequence
recognition specificity of these factors, increasing their affinity for sequences within the HBV
enhancer (Maguire etal., 1991). The pX protein can also function through a number of other
cellular factors including NF-kB, by which it up regulates the HIV LTR (Siddiqui et al., 1989,
Twu etal., 1989), AP-1 and AP-2 (Seto etal., 1990). The pX protein cannot transactivate
through AP-3 or OCT recognition sites (Seto et al., 1990) demonstrating that while a broad
range of host factors are targets the effect is not general.
The HTLV Tax protein, although structurally distinct, targets similar cellular pathways.
The Tax protein will bind to CREB and the closely related CREM protein, via a conserved
amino acid motif adjacent to the DNA binding domain of these two proteins (Adya etal., 1994,
Suzuki etal., 1993). This interaction is apparently restricted to these two bZIP proteins as no
binding was observed to ATF-1 (Adya et al., 1994). Again this protein/protein interaction
modifies the DNA binding specificty of the transcription factors. The binding of the resultant
protein complex to the promoter also serves to target the transcription activation domain of the
Tax protein to the assembling pol II complex (Fujisawa et al., 1991). Where concentrations of
transcription factors are not limiting, Tax has been reported to enhance the dimerization of
many bZIP transcription factors in addition to CREB (Wagner & Green 1993). A second distinct
action of the Tax protein is to activate NF-kB by triggering its translocation to the nucleus
(Leung & Nabel 1988). This function is mediated by a domain distinct to that involved in the
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modulation of bZIP transcription factors (Smith & Greene 1990, Semmes & Jeang 1992). The
mechanism of Tax induction of NF-kB is still unclear but it appears to target IkB, which holds
NF-kB in the cytoplasm, rather than induction of the promoters of NF-kB subunits (Kanno et
at, 1994, Munoz et at., 1994). Tax can interact with the Rel homolgy domain of the NF-kB
proteins (Suzuki etal. 1994) although it is not known if this interaction alters the DNA binding
specificity of the NF-kB complexes.
These two proteins, pX and Tax, belong to viruses from separate families and show no
sequence homology. The pX protein does show homology with known serine protease
inhibitors (Takada & Koike 1990). This may be of functional significance as high expression of
the HIV LTR in cell lines (Fransozo et a!., 1994) has been shown to be dependent on the
absence of a monocyte restricted family of serine proteases which modulate NF-kB activity.
This highlights a possible mechanism for pX mediated elevation of NF-kB activities; pX may
block the proteolytic degradation of functional NF-kB molecules.
This outline of the properties of the viral transactivators pX and Tax shows how
different viral proteins can function by modifying the same cellular pathways at distinct points.
These two proteins also highlight the domain structure possessed by a number of other viral
transactivators where distinct functions in the transactivation process are mediated
independently by separate domains. How does this relate to the MVV Tat protein? The exact
mode of MVV Tat action is still unknown. Studies on the LTR of the 1514 molecular clone
have, however, identified cis acting sequences within the LTR which are Tat responsive. This
region of the 1514 LTR contains both a degenerate AP-4 site and a consensus AP-1 site.
Transactivation can be mediated through either region but is optimal when both are present
(Gdovin etal., 1992, Neuveut etal., 1993). The Tat protein will also transactivate heterologous
promoters which bind AP-1 (Gdovin etal., 1992). Attempts to show direct, or indirect (via
cellular transcription factors), binding of Tat to the MVV LTR have failed (Neuveut etal., 1993).
It is still likely that the MVV Tat protein is functioning, at least in part, by being targeted to
promoters. Functional analysis of Tat/Gal4 fusion proteins, which allows Tat to be introduced to
a basal promoter via Gal 4 binding sites, revealed a potent transcription activation domain
which shows homology to other acidic activators (Carruth etal., 1994). The structure of the Tat
protein of MVV strain 1514 is shown in Fig.1.2. This domain structure is conserved between
all MVV isolates. Like other viral transactivators it possesses a number of distinct domains each




























































proposed as a means for the MVV Tat protein to target its activation domain to the promoter.
Although this sequence is not extensive enough to function as a full leucine zipper as found
in the bZIP transcription factors it could function to allow the Tat protein to hook itself onto bZIP
dimers such as AP-1 (which is composed of the Fos and Jun proteins). This type of loose
targeting interaction may explain the difficulty of demonstrating Tat interactions with
promoter/transcription factor complexes. Studies on the full length Tat protein (Carruth etal.,
1994) revealed the possibility of negative regulatory elements within the Tat protein itself.
These sequences would control the activation domain in the absence of the correct
protein/protein interactions. Interaction with leucine zipper containing transcription factors
(such as AP-1) may be required to generate the conformational changes required to 'unmask'
the activation domain. Although conjecture, this potential mode of action is analogous to that
seen in the Tax and pX transactivators. The observation that Tat can transactivate cellular
genes, including c-jun(Neuveut etal., 1993), suggests a general mode of action not primarily
targeted to the viral LTR. Any promoter containing binding sites for the factors with which Tat
interacts, or induces, will be a potential target for transactivation. In MVV where Tat trans-
activation of the LTR is poor this effect on cellular genes may in fact be the function of the Tat
protein. By maintaining the cell in an activated state the Tat protein can indirectly boost, and
maintain, viral transcription.
The cysteine rich domain of Tat may also play a role in the function of MVV Tat.
Peptides containing this domain are highly neurotoxic (Philippon etal., 1994, Hayman etal.,
1993) and appear to interfere with signal transduction processes in neurones. So in common
with other viral transactivators MVV Tat appears to posses several discrete functional domains
which may to some degree function independently even though present within the same
protein.
MVV is not the only lentivirus which shows a mechanism of Tat transactivation
apparently independent of a TAR region. FIV which appears more closely related to the
ruminant than primate Antiviruses (reviewed by Miyazawa et at., 1994a) also appears to
possess no TAR region and be only partially dependent on Tat (orf A) for viral replication. In all
three of these viruses (MVV, CAEV and FIV) the Tat protein appears to be only a marginal
transactivator of viral gene expression. In FIV, Tat deleted virus will grow in lymphoblastoid lines
(Miyazawa et al., 1993, Tomonaga etal., 1993). However, Tat deleted virus grows poorly in
primary feline T cell lines. The CAEV Tat protein has been reported as essential for in vitro
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replication of the virus (Saltarelli etal., 1993). Other workers have not been able to reproduce
this inhibition and have suggested that Tat is not required for in vitro virus growth (A. Harmache
personal communication). This, together with the prior discussion of the MVV protein, would
suggest that the FIV, CAEV and MVV Tat proteins may be more important for in vivo rather
than in vitro replication. The Tat proteins of these viruses may be involved in the modulation of
normal cellular processes so upregulating, or enhancing, viral gene expression.
1.6 Control of MVV Transcription
1.6.1 Structure and Functional Domains of the MVV LTR
Lentiviral transcription is controlled by two interacting components; basal transcription,
driven solely by the LTR sequences and Tat dependent transcription, which acts on the basal
component to transactivate transcription. As discussed in Section 1.5.3 the basal component
is unable to drive HIV-1 replication which is Tat dependent. In the non-primate lentiviruses
MVV, CAEV and FIV there is experimental evidence to support the proposition that the basal
component is competent to support viral replication in certain cell systems in vitro (A.
Harmache personnal communication, Miyazawa etal., 1993, Tomonaga etal., 1993). This
would suggest that these three viruses, unlike HIV, do not possess 'attenuated' promoters in
the LTR which require the action of Tat to produce fully processive pol II complexes. In
comparison with HIV there is still relatively little known about the regulatory sequences of the
MVV LTR and the role of these various motifs in viral replication. In Fig.1.3 a schematic outline
of the U3 promoter region of the MVV LTR is shown. All studies to date on the regulation of
MVV transcription have been performed on the 1514 LTR. The other isolates have a similar
but divergent structure and sequence (Chapter 3). A number of potential AP-1 sites have
been proposed in the LTR. Of these only the TATA box proximal sequence matches the
consensus sequence for an AP-1 site (Hess etal., 1989, Faisst & Meyer 1992).
The LTR sequence shows strong promoter activity and position independent
enhancer activity (Hess etal., 1985). The 1514 LTR appears capable of driving a limited cell
type specific expression of a reporter gene in transgenic animals (Small etal., 1989, Clements
et al., 1994). In transgenic mice expressing the chloramphenicol acetyl transferase gene
under the control of the LTR, expression is restricted to activated macrophages, lymphocytes,
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FIGURE 1.3
Potential regulatory sequences within the 1514 LTR are shown. The positions of the various






















neurones and other cells in the CNS (Small etal., 1989). Cellular activation appears to be a key
trigger for the activation of transcription of the MVV LTR. Activation, in vitro, of monocytes or
macrophages from these mice resulted in a further increase in transgene expression.
Transgenic sheep expressing the MVV env gene under the control of the LTR only show
expression of the Env protein in activated macrophages (Clements et al., 1994). However,
expression of the transgene in vivo has not yet been extensively studied in this system. They
have shown that while in vivo there is no evidence for Env expression in fibroblasts, upon in
vitro culture Env is expressed and syncitia form. This in vitro passage is likely to result in cellular
activation, which would appear to be required for MVV LTR activity.
These data do not suggest that the LTR is responsible for the in vivo tissue tropism of
the virus as expression, following activation, can be demonstarted in a variety of cell types.
Rather, it appears that in vivo LTR activation may be favoured in activated macrophages due to
the set of transcription factors produced as these cells differentiate and become activated. As
in HIV it is likely that tissue tropism is determined by a stage prior to provirus formation
(Schuitemaker etal., 1993).
Transcription from the MVV LTR may be activated by serum or phorbol ester
(Clements et al., 1992). This activity has been mapped using deletion mutants of the 1514
LTR (Hess etal., 1989, Clements etal., 1992). Figure 1.4 shows an outline of the functional
significance of various LTR sequences, as determined by deletion analysis (Hess etal., 1989),
and their effect on basal LTR activity. These studies identified several upstream regions which
appeared to contribute to the LTR's activity. At the 3' end of the U3 region a negative
regulatory element (NRE) was identified. Removal of this sequence resulted in an elevation of
LTR activity. Deletion of sequences around the start of the first 43bp repeat resulted in a drop
in activity suggesting the interaction of a positive regulatory factor with this site. Further
deletions towards the TATA box resulted in a steady decline in activity with deletion of the AP-
4 and TATA box proximal AP-1 site leaving an activity only just above background (Hess etal.,
1989).
As well as examining the contribution of sequences to LTR activity these workers also
tested the constructs for their response to induction via phorbol ester. These results are
summarised in Fig.1.5. The deletions were observed to have distinct effects on LTR
induction. Removal of the NRE resulted in an enhanced response to stimulation. Deletion of
the sequence near the 43bp repeat resulted in only a partial loss of the inducible response.
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FIGURE 1.4
The effects on LTR activity, as measure by CAT assay, of 5' deletions are shown (from Hess et
a/., 1989, Clements etal., 1994). The deletions from the 5' end are indicated below an outline

























The inducible response of the 5' deletions is illustrated (Hess et al., 1989, Clements et al.,

























Induction appeared to be highly dependent on the AP-4 and TATA box proximal AP-1 site;
removal of these sequences blocked induction. When the effect of these sequences in the
context of the whole LTR was examined by linker scanner mutants this effect was confirmed
(Hess et al., 1989). These studies highlighted the interaction of various elements within the
LTR and their apparently distinct functional roles.
Studies on the interaction of the cellular factors with the LTR revealed three protected
regions (Gabuzda etal., 1989). This data is shown in Fig.1.6. Of these footprints only one
overlies the consensus sequence for a known transcription factor; the TATA box proximal
consensus AP-1 site. Further studies on this sequence (Shih etal., 1992) have demonstrated
binding of a Fos and Jun containing complex (AP-1) to this sequence using extracts from the
human U937 monocytic cell line. The footprint over this consensus site was observed to be
phorbol ester inducible (Gabuzda et al., 1989). No footprints were observed over the other
AP-1 sites. This may reflect their non-consensus nature (Chapters 3 & 4).
The nature of the factors binding to the other two sequences were not elucidated.
The footprint over the coding strand from positions -87 to -81 appears homologous to a region
footprinted in the HIV-1 LTR (Garcia etal., 1987) and the HTLV-I LTR (Nyborg etal., 1988) but
the nature of this factor remains to be elucidated. Its presence in a number of lentiviral LTRs
suggests that it may be playing an important role in the transcription processes of these
viruses. The footprint over the -108 to -90 region appears to play an important role in the
activity of the LTR. Deletion of this region results in a sharp drop in LTR activity (Hess et al.,
1989, Clements etal., 1992, Fig.1.4.).
Studies on the regulation of MVV transcription have to date been limited to the 1514
virus. While all MVV strains share a common LTR structure, sequence variation between
strains could potentially affect the binding of cellular factors and thus the activity of the LTR.
This variation and its possible significance of this variation will be discussed in Section 1.6.3.
1.6.2 The AP-1 Complex
The transcription factor AP-1 is a dimer composed of members of the Fos and Jun
families of proteins (Johnson & McKnight 1989). The genes which compose these protein
families are called immediate early; cellular activation triggers their rapid upregulation. Although

















































































































































been identified c-Jun, JunB and JunD (Ryder etal., 1988, Ryseck etal., 1988, Ryder etal.,
1989). These three proteins can form both homo and heterodimers (Schutte etal., 1989).
Dimerization is more efficient between the Fos and Jun families than within the Jun family. This
more efficient dimerization leads to a higher affinity for AP-1 sites (Halazonetis et al., 1988,
Nakabeppu et al., 1988, Jones 1990). The Fos family is composed of four characterised
proteins; Fos, FosB, Fos-related-antigen-1 (Fra-1) and Fra-2 (Cohen & Curran 1988, Foletta
etal., 1994). Unlike the Jun family, these proteins do not form homodimers and must interact
with a Jun family member in order to bind DNA. These proteins contain 3 main domains; a basic
region which interacts with DNA, a leucine zipper involved in dimerisation (Sassone-Corsi et
al., 1988) and an acidic activation domain. At the transcriptional level these proteins are
regulated according to cell lineage (Wilkinson etal., 1989, Hilberg etal., 1993, Foletta etal.,
1994), activation signals (Ryder & Nathans 1988, Saffen et al., 1988, Redner et al., 1992,
Muegge etal., 1993, Yoshida etal., 1993), differentiation state (Matsui etal., 1990, Hilberg et
al., 1993, Agamennon etal., 1994) and cell cycle (Ryseck et al., 1988,Kovary & Bravo 1991).
In addition to this transcriptional regulation the protein products show distinct stabilities within
cells (Carillo et al., 1994, Gruda etal., 1994, Kovary & Bravo 1991)
AP-1 is activity is controlled by several distinct post-translational mechanisms. This
post translational regulation is demonstrated by the ability to induce AP-1 activity even in the
presence of protein synthesis inhibitors (Farina et al., 1993). Three distinct regulatory
mechanisms have been identified; phosphorylation, redox state and interaction with
regulatory proteins that block DNA binding activity. The involvement of a mechanism for
cytoplasmic retention of AP-1 was identified following the observation that nuclear transport of
Fos and Jun is not constitutive but requires continuing cell activation (Roux etal., 1990). Two
proteins have been identified which interact with AP-1. The IP-1 protein appears to interact
with Fos and Jun via their leucine zipper domains (Auwerx & Sassone-Corsi 1991). IP-1 is
inactivated by phosphorylation following Protein kinase A activation. Phosphorylation blocks
the IP-1/AP-1 interaction so generating active AP-1 complexes. The Jif-1 protein appears to
the homolog of an anti-oncogene, QM (Monteclaro & Vogt 1993). Unlike IP-1, Jif-1 does not
interact with the leucine zipper and appears solely to bind and inhibit the Jun proteins.
A second post-translation regulatory system involves phosphorylation of the Jun and
Fos proteins. The consequences of phosphorylation depend on which domain of the
proteins is phosphorylated (Karin & Smeal 1992). Phosphorylation of Jun within the C-terminal
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DNA binding domain leads to the repression of DNA binding activity (Boyle etat., 1991). In
contrast phosphorylation within the transactivation (N-terminal) domain has been proposed to
stimulate the activation capacity of AP-1 (Binetry etal., 1991, Pulverer etal., 1991, Bannister
et at., 1994). Regulation of JunB and JunD by phosphorylation of sites in the C-termini has
also been described (de Groot et at., 1992, Nikolahahi et at., 1993). The Fos protein is also
regulated by phosphorylation (Ofir et at., 1990). In this case phosphorylation is required for
Fos repression of the fos gene. Although the hypophosphorylated form cannot repress fos
transcription it can transactivate through a phorbol response element (AP-1 site).
Phosphorylation of Fra-1 and Fra-2 has also been reported (Gruda et at., 1994). For these
proteins in vitro phosphorylation by MAP kinases was shown to stimulate their DNA binding
activity. Both MAP kinases and Ha-Ras have been proposed as regulators of the Fos and Jun
family proteins (Gruda et at., 1994, Pulverer et al., 1991, Binetry et ai., 1991). The
phosphorylation of Jun also controls Fos stability (Papavassilou etal., 1992). In the absence of
Jun, or when bound to dephosphorylated Jun, the Fos protein was observed to be stabilised.
However, interaction with phosphorylated Jun led to the rapid degradation of Fos.
Phosphorylation of Jun and Fos appears to be dependent on the composition of the AP-1
dimer and on whether or not it is bound to DNA (Abate etal., 1993). AP-1 is not unique in that
phosphorylation affects its DNA binding activity. CREB, a bZIP transcription factor from the
ATF-CREB family, is also modulated by phosphorylation (Nicols et al., 1992). In this case
aphosphorylated CREB can only bind symmetrical CRE sites (high affinity) but not asymmetric
(low affinity) sites. In contrast, the phosphorylated form is capable of binding both sites
efficiently. Phosphorylation is thus a common mechanism for the regulation of transcription
factor activity.
The final mechanism identified for the regulation of AP-1 is the redox state of the Jun
and Fos proteins (Abate etal., 1990). Reduction of a cysteine residue in the DNA binding
domains of Fos and Jun by a cellular protein results in an enhanced DNA binding activity
(Abate et al., 1990, Xanthoudakis et al., 1992). The context of this cysteine residue also
appears to be important in the redox regulation of Fos and Jun (Ng etal., 1993). The relative
contribution of these three regulatory pathways and their interaction in given cell types has yet
to be determined.
Dimerisation occurs via the Leucine zipper domain, which is shared by two other
transcription factor families; ATF-CREB and C/EBP. The shared domain allows dimerisation
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between some of the proteins within these families (Ivashkiv efa/.,1990, Hai & Curran 1991).
The mechanism governing the dimerisation between families as well as within families is still
poorly understood. Dimerisation between factors in the same, or different families appears to
affect transcription in two ways; alteration of binding site selection and effects on
transactivation. These effects can range from potentiation to inhibition of transactivation
(Diamond etal., 1990, Ivashkiv etal., 1990, Ryseck & Bravo 1991, Suzuki etal., 1991, Hsu
etal., 1994). The preferential recognition of half sites by the dimer components has not been
studied in AP-1 but within the NF-kB family, which like AP-1 is composed of dimers, there is
evidence that different members of the family have distinct half site preferences (Urban etal.,
1991). This means that the binding site will select which dimers in the population bind the site
and also the complex will take on a specific orientation depending on the orientation of the site
within the promoter. This orientation effect has been described in the HIV-1 LTR where NF-
kB/Sp1 synergism is dependent on the orientation of the NF-kB sites (Perkins etal., 1993).
The AP-1 complex preferentially recognises the sequence TGA >C A^ (Fa'ss^ &
Meyer 1992). This consensus sequence for AP-1 binding represents an approximation to an
ideal AP-1 site and its presence is not an absolute requirement for AP-1 binding (Mermod et
al., 1988, van Lint etai, 1991, Jain et at., 1992, Vallet & Osborne 1994). In addition to this
core recognition site both flanking sequence and dimer composition will affect the affinity of
any given AP-1 complex for any AP-1 site (Ryseck & Bravo 1991, Hadman et al., 1993).
Dimerization affects not only the affinity for DNA binding sites but also the consequences of
binding. Dimer composition affects the ability of AP-1 to activate transcription (Ivashkiv etal.,
1990, Suzuki et al., 1991) and the transforming/transcription activation activities of the Jun
protein (Schutte et al., 1988, Chiu et al., 1989). In combination with c-Jun, Fra-2 causes
suppression of transactivation caused by c-Jun alone, whereas JunD-Fra-2 complexes exhibit
higher transactivation activity than JunD homodimers. In addition to these transactivation
effects different dimers may cause distinct changes in DNA topology. Both Fos and Jun
proteins are capable of bending DNA (Kerppola & Curran 1991a/b). However, the
consequences for DNA topology vary on dimer composition; Jun-Fos and Jun-Jun dimers
bend DNA in opposite directions. These could have two consequences; the bending
induced by a given AP-1 dimer selects which further factors can interact with the DNA or vice-
versa the promoter topology only allows the interaction of certain AP-1 complexes.
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The role of an AP-1 site in the regulation of transcription can thus be seen to vary
according to a number of conditions; cell lineage, the type of stimulus and context of the
binding site within the promoter. Thus, the presence of a consensus site within a promoter
sequence makes no predictions on the role of that site in the regulation of transcription from
that promoter.
1.6.3 Other cis- regulatory elements
The sequences discussed in the previous section as being important for the
regulation of MVV transcription are all positioned in the U3 region of the LTR upstream of the
TATA box. It is possible that there are additional cis -acting regulatory sequences elsewhere in
the genome.
In HIV-1 DNase hypersensitive sites (which represent regions containing an 'open'
chromatin conformation, Section 1.7) are associated with both the LTR and the pol gene,
which contains a genomic enhancer (Verdin etal., 1990,Verdin et at., 1991, van Lint et al.,
1994). This enhancer can be subdivided into two distinct regions one of which contains 3
binding sites for the transcripton factor AP-1 (van Lint eta/., 1991) and a second element
which binds four distinct nuclear proteins (van Lint eta/., 1994). Both these elements are
induced by phorbol esters. The presence of these inducible enhancer elements in HIV-1 may
in part explain the observations that deletion of the NF-kB sites within the LTR do not block
viral replication (Ross eta/., 1991, Kim etal., 1993). While this may in part reflect redundancy in
the LTR itself it may be that deletion of the inducible elements of the LTR may be
compensated for by the inducible genomic enhancer. A further putative role for the enhancer
is in the suppression of transcription from the 3' LTR. If this element preferentially acts on the
5' LTR then it may help downregulate the 3' sequence (Klaver & Berkhout 1994).
In addition to these sequences within the pol gene HIV-1 also contains a number of
transcription factor binding sites downstream of the TATA box within the R/U5 region of the
LTR (Kharroubi & Verdin 1994). Some of these sites, including Sp1 sites, appear to be
constitutively occupied as observed by mapping of DNasel hypersensitive sites (Verdin
1991).The LTR also contains a number of positioned nucleosomes (Verdin etal., 1993) one of
which is positioned between the TATA box and these downstream elements. This
nucleosome prevents DNase cutting of this region of the LTR in unactivated cells (Verdin
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1991). However following activation of the cells and induction of transcription this site
becomes hypersensitive (Verdin 1991, Verdin eta/., 1993). The modification of this
nucleosome, which is positioned over the transcription initiation site, has been proposed as a
key step in the activation of transcription from the LTR (Verdin et at., 1993). The nucleosomes
positioned elsewhere in the LTR do not appear to undergo such a marked modification
following the activation of transcription.
In MVV the various sequences involved in the regulation of transcription have not yet
been fully characterised. Using HIV-1 as a model system then it appears possible that there will
be other regulatory sequences downstream of the TATA box, possibly including a genomic
enhancer.
1.6.4 Components of Basal Transcription
As discussed in Section 1.5.3 lentiviral transcription may be divided into basal and Tat
activated components. The basal component of MVV transcription is determined by the
interaction of proteins bound to the regulatory sequences within the U3 promoter and the
basal transcription machinery assembled on the TATA box. The MVV promoter has the
classical structure of a pol II promoter; containing a TATA box and putative upstream sites for
the binding of factors which can activate transcription. The TATA box (or core promoter
element) is the site where the basal transcription complex assembles, including pol II, and
determines the site of transcription initiation (reviewed in Buratowski 1994, Conway & Conway
1993). The upstream elements, plus any enhancers elsewhere in the genome of the virus
(Section 1.6.3), determine the rate at which RNA polymerase II initiates new rounds of
transcription. The transcription machinery can be divided into two classes of factors; general
and regulatory. The general factors are involved in the formation of the basal complex at the
TATA box and are assembled into the transcription complex in all or the majority of promoters.
The regulatory factors are those which control the rate of transcription from a promoter and
represent enhancer or promoter binding factors. The interaction of these to sets of factors is
crucial for the regulation of transcription. The activity of the enhancer/promoter element can
show dependence on the TATA box sequence (Wefald etal., 1990). That is the exact complex
of general factors is in part determined by the TATA box sequence and may be promoter
specific. This complex may then respond differently to distinct upstream enhancer/promoter
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elements, suggesting that the function of upstream regulatory elements can be determined
by the basal complex assembled on the TATA box. This interaction of the general and
regulatory components has also been shown in HIV where mutations to Sp1 sequences are
compensated for by second site revertants in the TATA box which enhance the binding of
TFIID and TFIIA (Kashanchi etal., 1994). This results in a rescuing of these replication
defective viruses via an augmentation of basal RNA synthesis. These TATA box mutations did
not generate a more processive elongation complex and remained Tat inducible. These two
examples illustrate the co-dependence of the basal/general transcription machinery and the
regulatory factors.
The formation of the basal complex involves the assembly of over 20 proteins
(Buratowski 1994, Conaway & Conaway 1993). The first step in this process is the binding
TFIID to the TATA box. TFIID is composed of a number of polypeptides including the TATA box
binding factor itself (TBP) and several other distinct associated proteins. A number of other
proteins, called TAFs (Tightly Associated Factors), are also known to associate with TFIID
(reviewed in Pugh & Tijan 1991, Gill & Tijan 1992). One important feature of TAFs is that while
they are not required for basal transcription they are required for mediating regulated
transcription.The factor TFIIA can interact with TFIID when bound to DNA (or in its absence)
and appears to stabilise the interaction of TFIID with DNA. Once bound to DNA TFIID then
recruits TFIIB (Hisatake etal.. 1993) which is capable of binding to pol II and other members of
the basal complex, including TFIIF. A number of other factors are then recruited into this
complex including TFIIH. Before transcription can procede fully the complex must be activated
by the hydrolysis of ATP. This hydrolysis of ATP appears to be required, not for the initiation of
transcription, but rather for the conversion of an initiation complex into an elongation complex
(Goodrich & Tijan 1994). This hydrolysis step is apparently mediated by TFIIH and TFIIE, with
TFIIH encoding the ATPase activity.
The rate of transcription is determined by the interaction of upstream factors with the
basal complex described above. This interaction is mediated, in part, by a set of factors
defined as co-activators (Berger et at., 1990, Pugh & Tjian 1990, reviewed Tjian & Maniatis
1994). It appears that these co-activators are in some cases the previously identified TAF
factors.
Although most activators of transcription characterised to date appear to interact with
positive regulatory components of the basal complex there is another potential point of action.
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One cellular protein, Dr1, has been identified as a negative regulator of the basal transcription
machinery (Inostroza et al., 1992). It appears that this factor blocks basal transcription via a
direct interaction with TBP in the TFIID complex. This inhibitory step appears to be one target
of the adenovirus transactivator E1A (Kraus etal., 1994). E1A appears capable of blocking the
association of Dr1 with TBP. This block is mediated by a Dr1 binding site in the N-terminus of
the E1A protein. Thus, the presence of E1A in a promoter complex could block a Dr1
mediated inactivation of transcription. Dr1 is not the only example of a cellular negative
regulator of basal transcription (Hahn 1993).
Activators of transcription have generally been described as targeting various
components of the basal complex, including both the TFIID and TFIIB components (Tijan &
Maniatis 1994). The regulatory factors which bind to promoter and enhancer elements contain
activation domains which fall into several catagories; acidic (Hope & Struhl 1986), glutamine
rich (Courey etal., 1989) and proline rich (Mermod etal., 1989). These activation domains
mediate the interaction of transcription factors with the basal transcription machinery following
their interaction with a promoter or enhancer. The interactions between transcription factors
and the basal transcription complex may be either direct or indirect. The cofactors, which
mediate indirect activation, were identified when it was shown that while purified TFIID could
drive basal transcription it was unresponsive to activation by upstream Sp1 sites. Activation
was seen when semi-purified TFIID was used in the same assays (Pugh & Tijan 1990, Smale
et al., 1990). Several TAF factors, or co-activators, have been described as interacting with
transcriptional activators. The protein TAFII110 has been shown to bind the glutamine rich
activation domains of Sp1 (Hoey et al., 1993) and a cell line with a temperature sensitive defect
in TAFII250 was shown to be defective in Sp1 and VP16 activated transcription, but not basal
transcription (Wang & Tijan 1994). Mutation in a region of the Sp1 activation domain, which
contains alternating glutamine and hydrophobic residues, results in a decreased affinity for
TAFII110 and a reduced ability of the protein to activate transcription (Gill et al., 1994). While
Sp1 has been shown to act primarily through theTFIID complex the viral transactivator VP16,
which is targeted to promoters via its interaction with the cellular transcription factor Oct-1
(Kristie et al., 1990), appears to interact with TFIID, TFIIB and TFIIH (Berger et al., 1990,
Goodrich et al., 1993, Greenblatt et al., 1994). Titration of the factor responsible for the
activated transcription mediated by VP16 demonstrated that this factor is only involved in
activated transcription and has no effect on the basal component (Berger et al., 1990). The
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protein TAFII40 binds both the acidic activation domain of VP16 and also the basal
transcription factor TFIIB, suggesting a mechanism for enhanced recruitment of the
transcription complex (Goodrich etal., 1993). VP16 appears able to bind directly to TFIIB and
enhance its a stable assembly into a pre-initiation complex (Lin & Green 1991). This binding of
VP16 to TFIIB has been proposed to induce a conformational change in TFIIB. This
conformational change enhances the binding of of TFIIB to other components of the basal
complex which are recruited via their interaction with TFIIB, including TFIIF and pol II (Roberts &
Green 1994).This interaction with TFIIB appears to be essential for the transcription activation
mediated by VP-16 (Roberts etal., 1993).
These two factors VP16, which contains an acidic activation domain (Hope & Struhl
1986), and Sp1, which contains a nonacidic glutamine rich activation domain (Courey et at.,
1989), appear to be activating transcription via two distinct, but overlapping, sets of co-
activators. It should be noted that activation domains of the same type (i.e. acidic) may act
through distinct sets of associated factors (Hahn 1993). This provides a model for how multiple
distinct elements within a promoter can act synergistically to activate transcription, though it is
still unclear how multiple sites for the same factor mediate this effect (Carey 1991,Tjian &
Maniatis 1994). It has been proposed that activation of transcription is not solely dependent
on the number of activation domains assembled on the promoter, but also the number of
occupied factor binding sites (Oliviero & Struhl 1991). This would suggest a direct role for the
DNA binding of transcription factors in the transcriptional activation process, perhaps by
altering the conformatioon of the DNA in the promoter region.
It appears that transcription activators function by stimulating the rate of initiation by
increasing the rate of assembly of the basal transcription complexes (Lin & Green 1991). It has
been proposed that in vivo the interaction of the TBP component of TFIIB with the TATA box
is a rate limiting step in transcription (Klein & Struhl 1994). These workers making use of TATA
box mutants with upstream activator binding sites, proposed that activators function in part
through alleviation of this block by enhancing the association of TFIID with the TATA box.
The MVV promoter (Section 1.6.1) contains a number of potential binding sites for
activators of transcription. The relative importance of all these sequences has yet to be fully
elucidated. In MVV this basal component appears to be highly efficient at driving transcription
when compared to the HIV LTR and other cellular and viral promoters (Twu etal. ,1989). The
data from transgenic animal experiments (Hess etal., 1989, Clements 1994) suggests that in
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vivo the block in transcription is mediated, at least in part, by cellular activation state. These
observations support in vitro studies on the induction of AP-1 binding to the consensus site
correlated with activation of the 1514 LTR (Gabuzda etal., 1989, Shih etal., 1992). Thus, MVV
transcription appears to be tightly controlled by cellular activation state. The transcription factor
AP-1 has been proposed as the major inducible regulator of MVV transcription (Clements et
a!., 1992).
1.6.5 Tat Activated Transcription
As was mentioned in Section 1.5.3 the principle Tat responsive elements within the
MVV viral genome appear to be sites where cellular transcription factors can bind the LTR
(Gdovin & Clements 1992, Neuveut etal., 1993). These studies identified the TATA box
proximal AP-1 site as the main target for transactivation, but also suggested a role for the
adjacent AP-4 site. It is still unclear how the MVV Tat protein mediates its transactivating effect,
as it has not been possible to demonstrate association of Tat with cellular transcription factors
(Neuveut et al., 1993, J. Clements pers. comm.).
Studies on the transactivating potential of the MVV Tat protein consistently show only
low levels of induction. This, together with the data of some workers showing Tat to be
dispensable for in vitro replication, has led to the suggestion that the function of the MVV Tat
protein is tightly regulated and that its main target may not be the viral LTR itself but rather the
cellular genes for transcription factors which are involved in the control of transcription from the
LTR, such as c-fos and c-jun (Neuveut etal., 1993, Carruth etal., 1994). The exact role of Tat
in the transactivation of cellular genes remains unclear since some workers have shown
induction of both c-fos and c-jun (J. Clemence personnal communication), while others have
only observed induction of c-yunwith no effect on c-fos(Neuveut etal., 1993).
The work of Carruth et al. (1994) which mapped activation domains on Tat using
Gal4/Tat fusion proteins which could be directly targeted to a test promoter revealed the
acidic/hydrophobic region to be a potent activator of transcription (Fig.1.2.). In addition to the
identification of this activation domain two regions were identified which possessed a potential
negative regulatory function. One contained in amino acids 1-13, the other upstream of amino
acid 38, potentially in the leucine rich domain. These workers proposed a mechanism for Tat
action in which the free Tat protein has a minimal transactivating activity due to the action of the
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negative regulatory elements. Following interaction with a cellular factor, perhaps Fos or Jun
via the leucine rich domain, the activation domain is unmasked and the Tat protein
transactivates the promoter it is targeted to via the cellular factor. These workers also used
VP16 and HIV-1 Tat in competition experiments to 'squelch' MVV Tat transactivation.
Overexpression of either of these two proteins interfered with MVV Tat transactivation
suggesting that these three transactivators interact with an overlapping set of co-activator, or
TAF, proteins (Section 1.6.2). The action of HIV Tat suggests that a post initiation activation
may function in some cases to enhance elongation. HIV Tat has been shown to interact with
the TFIID component of the basal complex (Kaschanchi et al., 1994). This interaction would
explain TAR independent activation of the HIV LTR by Tat (Harrich et a/.,1990), suggesting the
role of the TAR region may be primarily to target the Tat protein to the promoter and basal
transcription complex. Thus multiple elements in the promoter can co-operate to enhance the
rate of transcription.
The role of the MVV Tat in viral replication, in vitro and in vivo, remains unclear. The
cellular factors with which it interacts remain to be fully characterised as does the set of cellular
genes susceptible to transactivation and the significance of this process to viral replication and
disease pathology.
1.7 Promoter Architecture
A number of distinct geographical isolates of MVV have been identified and
sequenced (Section 1.2). The LTR sequences of these viruses shows variation both between
and within isolates (Chapter 3). Sequence variation can potentially result in the alteration of
transcription factor binding to the promoter due to the deletion of existing sites or creation of
new sites via base changes in the sequence.
As well as this direct effect, alterations in transcription factor sites, or their position
relative to other sites in the promoter, may have a more subtle effect on promoter activity. This
effect is believed to be due to the 'stereospecific' complex which assembles on the promoter
(reviewed in Tjian & Maniatis 1994). It would appear that in a number of promoter and enhancer
systems transcriptional control is not solely dependent on the transcription factors interacting
with the basal machinery but also the 3-dimensional organisation of these factors. The
formation of these stereospecific complexes depends on the looping and bending of DNA to
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allow the complex to form in the correct conformation. A number of transcription factors have
been demonstrated to mediate the bending of DNA. This bending of DNA may result in either
positive (Giese et at., 1992, Giese & Grosschell 1993) or negative (Natesan & Gilman 1993)
regulation of gene transcription.
DNA looping (reviewed in Schief 1992) has been proposed as the mechanism by
which distant regulatory elements (e.g. enhancers) can mediate their effect. In the case of the
TCRa gene the enhancer is located 4.5kb downstream of the most distal Ca exon (Ho etal.,
1989, Winoto & Baltimore 1989). This highlights the large distances over which these
elements can operate. Changes in DNA structure would allow direct contact of these distal
elements with basal transcription machinery assembled on the promoter. Protein induced
changes in DNA structure may thus result in stereospecific complex formation at enhancers
and promoters and also mediate the looping of DNA required to bring these elements
together. There is still little direct evidence to date to prove that DNA looping does indeed
bring promoter and enhancer elements into close proximity. Indirect evidence comes from
several sources including prokaryotic systems (Schief 1992) and the ability of certain
transcription factors, such as Sp1, to mediate DNA looping in vitro (Su et al., 1991). These
systems provide a mechanism by which distal elements can be brought together and the
interaction stabilised. Further circumstantial evidence for DNA looping comes from the
'transvection' phenomenon in Drosophila.
Transvection occurs between certain combinations of mutant alleles and shows
dependence on chromosome pairing or allele proximity (Judd 1988, Geyer etal., 1990). The
phenomenon involves the transaction of what are normally c/sacting regulatory sequences.
The trans action of the enhancer sequences, which allows them to drive the transcription of
the other allele is dependent on the on the cis promoter sequences of the enhancer being
inactive (Geyer et al., 1990). This would suggest that under normal conditions the cis
interaction is strongly favoured. Identification of the factors mediating the trans effect have
shown that sequence specific transcription factors are responsible for mediating the effect
(Biggin etal., 1988). The phenomenon of transvection would appear to require DNA looping
to allow regulatory elements on different chromosomes to interact.
The effect of transcription factors on local DNA structure is better understood. DNA
bending in vitro has been observed using a number of different transcription factors; including
YY1, LEF-1 and SRY (Giese et al., 1992, Natesan & Gilman 1993). These three sequence
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specific factors all recognise DNA via a high mobility group (HMG) domain. The bending of
DNA induced by the factors YY1 and LEF1 has been described as essential for the function of
the whole element in which they are present (Giese et at., 1992, Carlsson et al., 1993,
Natesan & Gilman 1993). In the TCRa enhancer the minimal element contains a binding site
for the LEF-1 transcription factor (Travis etal., 1991, Waterman etal., 1991) which is flanked by
a site for CREB family members (Winoto & Baltimore 1989, Ho & Leiden 1990a) and an Ets site
(Ho etal., 1990). The LEF-1 factor is only active in the context of both these other two sites.
Deletion of either non-LEF-1 site blocks enhancer function and sites for the LEF-1 factor
alone do not activate transcription (Waterman & Jones 1990, Travis etal., 1991, Carlsson et
al., 1993). This has led to the suggestion that HMG domain promoters are 'architectural' factors
(Giese etal., 1992, reviewed in Grosschedl etal., 1994). While this is probably true in part, it is
probably an over simplification. In addition to inducing DNA bending the LEF-1 factor also
possesses a potent activation domain which may also be required for its function (Giese &
Grosschedl 1993, Carlsson etal., 1993).
The factors YY1 and SRY also appear to be regulating transcription via alterations in
DNA architecture (Natesan & Gilman 1993, Cohen et al., 1994). In the c-fos promoter the
action of the YY1 factor is to repress transcription. This does not appear to be an intrinsic
activity of the YY1 factor but rather is an effect of its binding site positioning within the
promoter (Natesan & Gilman 1993). Alteration of the YY1 recognition by reversing its
orientation within the promoter results in enhanced transcription from the promoter. This
would suggest that in the normal context the factor is functioning to hold the promoter in a
conformation which represses transcription. A similar mode of action has been proposed for
the SRY factor in control of the c-fra-1 promoter (Cohen et at., 1994), with the difference that in
the normal promoter SRY activates c-fra-1 transcription.
A further example of the formation of stereospecific complex formation at a promoter is
provided by the IFN-B promoter. The viral specific induction of transcription depends on a
precisely assembled complex of transcription factors (Thanos & Maniatis 1992, Du etal., 1993,
Tjian & Maniatis 1994). This promoter contains regulatory elements which bind NF-kB, IRF-1
and ATF-2-c-Jun dimers (Du & Maniatis 1992). In addition to these factors there are 3 sites
which specifically interact with the HMGI(Y) protein. The HMGI(Y) protein does not contain an
HMG domain, but does contain a highly charged basic sequence which is required for its
interaction with AT rich duplex DNA. These HMGI(Y) sites are believed to play a structural role
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due to the ability of the protein to bend DNA. The interaction of HMGI(Y) with the promoter is
required for the binding of NF-kB to the promoter (Thanos & Maniatis 1992). HMGI(Y) interacts
with a site between the two halves of the NF-kB site. The induced bend allows the binding of
NF-kB. The two factors appear able to bind simultaneously to the site, apparently because the
HMGI(Y) protein is interacting through the minor groove. The interaction of HMGI(Y) with the
promoter is not solely to make available DNA binding sites for other factors. The protein also
appears to play a direct role in the protein-protein contacts taking place at the promoter even
though it does not possess an activation domain itself (Du etal., 1993). The bending of DNA
by transcription factors is a general phenomenon not restricted to a single family. It is also seen
with the 'forkhead' proteins and the AP-1 complex (Kerrpola & Curran 1991a/b, Pierrou etal.,
1994).
All the examples described so far relate primarily to protein induced alterations in DNA
conformation. The structure of DNA can also effect the interaction of proteins bound to a
promoter. In this case the spacing of elements can affect their interaction. This effect has been
demonstrated in a number of systems (Cohen & Meselson 1986, Khalili etal., 1986, Takahashi
etal., 1986, Comb etal., 1988, Ondek efa/,,1988, Schatz & Chatton 1990). Each turn of the
DNA helix requires 10.5bp. Inserts between elements that represent half turns of the helix
result in a reduction of transcriptional activity, presumably by blocking the protein-protein
interactions of DNA binding factors. In the Drosophila Hsp70 promoter a periodic effect is
seen for inserts up to 800bp (Cohen & Meselson 1986). Using the SV40 early promoter
enhancer a similar effect was observed, though, the periodicity was lost with inserts over
125bp (Schatz & Chatton 1990). The limiting of the periodic effect to inserts below a certain
length would suggest that when the spacing reaches a certain level the protein-protein
interactions involved in activating transcription can bend the DNA to allow stable interactions. It
is important to note that spacing may have effects beyond simply rotating previously adjacent
sites so blocking their interaction (Huang & Jeang 1993, Khalili et al., 1986). A more subtle
effect may also be at work. In the HIV-1 LTR an increase in the TATA box Sp-1 sites spacing of
between 18 to 101 nucleotides results in either a partially or wholly replication defective virus
(Huang & Jeang 1993). For short inserts between the TATA box and Sp1 sites (10-40bp) an
increase in basal transcription was observed. However, these inserts blocked Tat
transactivation so preventing viral replication. For longer inserts both basal and Tat activated
transcription were reduced. The effect of these insertions does not appear to be rotational but
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rather would seem to be preventing the normal interaction of Sp1 with the basal transcriptional
machinery in some other way.
The spacing effect has also been described in enhancer elements. In the SV-40
system the enhancer has two levels of organisation both of which show redundancy (Ondek
et al. 1988). Enhancers are made up of multiple binding sites for cellular factors. Groups of
these sites ('enhancons'), can be duplicated or interchanged to create new enhancer
elements. Even though the full enhancer element is position independent, the spacing of
enhancons within the enhancer is crucial for proper function. This spacing effect is also
observed in the HIV LTR where NF-kB and Sp1 interact to drive transcription (Perkins et al.,
1993). The activity of this enhancer is dependent on both site orientation and spacing. Any
increase in spacing between the sites reduces the enhancers activity. This effect does not
appear to be due to a steric effect caused by rotation of sites around the DNA helix but rather
these two factors, Sp1 and NF-kB, must interact directly to activate transcription. This
interaction is mediated by the DNA binding domains, or a closely positioned sequence, rather
than the activation domains of the proteins (Perkins et al., 1994). Thus, any increase in site
spacing will interfere with the protein/protein contacts which are required for enhancer
function. This also explains the orientation effect as NF-kB site recognition is determined by
the subunits of the dimer (Urban etai, 1991). Since the Spl/NF-xB interaction is dependent
on the NF-kB unit involved the orientation of the NF-kB site will determine which component is
positioned to interact with Sp-1. Co-operative interaction between NF-kB and Sp1 is also
dependent on which member of the Sp family is bound to the GC boxes (Sp1 sites) in the HIV-
1 LTR (Majello et al., 1994). Only Sp1 co-operates with NF-kB to activate gene expression;
neither Sp3 nor Sp4 is capable of co-operating with NF-kB. This interaction was mapped to
the A trans -acting (activation) domain of Sp1. These two studies (Majello et al., 1994, Perkins
et al., 1994) indicate the complex interactions, involving distinct protein domains, occuring
between transcription factors at a promoter.
The formation of a stereospecific complex would thus appear to depend on two
interacting components; the transcription factors bound to the DNA and the DNA structure of
the promoter itself which will affect what interactions are possible. Before going on to discuss
the evidence for promoter variation being significant in the control of gene transcription it is
important to mention one further factor which may effect gene transcription; chromatin
structure.
36
Within the nucleus DNA is complexed into a nucleoprotein structure known as
chromatin (reviewed in Paranjape et al. 1994). Chromatin consisits of roughly a 2:1 mass ratio
of protein to DNA and a 1:1 mass ratio of histones to DNA, the other protein components
include the HMG proteins. Within the nucleus the chromatin structure is dynamic and is
capable of moving between a number of states. As a generalisation chromatin can be divided
into two catagories: euchromatin and heterochromatin. Within euchromatic regions the DNA is
believed to be available for transcription; either constitutively or following the correct cellular
activation events. Heterochromatin is more tightly condensed than euchromatin and insertion
of euchromatic genes into heterochromatic regions results in their silencing. However, in
Drosophila a number of genes are known to be present within heterochromatic regions (Gatti
1992). These genes appear to be specificly transcribed late in the cell cycle suggesting that
their presence within heterochromatic regions may play a role in their regulation.
Following integration the retroviral genome is likely to behave in a manner similar to
any cellular euchromatic gene. As discussed in section 1.4.1 the integration machinery
appears to target the viral genome to regions of the cellular genome where transcription is
active. Within euchromatic regions the chromatin is present in a 'beads-on-a-string' structure.
This is the basic structure of chromatin, condensation of which leads to the compaction of the
DNA and the formation of heterochromatin. Each 'bead' represents a nucleosome which
contains DNA wound twice around the core histone octamer and an associated histone H1
which is not part of the core particle (Noll & Kornberg 1977). Following a short nuclease
digestion a 'ladder' of DNA fragments is produced containing DNA from different numbers of
nucleosomes. The typical length of DNA associated with each nucleosome is 180-21 Obp.
Following a more extended nuclease digestion a 146bp ladder is generated. This represents
the DNA which is associated with the core particle (Simpson 1978) and is the DNA bound to
the histone octamer. The core particle does not contain histone H1. Histone H1, or linker
histone, is thought to interact with the DNA between each core particle. Histone H1 is
believed to play a role in the compaction of DNA and repression of transcription (Nacheva et
al. 1989, Kamakaka & Thomas 1990, Bresnick et al. 1992) although its full role remains to be
defined.
In addition to their structural role in the organisation of chromatin, nucleosomes may
also have a more subtle role in the regulation of transcription. In a number of promoters it is
clear that nucleosomes are 'positioned' in vivo (Benezra et al. 1986, Thomas & Elgin 1988,
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Buckler et al. 1991, McPherson etal. 1993). The positioning effect is thought to be affected
by the DNA sequence at the promoter. In general the minor groove of A/T rich sequences
faces towards the histone octamer and the minor groove of G/C rich sequences away from the
octamer (Satchwell etal. 1986, Satchwell & Travers 1989). Alternating A/T rich, G/C rich
sequences result in a curved template which preferentially associates with the core histone
octamer in vitro. This positioning effect has lead to the suggestion that nucleosomes may
inhibit transcription by blocking the recognition sites for transcription factors (Archer et al.
1992). Alterations in chromatin structure at promoters can be seen by mapping DNase
hypersensitive sites (Mueller & Wold 1989, Pfeifer & Riggs 1991, Verdin 1991). This indicates
that remodeling of nucleosomes appears to accompany the activation of transcription. There is
evidence to support the idea that while remodeling occurs the promoter is not truly
nucleosome free. Thus nucleosomes at promoters are remodelled rather than fully displaced.
The resulting alterations may generate a looser association of the histones with the DNA
allowing fuller access for transcription factors. Chemical crosslinking studies using the
Drosophila hsp70 genes indicate that core histones remain associated with the promoter
following activation (Solomon etal. 1988, Nacheva etal. 1989). In the MMTV promoter it would
appear that the induced DNase hypersensitive site is histone H1 depleted but remains
associated with the core octamer (Bresnick et al. 1992). The maintenance of nucleosomes is
also seen in the albumin enhancer (McPherson etal. 1993). This enhancer contains an array
of precisely positioned transcription factors and nucleosomes. In vitro studies with artificially
positioned nucleosomes have suggested that under low ionic strength conditions histone H1
reduces the mobility of nucleosome cores (Penning et al., 1994). This suggests that the
depletion of H1 at promoters is required to allow nucleosome remodeling, although whether
this is cause or effect is unclear. The association of Histone H1 with the nucleosome core may
have a differential effecton transcription factors. The basis of this interference remains to be
determined (Juan et al., 1994)
Nucleosome positioning can also affect the affinity of a transcription factor for its
binding site (Li & Wrange 1993). Depending on the positioning of the nucleosome on the
DNA sequence the GR/GRE (Glucocorticoid Receptor/ Element) affinity is seen to vary. This
effect is not due to alterations in DNA sequence which affect positioning of the nucleosome
on the DNA sequence, but simply requires the DNA to be bound to the core octamer. A similar
effect is seen with Sp1 (Baiyong et al., 1994). Like the GR, Sp1 is capable of binding its
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recognition site even when it is bound to a histone octamer. The interaction of Sp1 with its
binding site is 10 fold lower when the site is associated with a nucleosome core but binding
does not result in a dissociation of the DNA-histone complex. Rather a ternary Sp1
nucleosome complex is formed. The interaction of Sp1 with a nucleosome associated site
appears to be mediated solely via the DNA binding domain and appears not to require Sp1-
histone interactions. These two examples, GR and Sp1, although carried out in in vitro
systems suggest that nucleosomes need not be displaced to allow interactions between
transcription factors and their recognition sites. Indeed in vivo studies on the albumin
enhancer (McPherson et at., 1993) suggest that such ternary complexes are also formed in
the natural context.
The examples illustrated above show that a simple model of nucleosome involvement
in transcription, where nucleosomes inhibit transcription by covering transcription factor sites,
is an over simplification. These positioning effects suggests that there may be a combined
interaction between transcription factors and positioned nucleosomes for enhancer and
promoter function (Li & Wrange 1993, McPherson etal., 1993, Lewin 1994). One effect which
could be mediated by core nucleosomes which remain bound to a promoter is on closely
positioned transcription factor sites. On a linear DNA molecule two closely positioned
transcription factor sites may interfere due to the inability of both factors to bind. However if the
same template is now bent, around a histone or via some other set of factors, both sites could
potentially become available. While the full role of nucleosomes in the transcription process
remains unclear it is possible that they may be mediating a number of distinct effects. One
promoter which appears to show this complex interaction between transcription factors and
nucleosomes is the HIV-1 LTR (Verdin etal., 1993).
This section has highlighted the importance of 'stereospecifc' complexes at promoter
elements. This appears to involve a number of interacting processess; histone positioning
and alteration of DNA conformation, alteration of histone DNA interactions by sequence
specific DNA binding factors and the role of non-histone DNA binding proteins such as
HMGI(Y). Promoters cannot then be thought of as a series of discrete independent domains.
Rather alteration of promoter structure due to changes in DNA sequence is likely to affect a
number of complex interactions.
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1.8 LTR Variation - Possible Effects on Viral Replication
The retroviral LTR contains the sequences which direct the transcription of viral genes
in the correct cellular environment. As these sequences play a pivotal role in the viral lifecycle
does variation in this region of the genome play a role in viral pathogenesis?
In the murine type C retroviruses LTR variation appears to play an important part in the
control of viral pathogenicity (Golemis eta/., 1990). In a number of these viruses pathogenic
phenotypes have been mapped to the enhancer/promoter element of the LTR. Simply
exchanging a promoter/enhancer element can convert a non-oncogenic virus into an
oncogenic form (Celander & Haseltine 1984). These two LTRs differ in their promoter activity
and the cellular factors which bind to them ( Boral etal., 1989). Similar observations have been
made in avian retroviruses where defects in endogenous viruses, which block expression,
map to the LTR (Cullen et at., 1983). Activiation of endogenous virus also appeared to be
associated, in some cases, with the aquisition, via recombination, of new LTR sequences from
exogenous virus (Tsichlis & Coffin 1979). This work on simple retroviruses would suggest that
variation in promoter/enhancer sequences can lead to alterations in virus pathogenicity. Given
the high rate of mutation in retroviruses (reviewed in Katz & Skalka 1990) there are likely to be
a large number of different virus quasispecies with differing transcription rates available for
selection in vivo.
The possible significance of promoter variation has also been studied in HIV-1.
Promoter variation may manifest itself in one of two ways. Firstly, a relative enhancement or
reduction of transcription when compared to other quasispecies within the infected individual
and secondly alterations in promoter sequence which result in an altered tissue tropism of the
virus; mutations which lead to the aquisition of sites which bind transcription factors specific to
a certain cell type. In HIV-1 it is possible to isolate viral strains with distinct cell tropisms; ie T-cell,
monocyte/macrophage, glial cell. Studies on the mechanism of this tropism have shown that
the product of the env gene, gp120, is responsible (Sattentau^etal., 1988, Cheng-Meyer et
ai, 1990, Shiola etal., 1991, Westervelt etal., 1992, Sharpless etal., 1992). Using
transfection of molecular clones for T-ceil or macrophage tropic cell lines Schuitemaker etal.
(1993) demonstrated that all these viruses could productively infect T-cells or monocyte-
derived-macrophages (MDMs). However, when infection was performed by cell free virus the
expected cell tropism was observed. These experiments would suggest that the LTR does
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not itself control cell tropism. There is, however, evidence to suggest that the viral LTR may
become cell type adapted after tropism has been determined (Corboy et al., 1992). These
workers generated transgenic mice carrying a reporter gene under the control of the HIV-1
LTR. The LTRs used came from molecular clones derived from either the CNS or T cells of an
AIDS patient. Only the two LTRs from CNS derived virus were able to direct expression of the
reporter gene in the CNS. The LTR derived from the T cell tropic virus showed no CNS
expression. This data would suggest that LTR adaptation to the cell type which the virus is
infecting may be occuring in HIV-1.
The second aspect of LTR promoter variation is the effect on transcription rate and
growth rate and the significance, if any, of this to the infectious process in vivo. One recurring
problem with this type of study is the source of material from which the LTR sequences are
derived. Viral stocks maintained in vitro by passage in cell lines, or PBMs, undergo selection
for this culture environment (Delassus et al., 1991, Delassus et al., 1992). These studies
suggest that sequence alterations occur even following the replication involved in explant
culture. Several studies have been performed to test whether the transcriptional activity of the
LTR, and Tat transactivation, are selected to favour higher or lower transcription rates in vivo.
Longitudinal studies using PCR amplified material derived from PBMs without in vitro culture
appear to show that while variation in the both rate of basal transcription and degree of Tat
transactivation does occur there appears to be no selection, as both high and low activity
quasi-species occur simultaneously and fluctuate apparently at random (Delassus etal., 1991,
Michael etal., 199^, Delassus etal., 199^1. Variations in the LTR promoter sequences include
duplication of transcription factor sites and also point mutations which affect the binding of
transcription factors (Michael etal., 1994). In the studies described above only transcription
rate and Tat transactivation was examined, not the rate of replication of the viruses carrying
these variable LTR sequences.
Two groups have suggested that growth differences between HIV-1 molecular clones
may be due to LTR sequence variation (Englund etal., 1991, Koken et al., 1992). In both
these cases the molecular clones where derived from viral isolates using explant culture, so
the degree of in vitro selection had been kept to a minimum. Koken etal. (1992) reported a 5-
10% growth increase apparently due to the insertion of an additional Sp1 site. Englund etal.
(1991) examined 3 molecular clones derived form the same individual. One of the viruses,
which carried a deletion of an NF-kB site showed a lower transcription rate and a reduction in
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viral replication and cytopathic effect. In SIV comparison of viral strains which induce acute and
non-acute disease has identified a duplication within the LTR which inserts an extra NF-kB site
(Dollard etal., 1994). This duplication elevates LTR activity and increases the sensitivity of the
LTR to cell activation. These workers generated virus which was isogenic for all regions other
than the LTR and tested for any growth differences. From this experiment it was seen that the
virus with the LTR derived from the 'acute' virus showed enhanced growth kinetics. It remains
to be fully demonstrated that these LTR differences do indeed account for the differences in
growth rates and pathology of these two viral strains.
The conclusion from the various studies outlined above is that there does not appear
to be selection of viral promoters with a specific activity during infection. Even during the late
stage of disease and progression to AIDS there does not appear to be selection of higher
transcription rates (Delassus et at., 1992, Nagushummugan etal., 1992) although faster
replicating viral forms are present at the end stages of disease. Despite this it appears that in
vivo a large number of viral quasispecies with different transcription rates are tolerated. One
aspect of viral replication which may be most dramatically affected by transcription rate is the
conversion from early to late gene expression. In HIV this transition is under the control of the
Tat and Rev proteins. Elevation of transcription via Tat leads to a positive feedback on the
production of the small spliced RNAs. The accumulation of the products of these RNAs, most
importantly Rev, alters the splicing pattern and switches on the expression of the structural
genes. Following integration of the provirus the transition from a silent, latent state, to the
production of the early proteins will be under the sole control of the LTR sequences. Once the
threshold level of Tat is reached then it may transactivate viral and cellular genes. However, the
absolute rate of transcription from the LTR will limit the accumulation of Tat and Rev; the weaker
the promoter the longer it will take for these proteins to accumulate to the critical levels to
trigger expression of the structural genes. It is possible that only this early stage of the viral
lifecycle could be limited by the LTR transcription rate and that the later stages of infection are
limited at other steps. While the transactivating proteins of MVV and HIV appear to be
functioning by distinct pathways the viruses pass through similar steps in the infected cell.
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1.9 AIMS
The general aim of this work was to attempt to gather more information on the
regulation of MVV transcription. To date all the studies examining the control of transcription in
MVV have focused on the 1514 virus. The initial approach which was selected was to make
use of a transfection assay to determine the activity of various LTR forms. During the
sequencing of the British MVV isolate, EV-1, differences in both LTR sequence and LTR
organisation were observed between the two viruses EV-1 and 1514. Further, within the EV-1
population a number of LTR variants were observed. The activity of these sequences was
examined in order to determine the possible role of variation in the LTR activity within the viral
population. Comparison of the LTR sequences derived from the experimentally infected
animals with those present within the infecting population would allow conclusions to be
drawn on the degree of LTR selection in vivo. As the EV-1 variants included LTRs bearing
duplications of various regions of the LTR it was also of interest to use these sequences to





Unless otherwise stated, the chemicals used for this thesis were obtained from Sigma
Chemical Co., Poole, Dorset, UK. Restriction endonucleases and other DNA modifying
enzymes, were purchased from Northumberland Biologicals Ltd., Cramlington, U.K., New
England Biolabs., Hitchin, UK, Boehringer Mannheim, BCL, Lewes, UK, or Promega,
Southampton U.K., unless stated otherwise. Radiochemicals were supplied by Amersham
International PLC, Amersham, UK.
2.2 Bacterial Cultures
2.2.1 Bacterial Growth Media and Plates
The bacterial growth media used throughout this thesis was Luria Bertani (LB) broth.
This media was supplemented with ampicillin (100pg/ml) for the selection of transformed cells,
only plasmid vectors encoding the ampicillin resistance gene were used in these studies.
LB/agar plates were made with LB/1% (w/v) agar (Oxoid, Basingstoke, England), LBamp
plates were supplemented with 100pg/ml ampicillin.
Blue/white selection using the plasmid pCRII from the TA cloning kit (Invitrogen Corp.,
San Diego, California) was performed on LBamp plates with 200pg/ml 5-bromo-4-chloro-3-
indolyl-B-D-galactoside (X-gal). This vector was transformed into the supplied INVaF
competent E.coli which do not require IPTG (Isopropyl-B-D-Thiogalactoside) to induce the
expression of B-gal.
2.2.2 Bacterial Strains, Stocks and Culture
For general subcloning, E.coli strain JM101 ([F' traD36 lacl^ lacz M15] proAB supEthi
lac-proAB, Yannish-Perron et al 1985) was used for transformations. For vectors used in
transfection experiments, plasmids were transformed into competent DH5a cells (Gibco BRL,
Paisley, Scotland). Untransformed JM101 cells were cultured in LB and LBamp after
transformation. For long term storage bacterial stocks were kept at -70°C in 40%(v/v) glycerol.
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2.2.3 Preparation and Transformation of Competent Bacteria
One ml of a saturated overnight culture was added to 40ml LB and grown until OD60o
was between .35 and .40. For each transformation, 1.4ml of cells were spun down and
resuspended in 0.5ml MR (10mM MOPS pH7.0, 1mMRbCI2, 38mMCaCI2). The cells were
spun down again, resuspended in 0.5ml MRC (100mM MOPS pH6.5, 1mMRbCI2,
38mMCaCI2) and left on ice for 30 minutes. After this incubation, the cells were spun and
resuspended in 0.15ml MRC and 3pl of DMSO was added. DNA was then gently mixed in and
the cells were left on ice for 1 hr. The tubes were heat shocked for 35 seconds at 55°C, and
then returned to ice for 2 minutes. 1ml of LB was added to the cells and they were incubated
at 37°C for 1 hr and then plated on LBamp plates. The plates were checked 14-24hrs later for
transformed colonies. Manufacturers competent cells were used for a number of procedures
as described later in materials and methods.
2.3 Purification and Quantitation of Plasmid DNA
Small scale purification of plasmid DNA (minipreps) for screening transformed bacteria
for the correct plasmid DNA was performed using an alkali lysis procedure (Birnboim & Doly
1979). 1.5ml of a 10ml overnight culture of E.coli was pelleted in a microfuge. The bacterial
pellet was resuspended in Lysis buffer (25mM Tris pH8, 10mM EDTA, 50mM sucrose, 1mg/ml
lysozyme). Two volumes of alkaline SDS (0.2N NaOH, 1% SDS) were added and mixed gently
to avoid frothing until the solution was viscous. After the addition of 1.5 volumes of 3M NaAc
(pH4.8) and the chromosomal DNA, SDS/protein precipitate and high molecular weight RNA
was spun out by centrifugation at 12,000xg for 20 minutes in a benchtop microfuge. Nucleic
acid in the supernatant was precipitated by addition of 0.6 volumes isopropanol. Precipitated
DNA was collected by spinning at 12,000g for 15 minutes and resuspended in water or TE.
The DNA was extracted with phenol:chloroform:isoamyl alcohol (P:C:1,49:49:2, pH7.5). After
the first extraction, the RNase A was added (final concentration 100pg/ml) and incubated at
37°C for 30 minutes. After digestion of RNA the sample was extracted twice with P:C:I and
once with Chloroform:Isoamyl Alcohol (49:1), the DNA was precipitated from the aqueous
phase. Plasmid DNAs for use in transfection experiments were prepared using Qiagen
Columns (Qiagen Ltd.) to ensure reproducibility and purity of plasmid preparations. For
transfection plasmid DNA with A 280:260 of >1.8 was used.
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The concentration of DNA in a sample was routinely determined by running a 10%
aliquot on a 0.8-1.2% agarose gel. Minipreps gave a yield of 5-1 Opg. For transfections, DNA
was also quantitated using a spectrophotometer. An absorbance at 260nm of 1.0 is
equivalent to 50gg/ml double stranded DNA. The OD260/280 ratio gives a measure of
sample purity, where a ratio of 1.8 is indicated a sample is free from protein or phenol
contamination (Sambrook et al 1989).
2.4 DNA Sequencing
Sequencing was carried out using the dideoxy chain termination method of Sanger et
al (1977). Double stranded DNA sequencing was performed after an alkali denaturation
protocol and using the Sequenase kit (USB Corporation). Plasmid DNA (1-5pg) in a volume of
20pl was denatured by the addition of 2pl denaturing mix (2M NaOH, 2mM EDTA). After 5
minutes at room temperature the solution was neutralised (6.2pl 3M NaAc pH5.2) and DNA
precipitated (7pl H20 and 75pl 100% EtOH). Pelleted DNA was washed with 70% EtOH and
resuspended in 7pl H20, 2pl 5x Sequenase buffer and 1pl sequencing primer (0.1 pmol).
Annealing was carried out by heating to 65°C for 2 minutes followed by cooling to about
35°C over 20-30 minutes. Full reaction volumes were collected by a brief spin. Sequencing
reactions were performed using a USB Sequenase kit as per manufacturer's instructions.
Briefly, 1pl 0.1M DTT, 2pl 1/5 Labelling mix, 0.5pl a^S-dATP and 2pl 1/8 sequenase were
added. The reaction was incubated at room temperature for 5 min. After extension, 3.5pl of
the reaction was added to each of four tubes containing 2.5pl of Termination mix (A,C,G,T)
and incubated at 37°C for 5 minutes. Reactions were terminated by the addition of 4pl of
Stop mix. When compressions were observed in the DNA sequence reactions were repeated
in the presence of 10% DMSO (labelling mix was diluted1/5 in 50% DMSO).
Biorad Sequi-Gen gel electrophoresis equipment was used for resolving the
products of the sequencing reactions. Sequencing gels were 0.5xTBE (1x 89mM Tris-
Borate, 89mM Boric Acid, 2mM EDTA), 6% Acrylamide (29:1 Acrylamide:Bis), 6M Urea. Gels
were pre-run until temperature reached 55°C. Sequencing samples were heated to 75°C for
2 min before running and loaded at 2pl per well. Gels were run for between 2 to 8 hours to
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resolve the products of the sequencing reactions. Prior to autoradiography, using X-OMAT
AR film, gels were dried down on Whatman no.3 paper.
Sequence data was analysed using version 7.3 of the University of Wisconsin
Genetics Computer group sequence analysis software, UWGCG 7.3 (Devereux et al 1984).
2.5 Restriction Digests
Restriction digests were performed in manufacturer's specified buffers. For double
digests the buffer giving maximum activity for both enzymes was selected from manufacturer's
tables. Generally 1-5gg of plasmid DNA was digested with 6-10 units of restriction enzyme for
2hrs at 37°C.
2.6 DNA Ligation
2.6.1 Preparation of Vector
Vector DNA for use in ligation reactions was linearised by digestion with the
appropriate restriction enzyme. In cases where a double digestion was performed single
enzyme controls were included. After linearization, vector DNA was treated with calf intestinal
phosphatase (CIP) to remove 5'Phosphate groups which greatly reduces the incidence of
vector self ligation (Maniatis). The DNA was incubated with CIP (-.01 unit per pg DNA) for 30
minutes at 37°C.
2.6.2 Preparation of Inserts
Insert DNA was excised from the relevant plasmid by digestion with restriction
enzymes and purified by separation through agarose gel. Two mechanisms of DNA
purification from gels were used. For fragments over 600bp a Geneclean II kit was used.
Where the band was below 600bp, the band containing the insert was excised from the gel
and spun through glass wool, at 6500rpm for 15 min in a microcentrifuge. The insert was then
precipitated and an aliquot used for quantification by electrophoresis.
When synthetic oligonucleotides were used as inserts they had first to be
phosphorylated. This was performed by incubating 100pmol of oligonucleotides with ATP
(1mM) and T4 polynucleotide kinase (10 units) for 10 minutes at 37°C. For ligation, 50-1 OOng
of dephosphorylated vector was used in the presence of a 10 fold molar excess of insert.
47
2.6.3 Ligation Reactions
Cohesive end ligations were carried out overnight at room temperature with a iigase
concentration of 3-5 weiss units and manufacturers buffer. Blunt end ligations were carried
out at 4cC overnight using a ligase concentration of 6-10 weiss units. In general, 50-1 OOng of
vector DNA was used for each ligation reaction with a three fold molar excess of insert. PCR
reaction products were cloned using a TA cloning vector, pCRII (Invitrogen corp.), as per
manufacturers instructions.
2.7 Agarose Gel Electrophoresis
Agarose gels of between 0.5 and 1.5% were used depending on the size of
fragments being separated. Standard low IEEO agarose was used for all separations. A 6x
loading buffer was used for all samples (0.25% bromophenol blue, 0.25% xylene cyanol and
15% Ficoll in H20). Gels were run in 1x TAE buffer (0.04M Tris-acetate, 1mM EDTA, pH7.6)
containing 0.5pg/ml EtBr at between 50 and 80 volts.
2.8 PCR
PCR reactions to amplify LTR sequences were carried out in 100pl volumes in 0.5ml
sterile eppendorf tubes. Reactions were performed in 1x PCR buffer (10mM Tris pH8.8,
1.5mM MgCI2, 3mM DTT, 50mM KCI, 17|ig/ml BSA, 1mM dNTPs) with ~50ng target DNA,
1 unit Thermus Aquaticus (Taq) polymerase and primers (25-50pmoles). Cycling was
performed using a Techne Programmable Driblock PHC-1. Amplification was performed over
35 cycles of the following conditions; 95°C/0.6 minutes, 54°C/0.5 minutes and 72°C/1
minute. This was followed by 7.5 minutes at 72°C to allow completion of partial extension
products. All primers were supplied by OSWEL DNA Sevices (Dept. of Chemistry, Kings
Buildings, West Mains road, Edinburgh). After amplification, 10% of the reaction product was
analysed on an agarose gel as described in section 2.6.
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2.9 Cloning into CAT Reporter Plasmids
2.9.1 CAT vectors
Two CAT reporter plasmids were used; pCAT12 (Thompson et at. 1994) which
contains no promoter sequences in front of the Tn9 CAT gene and A56(a generous gift from
Dr. J. Quinn) which contains 56 bases of the c-fos promoter. The vector pCATl2 was used to
assay activity of the LTR clones (Section2.9.2) these contained complete promoter
sequences, including a TATA box. The vector A56 was used to examine functional roles for
the various LTR oligos.
2.9.2 Cloning Full Length LTRs into pCAT 1 2
The following full length LTRs were cloned into pCAT12; EV-1 LTRs 1, 48, 44, 30, 28,
19, 18 and the 1514 LTR. EV-1 LTRs 30, 19, 18 and 28 were in the correct orientation for
direct cloning from pTZ18R by double digest with Sac1/BamH1. After removal from pTZ18R,
the LTRs were gel purified and ligated into pCAT12.
EV-1 LTRs 1,48 and 44 were in the wrong orientation for direct cloning so were
cloned by PCR using primers 974S and 975S. These primers were designed to match those
used in the original LTR cloning with the addition of restriction enzyme sites. There was no
existing 1514 LTR clone so a PCR was carried out using a HIRT preparation of 1514 infected
cells (provided by Dr. D. Roy) and primers 974S and B261. The primers used for cloning the
LTRs are shown in Fig.2.1.






Amplification products were cloned into pCRII (Invitrogen TA cloning kit) and
sequenced. The pCRII vector contains annealing sites for M13 sequencing primers. These
were used to confirm the sequence of the cloned DNA. After confirmation that the PCR
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cloned LTRs were of the correct sequence and the absence of errors introduced by PCR,
these inserts were cut out and inserted into pCAT12. The orientation of LTRs for all pCAT
vectors was confirmed using an internal primer 31OL.
2.9.2 Cloning of partial LTR sequences
Two EV-1 LTRs, LTR-1 and LTR-48, were used to generate truncated LTR CAT
vectors. PCR was performed using the full length LTR as target and primers 975S and 309X
(Fig.2.1). The amplified products were cloned into pCRII, sequenced, then transferred to
pCAT12.
2.9.3 Oligonucleotides and Cloning into A56
Double stranded oligos were cloned into the vector A56. Oligonucleotides were
inserted upstream of the c-fos TATA box sequence using a unique Sal I site in the vector. A list
of the oligonucleotides used in these experiments are outlined in Fig.2.2. All of these
oligonucleotides, with the exception of the 1514 AP-1 and EV-1 AP-1 sequences, have Sal I
compatible overhangs to facilitate cloning into A56.
Ligations were carried out using phosphorylated oligonucleotides (Section 2.5).
Transformed colonies were screened for insert by digestion with Sal I. Insertion of
oligonucleotide into the plasmid results in the loss of the Sal I site, allowing screening of
samples prior to sequencing. Cloning efficiency varied from 30-80%. All colonies where insert
was present were sequenced across the Sal I site. These vectors are shown in Fig.2.3.
2.10 Cell Lines and Tissue Culture
The primary chondrocyte cell line used in this thesis (supplied by Lawrence Dickson)
was derived from the carpal joint of a MVV negative sheep and grown in culture as fibroblast-
like monolayers. The cells were grown to pass 5 and then frozen to supply a bank of cells for
future experiments. For storage, the cells were frozen as 1ml aliquots in freezing mix (91%
serum 9% DMSO). The cells were slowly frozen to -70°C overnight then placed in liquid
nitrogen for long term storage. All experiments described in this thesis used these cells at
between passes 10 and 20. Cells were cultured in DMEM supplemented with 10% FCS,
penicillin (100 units/ml), streptomycin (100pg/ml) and L-glutamine (2mM). Cells were grown
until monolayers reached confluence then split at either 1:3 or 1:4. Cells were trypsinized with
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FIGURE 2.2 Synthetic oligonucleotides
Control AP-1 TTCCGGCTGACTCATCAAGCG (B260)
AAGGCCGACTGAGTAGTTCGC (B619)
1514 AP-1 TGCTTGAGTCATAACC (B533)
ACGAACTCAGTATTGG (B532)
EV-1 AP-1 TGCTTAAGTCATAACC (C146)
ACGAATTCAGTATTGG (C145)
1514 oligo TGATGCTTGAGTCATAACCGCA (B383)
ACTACGAACTCAGTATTGGCGT (B384)
EV-1 ex vivo TGATGCTTAAGTCATAACCGCA (B535)
ACTACGAATTCAGTATTGGCGT (B534)
EV-1 ex vitro TGATGCTTAAGTCATAACCACA (B245)
ACTACGAATTCAGTATTGGTGT (B244)
VSS oligo GAGTCATAACCGCA (C144)
CTCAGTATTGGCGA (C143)




The synthetic oligonucleotides used in this work are listed above. With the exception of
the 1514 and EV-1 AP-1 sequences all possess Sal 1 overhangs (TCGA) for cloning into the A56
vector. The oligonucleotides are identified by their Oswel codes. The positioning of these
sequences is discussed fully in Chapter 4.
FIGURE 2.3
The A56 vectors generated during this work are listed. The orientation is given relative to the
c-fos TATA box. Arrows denote orientation of oligonucleotides with relation to the basal
promoter. Each arrow represents a single copy of the oligonucleotide.
A56 VECTORS





































Trypsin/Versene (0.05% w/v trypsin: 0.02% w/v versene) after having first been washed with
0.02% versene to remove all culture media. For transfection, chondrocytes were split into
60mm dishes and grown to 80-90% confluence.
HeLa Ohio cells were obtained from the European Collection of Animal Cell Cultures
(ECACC, Porton Down, Salisbury). These cells were cultured in DMEM supplimented with 5%
FCS, penicillin (100 units/ml), streptomycin (100pg/ml) and L-glutamine (2mM). Cultures were
grown to confluence then split 1:10 as described above. Stocks of HeLa cells were frozen in
liquid nitrogen using the same protocol as described for the chondrocytes.
2.11 Transfection and Reporter Gene Analysis
2.11.1 Transfection
Transfection was performed using a calcium phosphate precipitation protocol.
Immediately prior to transfection, media were aspirated and replaced with fresh media
containing 5% FCS. Each 60mm dish (~3 x 10® cells) was treated with 0.5ml DNA/calcium
phosphate precipitate (5pg plasmid/plate). Each 1 ml of precipitate was composed of 500pl 2 x
DNA precipitation buffer (50mM Hepes pH7.05, 1.5mM Na2HP04, 10mM KCI, 280mM NaCI,
12mM Glucose), 62pl 2M CaCI2, 10-20pg DNA and dH20 to a final volume of 1ml. The DNA
and dH20 and CaCI2 were placed in a sterile tube and the 2x precipitation buffer was added
slowly with constant gentle mixing. The samples were then left to sit at room temperature for
25-30 minutes to allow the precipitate to form. The precipitate was then added to the culture
medium of each plate. The plates were incubated for 4 hours.
After the incubation, the media were aspirated from the plates and the monolayers
washed with 4ml prewarmed PBS. The cells were then shocked with 15% glycerol (in 1x
precipitation buffer) for 1 minute. The shocking buffer was removed and replaced with culture
medium. Cells were harvested 44 hrs post transfection.
2.11.2 Preparation of Cell Extracts for Enzyme Assays
Whole cell extracts were prepared from transfected cells by a freeze thaw method.
Cells were scraped from plates after washing in PBS containing 1 mM EDTA. Harvested cells
were kept on ice. Cells from each plate were collected in 1.5ml and spun down, the pelleted
cells were then resuspended in 250mM Tris pH8.0.
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Lysis was performed by 3 cycles of dry ice/methanol to 37°C water bath. Debris was
removed by a 5 min 13500 rpm microcentrifuge spin. CAT and (3-Gal activities in this extract
were then measured.
2.11.3 Assay for CAT Activity in Cell Extracts
CAT activity in the extract was determined by liquid scintillation counting as described
by Seed & Sheen (1988). Briefly, 10pil of extract was mixed with 5pil n-butyryl CoA (5mg/ml),
2pl ^C-chloramphenicol (0.025mCi/ml) and 113pl 250mM Tris pH8.0. After incubating for
3hrs at 37°C the reactions were placed on ice and extracted with 250pl mixed xylenes
(Aldrich Chemical co., Dorset England). The tubes were mixed well then spun at 13500rpm in
a microcentrifuge for 3 minutes. The upper organic phase was removed and extracted with
250pl H20. After this back extraction 125pl of the organic phase was placed in a scintillation
phial, mixed with scintillation fluid and counted for radioactivity.
2.11.4 Assay for B-Gal Activity in Cell Extracts
The reporter plasmid pSVBgal (Promega) was used as a control for transfection
efficiency. This plasmid contains the 8-gal gene under the control of the SV-40 promoter and
enhancer, to give high level expression. Extracts were assayed for I3-Gal activity as follows.
50pl of extract was mixed with 50pl of 2x B-Gal assay buffer (120mM Na2HP04, 80mM
NaH2P04, 2mM MgCI2, 100mM B-mercaptoethanol, 1.33mg/ml ONPG [o-nitrophenyl-8-D-
galactopyranoside]) in a flat bottom microtitre plate (Dynatech corp.). The plate was incubated
at 37°C for 1-2 hrs or until a strong positive reaction was observed. Reactions were stopped
by the addition of 150pl 1M NaC03. B-Gal activity was measured by determing OD405 on a
microtitre plate reader (Dynatech corp.).
2.12 Preparation of Nuclear Extracts
Nuclear extracts were prepared as described by (Schreiber et al. 1989).This is a
modified version of the protocol described by Dingman etal. (1983). Briefly, 1x10^ cells were
collected and resuspended on ice in 400pl ice cold buffer A (1 OmM Hepes pH7.9, 10mM KCI,
0.1 mM EDTA, 0.1 mM EGTA, 1mM DTT). After a 15 minute incubation in this hypotonic buffer,
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the cells were lysed by the addition of 25pl of 10% Triton X-100. The sample was vortexed for
10 seconds and the nuclei were then immediately spun out and resuspended in 50(il of
buffer B (20mM Hepes pH7.9, 0.4M NaCI, 1mM EDTA, 1mM EGTA, 1mM DTT).
The nuclei were then rocked vigourously at 4°C for 15 minutes. Finally the nuclei
were spun out and the nuclear extract was aliquoted and stored at -70°C. Prior to freezing,
protein concentration was determined (Biorad protein assay kit) and the extract diluted to
5pg/pl using buffer B. All buffers for nuclear extract contained the following proteolytic
inhibitors; 5pg/ml aprotonoin and leupeptin, 2p.g/ml pepstatin and 1mM PMSF
(Phenylmethylsulphonyl fluoride), from a fresh 50mM stock in isopropanol.
2.13 Gel Retardation
Gel retardation assays were performed essentially as described by Goodwin (1990)
with minor modifications.
2.13.1 Generation of Radiolabeled Probes
Target DNA sequences for use in the assay were radiolabeled using T4
polynucleotide kinase and y32P-ATP. Unincorporated y32P-ATP was removed by spin
column chromatography through Sephadex G25. Approximately 50,000 cpm of probe were
used per reaction.
2.13.2 Gel Retardation Assay
Reactions were performed as follows. In a microcentrifuge tube, 1p,l each of nuclear
extract (5pg), poly [dl-dC.dl-dC] (5pg) and 5x retardation buffer (20% glycerol, 50mM Hepes
pH7.6, 5mM MgCI2, 2.5mM EDTA, 2.5mM DTT) were mixed. For all reactions, the final
concentrations of NaCI and Glycerol were 80mM and 4% respectively. The competitor poly [dl-
dC.dl-dC] was used to reduce background generated by non-specific protein-DNA
interactions. The poly [dl-dC.dl-dC] was sonicated and annealed (95°C then slow cooling) to
provide material with a large number of free ends. The size of this material was checked by
agar gel electrophoresis (50-500b.p). Reactions were left for a 5 minute preincubation to allow
the removal of non-specific DNA binding proteins. Specific binding proteins were then
removed by the addition of competitor oligonucleotides. After a further 5 minute incubation,
1 fj.l of radiolabeled probe DNA was added to the side of each tube. Mixing was performed by
a brief microcentrifuge spin. Samples were left for a further 10 minutes. All incubations were
carried out on ice.
Complexes were separated by electrophoresis through a 4% non-denaturing
polyacrylamide gel in 0.4 x TBE buffer. An acrylamide:bis ratio of 29:1 was used, and gels
were cast using 1,5mm spacers. Electrophoresis was carried out at 4°C with recirculation of
the buffer. The gels were run at a constant 150V and prerun for 30 minutes prior to addition of
the samples. At this stage, 5pl of tracking dye was added to the wells in order to monitor the
running of the gel. To limit diffusion and dissociation of complexes, the samples were applied
to the gel with the current flowing. Gels were run for ~3hrs or until the bromophenol blue band
was ~3cm from the bottom of the gel. After electrophoresis the gels were dried on Whatman
no.3 paper. Dried gels were exposed to Kodak X-OMAT AR film for 1hrto 3 days depending
on the strength of the signal.
For gel super shift experiments, complexes were formed as described above. After
incubation with radiolabelled probe, antibody was added and samples incubated on ice for 30
minutes. Samples were then applied to the gel as described above. The rabbit anti-jun
antibody was obtained from Santa-Cruz Biotech. (San Diego, USA). This antibody was
generated against a peptide from murine c-Jun and is reactive against all Jun family members.
A control rabbit IgG was obtained from Sigma.
2.14 UV Crosslinking
UV crosslinking of DNA to protein was performed essentially as described by Ausubel
et al. (1993). The target oligonucleotide was BrdU substituted and hybridised to the
corresponding sequence to generate a double stranded oligonucleotide (Fig.2.4).
Fig.2.4 Probe for UV crossiinking
Oligo
C144 TCGACAGTCATAACCGCA
H0075 GTCAGTAXTGGCGXAGCT X= 5 Bromo dU
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2.14.1 Formation of DNA-Protein Complexes
Complexes were formed as in the standard gel retardation protocol (Section 2.13.2).
With the exception of using the BrdU substituted oligo as probe. Crosslinking was carried out
using a UV Stratalinker 1800 (Stratagene Ltd.). Samples were placed, on ice, at a standard
distance from the UV tubes. Sample exposure to UV was timed using the Stratalinker's built in
timer, this allowed consistent exposure between experiments.
Aliquots were removed at various time points and mixed with SDS reducing buffer
(150mM B-mercaptoethanol, 15% glycerol, 0.05% SDS, 0.005% (w/v) bromophenol blue,
50mM TrisHCI pH6.8). Reactions were assembled to give 5pg of protein and 50,000cpm per
aliquot. Optimisation of crosslinking conditions is described in Chapter 4.6.2.
2.14.2 SDS-PAGE of Crosslinked Complexes
Complexes were resolved by discontinuous polyacrylamide gel electrophoresis run
under reducing conditions (Laemmli 1970) using Biorad Mini-protean II vertical slab gel
apparatus.
A stock solution of 30% acrylamide:0.8% bisacrylamide was diluted to 10% in 250mM
TrisHCI pH8.7, 1.3mM EDTA and 0.1% SDS for the main gel. Polymerisation was carried out
by adding 0.5% APS (ammonium persulfate) and 0.05% TEMED. Gels were poured using
0.75mm spacers. The stacking gel contained 3.5% stock acrylamide, 145mM TrisHCI pH6.8
and 0.1% SDS. After polymerisation, the samples were electrophoresed at 200V in 25mM
TrisHCI, 6mM EDTA, 0.1% SDS and 156mM glycine. All samples including C14 labelled
markers (Amersham) were boiled for 3 minutes in SDS reducing buffer immediately prior to
electrophoresis. After electrophoresis, the gels were treated with EN3HANCE (NEN research
products, Boston, USA) to improve detection of C14 labelled MWT markers. After this
treatment, the gels were dried onto Whatman no.3 paper and autoradiographed at -70°C




As discussed in Chapter 1 the principal sequences governing transcription are
positioned within the U3/R region of the LTR. Unlike HIV, efficient transcription in MVV does
not appear to be dependent on the presence of the Tat protein. The importance of the trans-
activator Tat in HIV is shown by the absolute dependency of viral replication on the presence
of functional Tat protein (Dayton et al., 1986, Fisher etal., 1986). This absolute dependence
is not seen in MVV.
While LTR variation has been described in MVV there has been no examination to
date on the effects of this variation on LTR function. The significance of this sequence
variation for viral replication and the infectious process in vivo is unclear in MVV. When LTR
variation is followed after experimental MVV infection there is some limited evidence for
i•?
selection of certain LTR sequences from the infecting population (Sargan etal., 199Jfy. The
question then becomes: does sequence variation give rise to functional diversity in the LTR
population? One important distinction between the ruminant lentiviruses, MVV and CAEV,
and HIV is the distinct regulatory role of the Tat protein in the Ovine and Caprine viruses.
There is still some controversy regarding the importance of Tat in these viruses and whether
or not it is absolutely required for viral growth in vitro and in vivo (Saltarelli et ai., 1993, A.
Harmache pers. com).
The MVV Tat protein is considerably less active than HIV Tat. While HIV Tat shows
transactivation from a hundred to several thousand fold, depending on the cell line used
(reviewed by Antoni et al 1994). The MVV Tat protein shows a less marked effect (Gourdou
etal., 1989, Gdovin & Clements 1992, Neuveut etal., 1993). This difference may in part
reflect different U3 promoter activities between the two viruses (Chapter 1). Estimations of
MVV Tat transactivation vary from 5-40 fold, making the MVV protein between 10 and 100 fold
less active than HIV Tat. This marked difference in transactivation potential indicates functional
differences between the two proteins. In MVV the Tat target sequences appear to be located
solely within the U3 promoter region of the LTR (Hess etal., 1989) and there is no evidence
for a TAR region (Hess et al., 1989). Thus the sole targets for MVV Tat action appear to be the
cellular factors which interact with the U3 region of the LTR. There is however no evidence to
date for either direct or indirect binding of the MVV Tat protein to MVV LTR sequences
(Gdovin & Clements 1992 & J. Clements pers. communication).
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Variation in sites for transcription factors within the LTR does occur between the MVV
isolates sequenced to date (Querat etal., 1990, Sargan etal., 1991, Andresson etal., 1992).
As the U3 LTR region appears to represent the sole target for the regulation of MVV
transcription variation within the U3 promoter region of the LTR may thus be of greater
significance than in HIV.
As a number of LTR variants had been identified during the sequencing of EV-1 these
LTRs were used to test the effects of sequence variation on the rate of transcription from the
LTR. These experiments were performed by inserting LTR sequences upstream of the CAT
reporter gene in a transfection vector.
3.2 Overview of EV-1 LTR Variants
3.2.1 LTR Populations in vitro and in vivo
The MVV biological clone, EV-1, was derived from explant culture of a sheep showing
Maedi disease and after several passes in tissue culture this virus was sequenced (Sargan et
al., 1991). This initial isolate was also used to generate laboratory stocks of virus for future
experimental infections. The population of LTRs derived from this in vitro virus are shown in
Fig.3.1 (from Sargan etal., 1995). These LTR sequences vary due to point mutations but aiso
show variable repeat structures. These repeats can be classified according to the region
repeated and the repeat boundaries. This gives four basic repeat types (as illustrated in
Fig.3.1). Type I repeats cover the upstream region of the LTR, and, depending on their size
are classified as type IA or IB. The type II repeats cover an extended region of the LTR
including AP-1/AP-4/AP-1 element. Type III repeats cover only this AP-1/AP-4/AP-1 region. In
addition to this subdivision based on repeat structures the LTRs can also be subdivided via
the presence or absence of an insert at position 90. This division is important when these ex
vitro sequences are compared to those found in vivo.
Since the virus from which the initial LTRs were isolated was used for subsequent
experimetal infections it was also possible to obtain LTR sequences from the lymph nodes and
peripheral blood of two experimentally infected sheep (Sargan et al., 1995). These ex vivo
LTR sequences are shown in Fig.3.2. As the LTRs isolated from the infected animals were
derived from the tissue culture virus, these two populations are directly related. The
relationship between these two LTR populations can be seen in two ways. Either the ex vivo
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FIGURE 3.1 LTR variants obtained from tissue culture
LTR sequences obtained following PCR from DNA of in vitro EV-1 infected cells are shown.
Sequences are aligned against LTR 1 as this was the first sequence obtained. The four repeat
types are given at the top of the figure along with the nucleotide positions.
The numbering system used throughout this thesis for the LTR sequences is as follows; position 1
corresponds to position 8955 of the published EV-1 sequence (Sargan et al., 1991) and 8773 of 1514
(Sonigo etal., 1985).




















































































FIGURE 3.2 LTR variants from experimentally infected sheep
LTR sequences obtained from two experimentally infected sheep are shown. Sheep 649 (top
3 panels) was infected and then used to obtain samples for PCR at defined time points after
infetction, shown on the right hand side of each panel. Sheep 848, a chronically infected
animal, was used to obtain data on LTR sequences late in infection. Repeat types, from





































































































































LTRs are a subpopulation of the in vitro LTR sequences or they are rapidly evolved from the
tissue culture population. The in vivo LTRs all have an insert present at position 88
suggesting that they are derived from the second, insert bearing, group of in vitro LTRs.
The variation between the in vitro and in vivo LTR populations does suggest a
degree of selective pressure being exerted on LTR sequences within the infected animal
since the ex vivo LTRs are all derived from the in vitro population. This idea of LTR selection
during infection is dependent on both the ex vivo and ex vitro populations described here
truly representing the actual LTR variants present within each milieu.
These LTR sequences cannot be taken as representing the entire population of
those present in the population as only a single primer pair were used to generate the
sequences shown in Fig.3.1. While the sequences described are primer dependent it is
unlikely a given LTR structure or sequence is linked to the upstream and down stream primer
sites given the high recombination rates seen in lentiviruses. This is discussed more fully in
section 3.2.3.
3.2.2 PCR error and LTR variation
With such a large variation in LTR structure and sequence observed it is important to
assess the possible contribution of PCR artifacts. Any cloning strategy based around PCR is
error prone due to the large number of polymerisation cycles. The most common form of PCR
artifact is base substitution, with purine to purine (A-G) transition being the most frequent.
Other commonly encountered artifacts are single base deletions/insertions and inversions.
Estimations as to the frequency of errors with PCR vary from 0.126% to 0.03% of bases
(Meyerhans etal., 1989, Perrin et al., 1990, Carey & Dalziel 1994) depending on template
and reaction conditions. The error rate for the conditions used to clone the MVV LTRs was
calculated at 0.07% (1:1500) (Sargan etal., 1994). Taking this error rate then the frequency of
point mutations can be taken as just over one per 5 LTR sequences, the cloned sequence of
these LTRs being between 300-350 base pairs. The significance of point mutations is hard to
discern due to the problems posed by separating genuine variation from PCR artifact. The
possible significance of these changes will be discussed separately in each context and will
mainly feature in discussions of possible transcription factor binding sites where a single base
change may have a sizable effect on site affinity for a particular factor.
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While a number of the single base variations between these LTR sequences may be
attributable to polymerase infidelity, the insertion and deletion of repeat structures or the
addition/removal of larger inserts is less readily explained. Possible mechanisms for the
insertion of repeats during PCR are outlined in Fig.3.3. This type of artifact would be
dependent not on polymerase error but rather the mechanics of the PCR process and the
nature of the target sequence, ie. the presence of small repeated motifs.
Loss of repeats from a sequence can occur via a reverse process to that outlined in
Fig.3.3. In this case a sequence containing repeats is partially extended then dissociated, the
first repeat can then anneal to the second allowing the generation of a truncated, repeatless,
sequence. It should be noted that loss of repeats can be mediated by any sequence within
the repeated region thus making repeat loss a far more efficient reaction than repeat insertion.
During the original cloning of the EV-1 LTRs this generation/loss of repeats was
examined. PCR reactions were carried out using a single, cloned, LTR sequence as the
template. LTRs which did or did not posses repeats were analyzed in separate reactions.
Analysis of the products revealed that while it was possible to lose repeats during the
amplification procedure, there was no evidence for their generation (Sargan et at., 199Jt). It
can be concluded with reasonable certainty that the presence of repeat structures within the
two populations of virus is a genuine phenomenon.
3.2.3 Viral mechanisms for the generation of repeat structures
As the LTR variants observed appear to be products of the viral life cycle, both in vivo
and in vitro, the question of how these structures arise must be addressed (assuming that a
single progenitor LTR type is capable of giving rise to all the repeat structures discussed in
these studies).
As PCR artifacts do not appear to be responsible for the generation of the repeat
structures observed they must arise spontaneously during the MVV life cycle. One method
for the insertion of repeat structures into nucleic acid is recombination between related
sequences. Recombination is known to occur between distinct viral quasispecies in HIV
infected individuals (Howell etal., 1991). Recombination can theoretically occur at two stages
of the retroviral lifecycle - during reverse transcription or between two proviral DNA sequences
after superinfection. When these two possible mechanisms are tested experimentally only co-
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FIGURE 3.3 Schematic outline for the introduction of repeats via PCR
A template containing repeated sequences (1) is extended from a 5' primer. This gives rise to a
number of extended species (2). Only those extended beyond the site for the reverse primer
(2A) act as templates for the second, reverse primer.
In the case of partially extended products which terminate at the end of the first (2E) or second
(2C) repeat these can then reanneal to the full length template. This will give rise to species
with a repeat (3a) or deletion of the sequence between the two repeats (3b).
reverse
primer
infection leads to the generation of recombinant viruses (reviewed in Coffin 1979).
Recombination during reverse transcription is possible due to the presence of two
viral genomes and the ability of the reverse transcriptase to jump when it reaches the end of a
template, as it has to do when it reaches the end of one genome and switches to the other, or
when it encounters a break in the strand it is processing (Junghans etal., 1982, Coffin 1979).
Reverse transcriptase normally transfers at the end of the genome via paired homologous
sequences, however the enzyme can make strand transfers in the absence of extended
homology. This step may be triggered by pausing of the polymerase (Buiser etal., 1993). In
this scenario misalignment of the two genomes would allow the introduction of repeats into
the MVV sequence.
In the ex vivo sequences, only a single repeat type was found. Comparison of the
boundary sequences in these LTRs shows a conserved sequence at the start and end of
each repeat (TAACCGCAA) Fig.3.2. This sequence represents a possible region for template
misalignment prior to recombination events. In the case of the repeats unique to the in vitro
population, there is no evidence for conserved regions at the repeat boundaries. This may be
due to a slightly modified system operating in vitro. Differences between the in vitro and in
vivo environment will no doubt arise in relation to rate of viral replication within cells and
multiplicity of infection ( Haase etal., 1982 , Harris etal., 1984, Peluso etal., 1985).
In vivo there is likely to be a very low multiplicity of infection with limited viral replication
rates (Peluso etai, 1985). In contrast, in vitro the high replication rates together with the high
multiplicity of infection (Haase etal., 1982, Harris etal., 1984) is likely to force any processes
occurring at low frequency in vivo to much higher rates, with the possibility of allowing
interactions which would be blocked in vivo due to low affinity.
3.2.4 Selection of LTRs for functional analysis
The sequencing of the EV-1 virus showed a large number of LTR variants. However,
simply by analysing the sequence it is impossible to ascertain whether these are functional
promoters. None of the sequences generated were obviously defective in that they all
contain conserved TATA boxes and sequences with homology to transcription factor binding
sites. Functional analysis was carried out to answer two separate questions; firstly are the
variants active as promoters and secondly are there significant differences in their activity.
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For these studies a representative group of the ex vitro LTRs were selected for
analysis; LTRs 1,18,19,28,30,44, and 48. These LTRs together with the 1514 LTR are
illustrated in Fig. 3.4. LTRs 18,44 and 48 bear closest similarity to the ex vivo sequences. The
repeat boundaries of LTR 18 match those found in vivo, while the repeats in LTR 44 are
slightly extended when compared to those seen in vivo. LTR 48 is homologous to the
repeatless LTR forms found in vivo.
While only a single repeat type is observed in the ex vivo LTR population the ex-vitro
LTRs show a greater number of repeat patterns. These distinct structures are represented by
LTRs 28,19 and 30: LTRs 19 and 30 show similar but not identical repeat structure, with LTR 1
possessing no repeats.
The 1514 LTR was included in this study as it is the only MVV LTR to be characterised
functionally. Comparison of the EV-1 sequences with 1514 can be used to address the
significance of the divergence between these two viruses.
To summarise, the LTRs used in this study can be divided into two groups on the
basis of their similarity to ex vivo sequence. LTRs 18,44 and 48 can be classified as being ex
vivo like in that they most closely match the sequence and repeat boundaries of the LTRs
present in infected animals. LTRs 1,19,28 and 30 differ in that they all lack the insert at
position 88 and in the case of LTR 28 possess a repeat not represented in ex vivo
sequences.
3.3 Determination of relative LTR activities
3.3.1 Experimental design
In attempting to assess the significance of any variation in LTR activity seen in these
experiments the possible impact of systematic errors during transfection analysis must be
addressed. These can be divided into two different categories, variation in transfection
efficiency and quantification of reporter gene products within transfected cells.
Transfection efficiency can vary according to several parameters; variation in the
amount of DNA transfected (inaccurate DNA quantitation), contaminants in the DNA which
inhibit transfection or are toxic to cells and cell passage number. The use of a second plasmid
with an assayable product should allow correction for most of these errors. In these
































































































































































































































































































































Reduced transfection efficiencies due to variation in quantity or quality of the DNA under
investigation will also lead to variation in transfection efficiency of the second plasmid. In these
studies DNA purity and concentration was checked by spectrophotometer and DNA integrity
confirmed by gel electrophoresis. Throughout these studies the level of 13-gal activity was
consistent within different transfection experiments suggesting no major variation in DNA
quality or transfection efficiency.
The second set of errors may occur during preparation of cell extracts and
quantification of reporter gene products. Any technique for the production of cell extracts for
enzyme assay is likely to give some variation in efficiency. As a second control enzyme, 6-Gal,
was present in addition to CAT it is assumed that both of these proteins should be extracted
from cells with a similar efficiency during the freeze thaw process. Since a second enzyme was
used the final measure of promoter (LTR) activity is given by the CAT:B-gal ratio for each cell
extract in an experiment. A second point in relation to the quantitation of reporter gene activity
is that for these studies enzyme activities were assayed directly rather than using the products
of the transfection vectors as substrates for ELISA assays. Any enzyme assay must be
performed in the linear range to ensure valid results. For the I3-Gal assays this does not
represent a problem as there tended to be no significant variation in B-gal activity between
extracts within each transfection. In the case of the CAT assay, however, different constructs
did show a several fold variation in activity. For this reason the phase extraction assay using n-
butyryl CoA was used, this assay being linear for CAT concentrations varying by three orders
of magnitude (Seed & Sheen 1988). None of the constructs used in this study showed
variation of this magnitude allowing all samples to be assayed in parallel without dilution.
One potential drawback of using a second assay plasmid to control for transfection
efficiency is that the two plasmids may interfere with each other (Farr & Roman 1991). This
effect may at least in part be accounted for by competition between the plasmid promoters for
limiting cellular transcription factors. In order to test that the pCAT LTR and 13-Gal vectors were
compatible, chondrocytes were transfected with 5pg of pCAT 1514 (which contains the 1514
LTR sequence) and 5pg of either pSV2B-Gal or pUC18. For these experiments the CAT
activity in the presence of the I3-Gal plasmid was compared to that seen in its absence. When
expressed as a percentage, the activity in the presence of pSV2(3Gal was 98 +/- 11% of the
that when no SV-40 promoter enhancer sequences were present. This represents data from
four independent transfections.
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3.3.2 LTR Activity in transfection assays
The relative activities of these eight LTRs were analysed by transfection into
chondrocytes growing in 5% FCS. Transfections were performed 44 hours prior to
preparation of cell extracts by freeze thaw lysis. Both CAT and I3-Gal activities were determined
for all extracts using the I3-Gal activity to correct for transfection efficiency. For this analysis the
activity of the EV-1 LTRs was expressed as a percentage of 1514 activity.
The data from these experiments is shown in Fig.3.5. All of the EV-1 derived LTRs are
active and show activities equal to or below that of the 1514 LTR. These data show significant
variation in activity within the group of LTRs tested. Under these assay conditions the activity
of the pCAT12 vector was >1 % of the 1514 LTR.
The main question to be addressed is the effect of sequence and structural variation
on LTR activity. Those LTRs with similar repeat structures but slightly varying boundaries, i.e.
LTRs19 & 30 and 18 & 44, show the same relative activity (p>0.05) suggesting that the exact
positioning of repeat boundaries has little effect on LTR activity.
The effect of the repeat in modulating the activity of the LTR in comparison with the
repeatless version is seen to be dependent on the entire LTR sequence and not just the
repeat region itself. This is shown by comparing the activity of LTR1 with LTRs 19 & 30 and
LTR48 with LTRs 19 & 44. LTRs 18, 19, 30 and 44 have closely related repeat regions but the
introduction of these repeats in one case reduces LTR activity (LTRs 19 and 30 versus LTR 1,
p<.0001) and in the other elevates activity (LTRs 18 and 44 versus LTR 48, p<.0005). The
activities of LTRs 19 & 30 are equivalent to LTR 48 (p values of 0.23 and 0.36 respectively).
The most obvious distinction between LTRs 48 and 1 is the presence of the 12 base
pair insert in LTR 48 (and the related LTRs 18 and 44). However, these two LTRs also differ at a
number of other positions due to point mutations. The relative activities of LTR 1 and 48
suggest that while the context of LTR 48 allows a positive action for repeat structures its
activity is lower than that of LTR 1. The single LTR with an upstream repeat analysed in this
study, LTR 28, shows an activity intermediate between LTR 1 and LTR 48.
Taken together, this data would support the proposition that promoter activity is not
determined by having a given number of transcription factor binding sites within a promoter,
but rather is dependent on the relative positions of these sites. This is seen in comparison of
potential transcription factor sites within different sets of repeats. While LTR 44 repeats
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The raw data used to generate figure 3.5 is shown below. Data is given as percent 1514 activity.
Expt. 1 2 3 4 5 6 mean SD
1 89 76 86 81 71 80 80.5 6.5
18 51 57 54 62 55 49 54.7 4.6
19 28 13 20 19 24 15 19.8 5.6
28 71 67 70 66 60 63 66.2 4.2
30 23 19 34 40 34 35 30.8 8.0
44 54 45 72 60 58 48 56.2 9.6
48 15 36 24 37 15 28 25.8 9.7
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% 1514 Activity
Activity of EV-1 LTR sequences in pCAT12 vector expressed as %1514 activity. All points are
the average of six independent transfections with two plasmid preparations. Data is expressed
as mean plus one standard deviation.
*
- Denotes sequences significantly different from LTR 1 (p<0.02)
A - Denotes sequences significantly different from LTR 48 and LTR 1 (p<0.05)
Data was analysed using a two sample t-test.
essentially the same region as LTRs 19 and 30, it shows significantly higher promoter activity
and an elevation in activity from its repeatless counterpart LTR 48. In contrast, LTRs 19 and 30
show a much reduced activity when compared to LTR 1 even though these repeats cover
regions believed to bind transactivating factors such as AP-1. Indeed LTR 30 differs from LTR
1 at only a single base, an A to G conversion within the repeated sequence. This would
suggest that it is the presence of the repeat and not point mutations which are the cause of
the decreased activity of LTR 30 in comparison with LTR 1, which was highly consistent
between different DNA preparations.
In relation to the ex-vivo like LTRs 18/44 and 48, the elevation in activity would
suggest the presence of binding sites for transactivating factors within the repeated region.
An alternative explanation is also possible in that the repeat removes a negative regulator,
present in the upstream region, sufficiently distant from the initiation complex around the
TATA box to dilute its effect. A full explanation of these observations on LTR activity will be
dependent on a description of the transcription factors which may be interacting with the LTR
within the cell.
3.4 Identification of potential transcription factor binding sites in the
EV-1 LTRs
The transfection assays described above illustrate the effects of repeat structure on
LTR activity. From these experiments, it appears likely that there may be a binding site for a
transcriptional activator within the region outlined in Fig 3.6. This Figure also shows this region
from two other MVV viruses; SA-OMVV and KV1772.
This region contains the only site in the MVV LTR which interacts with a characterised
transcription factor. In footprinting and gel retardation experiments using the 1514 LTR
(Gabuzda etal., 1989, Shih et at., 1992) the TATA box proximal consensus AP-1 site has
been shown to interact with cellular Fos and Jun proteins (Shih et at., 1992). This is in contrast
to the other degenerate AP-1 sites present within the 1514 LTR. This consensus AP-1 site is
mutated in the EV-1 LTRs (Fig. 3.1/2/6). The loss of the TATA box proximal consensus site is
observed in all EV-1 LTR types, with none of the ex vivo or ex vitro LTR sequences showing a












































































































































The loss of the consensus AP-1 site in the EV-1 LTRs is in contrast to the 1772
(Icelandic) neurovirulant isolate derived from the 1514 virus. In this virus the TATA box
proximal site (position 129) is mutated from consensus. However, the site at position 106 (Fig
3.6) is back mutated to a consensus AP-1 site. This observation would appear to suggest that
the presence of a consensus AP-1 site, within this region, is important for LTR function, at
least in the context of the 1514 LTR and those derived from it. The SA-OMVV virus (a South
African isolate) also shows the loss of the consensus AP-1 site. This virus is a distinct
geographical isolate to EV-1 suggesting that LTR regulation may have diverged between
distinct geographical isolates.
Comparison of the AP-1 sites present in EV-1 and 1514 (Fig. 3.7) shows that while
the EV-1 LTRs have a number of degenerate AP-1 sites none of these match the consensus
sequence. AP-1 binding is not absolutely dependent on the presence of a full consensus
sequence (van Lint et at., 1991, Jain et at., 1992). However, variation from the optimum
(consensus) site does result in a reduction of site affinity. None of the 1514 AP-1 sites with
the exception of the consensus site at position 129 has been shown to bind AP-1 (Gabuzda
etat., 1989). Only in one case do mutations in the EV-1 sequences generate a sequence with
closer homolgy to the AP-1 consensus; position 56 in LTRs 1, 28, 19 & 30. This sequence
matches that known to bind AP-1 with low affinity in the IL-2 promoter (Jain et at., 1992). It
should, however, be noted that the site found at this position in all the ex vivo LTRs is that
present in LTRs 18, 44 & 48 which is even further from consensus than the sequence which
failed to footprint in 1514. The observation that repeats of the region outlined in Fig.3.6 can
result in elevation of transcription suggests that there is a functional site for a cellular
transcription factor within this region. The presence of the near consensus AP-1 site (position
129) in this region suggests that this site may be responsible for this observation.
While it is impossible to discount AP-1 interactions with the EV-1 LTRs simply by
sequence comparisons two preliminary conclusions may still be drawn. Firstly that the EV-1
LTRs do not contain a high affinity AP-1 site. If the factor is binding it is doing so to a low affinity
non-consensus site. The second, and related point is that, these two viruses EV-1 and 1514
may not be regulating transcription from the LTR in an identical manner. The final result may be
similar but the underlying mechanism different.
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LTRs 1,28,19 & 30
LTRs 18, 44 & 48
LTRs 18, 30, 44 & 48
LTRs 1, 19 &28
LTR 19b (second repeat)
LTRs 1, 19, 28 & 30
LTRs 18, 44 & 48
1514 TGAGTCA
EV-1 TAAGTCA All EV-1 LTRs
TGAGTCA
C A
AP-1 sites are shown from EV-1 and 1514 LTRs. Positions of sites are as shown on Fig.3.4. In
1514 the only site which binds AP-1 is at position 129 (the TATA box proximal site), all the
other degenerate 1514 sequences do not bind the factor (Gabuzda et al., 1989). The EV-1
sequences are compared to the 1514 sites. Base changes in the EV-1 sites are underlined. In
no case do the differences from the degenerate 1514 AP-1 sequences generate consensus
recognition sites in the corresponding EV-1 sequences. These sequences are discussed in
relation to the ex vivo LTRs in the main text.
In addition to the DNase footprint over the AP-1 site, two other sites have been
shown to generate specific footprints in the 1514 LTR (Gabuzda etal., 1989): one at position
75 (in the second repeat) the other at position 90 (Fig.3.4). The 1514 sequences footprinted
are compared with those present within EV-1 in Fig.3.8. The footprint in 1514 at position 75 is
present as a single copy at the end of the 53 bp repeat and extends beyond the repeated
sequence. The EV-1 LTRs also have a single copy of this region. This region is partially
conserved between the two viruses (Fig.3.8) and so may be functional in both EV-1 and 1514
LTRs.
The other 1514 DNase footprint (position 90 Fig.3.4) is over a region which is not
present in all the EV-1 LTRs. This site at position 90 in the 1514 LTR only has a potential
homolog in the ex vivo LTRs (Fig.3.2) and ex vitro LTRs18, 44 and 48, the ex vitro LTRs with
closest similarity to those found in vivo. Although this site is not identical in 1514 and these
ex-vivo EV-1 LTR types it is homologous (Fig.3.8). This sequence is deleted in the EV-1 LTRs
1, 19, 28 and 30. In relation to the transfection data this sequence appears to have a negative
effect on the transcription from the LTR, LTR 1 compared to LTR 48 (Fig.3.5).
The MVV LTR contains a number of other sequences which are potential targets for
transcription factor binding. Most of these are degenerate with low homology to consensus
sequences. It is problematic to assign functionality to these sequences for two reasons.
Firstly consensus sequences are often just 'best fits' and do not represent the only
sequences capable of binding a factor (Mermod et al., 1988); they are useful only as a rough
guide to indentify putative high affinity binding sites. Secondly flanking regions can play a
critical role in determining a site's affinity for a given transcription factor (Ryseck & Bravo 1991,
Nielsen etal., 1994).
One example of these degenerate transcription factor sites within the LTR is the non-
consensus AP-4 site at position 116 (Fig.3.3). While there is no evidence that this site binds
AP-4 it has been proposed as the target for a factor which recognises both this sequence and
the down stream proximal AP-1 site (Neuveut etal., 1993). This factor appears dependent on
the presence of both the AP-4 and AP-1 sequences.
Two further sites of interest within both the 1514 and EV-1 LTRs are the consensus
E-box sites (CANNTG) (Faisst & Meyer 1992) at positions 73 and 142 in EV-1 and positions 73
(within both copies of the 53 bp repeat) and 142 in 1514. This site is in close proximity to the
1514 footprint site (position 76) although not underlying it (Fig.3.4). The E-box transcription
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Figure 3.8 Potential Transcription Factor













--AAA-- LTRs 18, 44, 48
Comparison of footprinted regions of the 1514 LTR with the anaiagous regions of the EV-1
LTRs. The ex vivo LTR sequences match LTRs 48 & 18 for the sequence at the position75
footprint. Only LTRs 18, 44 & 48 of the ex vitro LTRs contain the insert which contains the
1514 position 96 footprint. All ex wVoLTRs contain this sequence.
LTR 1 & 28
LTR 19 (1st repeat)
LTR 19 (2nd repeat)
LTR 30 (1st)
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factors are members of the basic Helix-Loop-Helix (bHLH) family (reviewed by Garrel &
Campuzano 1991). Like the products of the fos and jun gene families these proteins form
dimers so modulating their transactivating and sequence recognition abilities. E-box factor
binding sites have been described as both positive and negative regulatory elements
depending on cell type and differentiation stage. The range of E-box binding factors
expressed by any given cell type will depend on cell lineage and activation state. These two
E-boxes are in addition to the E-box site within the degenarate AP-4 site which makes up part
of the AP-4 recognition sequence.
3.5 Serum induction of MVV LTRs
In addition to the comparisons of steady state LTR activity, it was decided to analyse
the induction potential of the different LTRs. A number of transcription factors, including
AP-1, are known to be upreguiated upon serum stimulation of cells. Differences in the
induction potential of the LTRs may therefore reflect variations in transcription factor binding.
For these experiments the cells were transfected and then placed in 0.5% FCS. This
was replaced with either fresh 0.5% FCS media or media supplemented with 10% FCS 12 hrs
prior to harvesting. It was not possible to withdraw completely serum from the chondrocytes
after transfection as this leads to extensive cell death. For this experiment only LTRs 1, 18, 48
and 1514 were assayed.
The results from these experiments are shown in Fig.3.9. Under these conditions all
four LTRs show identical levels of induction (approximately 2 fold). This similarity in response
may be due to the same transactivating factors acting on each LTR type or alternatively
different factors with similar induction/transactivating potential. This is particularly relevant in
comparison between the 1514 and EV-1 LTRs in relation to the apparent lack of a consensus
AP-1 site within the EV-1 LTRs. A further point is the role of inducible versus constitutive
transcription factors in determining LTR activity within this system. The exact nature of the
chondrocytes' response to serum induction is unknown, although these cells do show an
inducible AP-1 activity (Sections 4.6.1 and 4.7). While it is possible to assign the induction
observed to inducible DNA binding proteins an alternative explanation is that the observed
induction is due to an upregulation of other components of the transcription complex, such as
the basal factors which assemble on the TATA box binding protein. Thus the effect observed
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FIGURE 3.9 Serum induction of LTRs
3 -
rrmc.2 2u3"OC-Si 1oLL
1514 LTR 1 LTR 48 LTR 18
The serum induction of the four LTRs 1, 18, 48 and 1514 was compared. Induced ceils were
grown in 10% FCS. Induction is measured over the activity of LTRs in cells growing in 0.5%
FCS. "Tie data for all LTRs is the mean of four independent transfections, with the exception
of the 1514 data which is from 5 transfections.
is not promoter specific but could represent a general activation of transcription. This
supported by the increase in expression from the (3-Gal plasmid, both vectors showed an
equivalent rise in activity.
3.6 Discussion
3.6.1 Is the LTR of MVV virus under selective pressure In Vivo ?
The EV-1 LTRs isolated from infected animals show reduced diversity when
compared to those seen in vitro. One possible explanation, that many of the ex vitro LTR
types are non-functional, is countered by the observation that all the ex vitro LTRs tested by
transfection analysis were functional and could drive transcription. These two observations,
the reduced diversity of LTR types seen in vivo and the lack of non-functional LTR types in
the ex vitro population, suggests that the MVV LTR may be under selective pressure in vivo.
Comparing the LTR populations in the two animals from which the ex vivo LTRs were derived
it is clear that in both animals the same LTR type has been selected. This LTR appears to be
most closely related to the ex vitro LTR 48.
Examining the ex vivo LTR sequences presented in Fig.3.2 then sheep 848, the
chronically infected animal, shows only repeatless sequence in both blood and lymph. These
LTRs differ at a larger number of sites due to point mutation so a number of these alterations
may represent true population variation. As the only variation between these sequences is
accounted for by point mutation, and not introduction of repeats, it is possible that a single
progenitor LTR type was present at the initiation of infection.
In sheep 649, there was only a single LTR type early in infection (day 9). In the day 9
population only 1 out of 10 LTRs (LTR 13) shows variation. This mutation, a TC inversion at
position 225 (Fig.3.2), might be assigned to PCR error suggesting that only a single LTR
sequence was selected from the infecting population (Fig.3.1). At later time points, 15 days
and 5 months post infection, there is evidence for the generation of repeat structures within
this LTR, although only a single repeat type appears to be tolerated. As well as repeats, the
later time points from sheep 649 show an accumulation of point mutations which may illustrate
sequence divergence within the viral population. An important point to note is that these
mutated forms accumulate later in infection and are not present at the early time point. This
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lack of sequence diversity early in infection suggests a possible bottleneck in LTR evolution
within the animal. The error rate for the PCR used to generate these sequences was low,
estimated at less than 1 in 2400 bases, for sequences derived from LTR 7. Thus most of the
sequence variation observed can probably be described as genuine rather than as an artifact
of the PCR amplification.
Two mechanisms may account for this apparent in vivo selection. Firstly, of all the LTRs
seen in vitro only a single form may be functional in vivo, i.e. an LTR 48 derivative. A second
explanation is that early in infection only a small population of infected cells escape the
immune response. In this scenario, the selection of the founding LTR population is random
and independent of LTR sequence. As only two infected animals were analysed this second
argument cannot be discarded, although given that there is a large population of distinct in
vitro variants it is surprising that in both infected animals the same progenitor LTR sequence
appears to have been selected.
The data from the transfection experiments suggests that the variations observed in
LTR structure affect the rate of transcription from the LTR. Combining the results of the
transfection analysis with the variation in LTR type seen in vivo then it appears that early in
infection (day 9, sheep 649) only LTRs with low rates of replication are selected. The reason
why LTR 48 like structures are selected over LTRs 19 and 30 is unclear but suggests that
sequence considerations also play a part and that not any LTR with a low promoter activity will
be selected. This suggests that the insert at position 90 while not a requirement for in vitro
growth is required in vivo. At later time points repeat variants appear to be tolerated (Sheep
649 day 9 and 5 months) although only a single repeat type is represented. This would
suggest that these repeat-bearing LTRs are derived from the day 9 LTR rather than
representing virus not detected at the earlier time points.
The LTR population found in sheep 848 (the chronicaly infected animal) suggests
that LTR variants containing repeats are not a requirement for on going infection and virus
replication late in disease can be maintained by a similar LTR type to that found at the onset of
infection. The issue of LTR selection during the PCR process should be mentioned. While
there is unlikely to be linkage between the sequences used to generate primers for the
amplification of LTR sequence and the U3 promoter regions within the LTR, it is still true that
the LTR population described is not an exact match to that actually present within the animal.
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3.6.2 Possible significance of variations in LTR activity
While the effects on LTR activity caused by sequence variation were not large they
may have implications for the regulation of viral replication. This statement is dependent on
the observed differences in LTR activity holding true for the transcription of the entire viral
genome during in vivo infection. Extrapolation of these results to the situation in vivo is
hampered by several observations. These involve the validity of comparing simplified in vitro
systems with the process of viral replication in vivo.
The first issue is the cell type that is used to analyse LTR activity in these studies is not
the cell type predominantly infected in vivo (Brahic efa/., 1981, Narayan etai., 1982, Narayan
et ai., 1983 & Gendelman etat., 1985). While MVV virus will productively infect chondrocytes
in vitro it is unknown whether or not this cell type is productively infected in vivo. The target
cells for MVV infection in vivo are primarily those of the monocyte and macrophage lineage
and their precursors in the bone marrow. Productive infection in vivo is not limited to these
cell types. There is some evidence for other, epithelial and fibroblast like cells also being
productively infected, at low frequency, in vivo (Chapter 1.4.4., C. Zink personal
communication). Previous studies on the 1514 LTR have made use of a variety of different
cell types. These studies have shown that while the absolute activity does vary, different cell
lines reflect the same general trends. This would support the proposition that the differences
in LTR activity seen within these studies would be reflected over a variety of cell lines and
possibly also in vivo.
While the cell type under study may not affect the general conclusions on variant
activity it should still be pointed out that these two cell types, chondrocytes and
macrophages, are likely to express overlapping but distinct sets of transcription factors.
Some, such as AP-1, are likely to be present in both. However the exact composition, i.e.
which members of the jun and fos families the cells express, is likely to vary. This variation in
composition may have an effect on the transactivating properties of the complexes
generated.There is also the possibility of lineage restricted factors which are present in the
monocyte/macrophage lineage but not chondrocytes. Thus while the variation in activity of
the different LTR structures used in this study may be genuine the magnitude of functional
variation may differ in-vivo.
A second issue is the absence of viral transactivators in the comparison of LTR activity
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described here. In normal MVV infection the transactivator protein Tat will also be regulating
the rate of viral transcription. The MVV Tat protein appears to function in a distinct manner to
that of the other lentiviral Tat proteins, with the possible exception of the CAEV and FIV
proteins, due to the lack of a TAR region in MVV (Chapter 1.5.3). The MVV Tat protein
therefore appears to be acting solely through cellular transcription factors which bind to the
LTR (Gdovin & Clements 1992, Neuveut etal., 1993). This effect could be mediated by one
of two mechanisms. The MVV Tat protein may be directly transactivating cellular genes so
raising the levels of transcription factors which can activate transcription from the LTR. This
effect has been described in relation to the cellular c-jun gene (Neuveut etal., 1993). A
second point of action is the transcription complex assembled on the LTR. The MVV Tat
protein could be interacting with cellular transcription factors so directing its transcription
activation domain (Carruth etal., 1994) to promoters. This mode of action is seen in the HTLV
transactivator Tax (Zao et al., 1991, Zao et at., 1992, Adya et al., 1994) and the HBV X protein
(Maguire et al., 1991). It should be noted that these two modes of action are not mutually
exclusive. If the MVV Tat protein is acting in this way, via interactions with cellular transcription
factors, it is likely to trigger a general cellular activation or maintenance of an activated
phenotype following normal stimulation of the infected cell in vivo. If so, the Tat protein is
relying on interactions with cellular factors for targeting to the LTR it will also be targeted to any
other cellular promoter or enhancer binding that factor or factors. MVV Tat may therefore
boost viral replication not by greatly elevating the rate of transcription from the viral LTR but
rather by keeping the infected cell in an activated state. This would maintain high levels of
cellular factors so allowing viral transcription to continue for a prolonged period. This may
explain why the MVV LTR shows only weak transactivation in response to Tat; the LTR does
not represent the primary, direct, target for transactivation. The absence of Tat within these
studies is most likely to show itself in a general reduction of activity rather than as a gross
differential effect between LTRs. with the possible exception of the EV-1 LTRs versus 1514.
Differences between these two sets of LTRs, in relation to their Tat responsiveness,
may arise in two ways. Firstly the sequence divergence between the two strains may have
altered the transactivation potential of the two Tat proteins. Secondly MVV Tat has been
proposed to be to acting primarily through the consensus AP-1 site and the adjacent AP-4
like sequence within the 1514 LTR (Gdovin etal., 1992 & Neuveut etal., 1993). The lack of a
consensus AP-1 site in the EV-1 LTRs may therefore result in an alteration of Tat
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transactivation potential or altered target for Tat activity within the EV-1 LTRs.
Given these problems around variations in transcription factor expression between
chondrocytes and macrophages and the possible effects of Tat on the LTR sequences
studied here it is still possible to draw some tentative conclusions. The first is that a certain
LTR structure, and possibly activity, is prefered in vivo. This would appear to be a structure
which gives a relatively low level of transcription; the most active LTR types do not appear to
be selected. In relation to the viral lifecycle in vivo this observation fits in with the idea of
immune evasion by restricted replication or latency. There is insufficient antigen production
within the infected cell to trigger immune effector cells (most importantly CD8 cytotoxic cells).
This would lead to the survival and dissemination of infected monocytes. Activation of cells
could then lead to a burst of viral replication before killing by immune effector cells. This
Trojan Horse' model for the spread of virus is dependent on the infected cell being able to
escape immune surveilance up until the point the cell is activated so allowing maximal
production of progeny virus before killing. This slow spread of virus in MVV infected sheep is
supported by the observation that there is little or no detectable virus within the blood of
infected animals. This type of slow spread may be of more importance to MVV than the
immunodeficiency viruses, where suppression of the immune sytem eventually allows almost
unchecked viral replication at the end stage of disease. In MVV there appears to be no major
defect in the cell mediated immune response right up until death. However, there is a
reduction in lgG2 levels in MVV infected animals which may supress antibody dependent cell
cytotoxicity and indicate a more subtle disruption of the immune system than is seen in the
immunodeficiency viruses. Tight regulation of transcription is thus central to the survival of
MVV within the animal. It should be stated that this regulation of transcription and expression
of viral protein is under the control of sequences other than the LTR. The Tat and Rev
proteins will also play a role. However, the U3 promoter sequences play a pivitol role in that
they probably represent the on/off switch for viral transcription and control the accumulation of
these early proteins which may trigger the switch to the production of infectious virus when
they accumulate to a sufficient level.
The second point raised by the sequence comparisons and functional analysis of
LTRs in this chapter is whether the EV-1 and 1514 have truly identical transcriptional control
strategies. The comparison of activities shows that the ex vivo EV-1 LTRs show a lower activity
than the 1514 LTR. While this difference was not huge it was reproducible. The absence of a
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consensus AP-1 site in the AP-1/AP-4/AP-1 region of the EV-1 viruses when compared to its
maintenance in the 1772 and 1514 viruses suggests that while the 1514 and EV-1 LTRs have
very similar LTR structures there may be some differences in the fine tuning of the
mechanisms controlling transcription.
As the consensus AP-1 site in the 1514 LTR has been proposed as the principle
regulator of LTR induction, and given the importance of induction in the lentiviral lifecycle, it
seems unlikely that the EV-1 LTRs have completely lost the ability to bind this factor. As LTR
48 can be taken as the best match to the 1514 LTR of all the EV-1 sequences and this
sequence responds in a positive manner to duplication of the AP-1/AP-4/AP-1 element (LTR
18) it seems likely that this region of the EV-1 LTRs does contain a cis acting positive
regulatory element. The best candidate for this sequence is the degenarate AP-1 site at





In the previous chapter experiments with the EV-1 LTR variants suggested that the
AP-1/AP-4/AP-1 region (Fig.3.6) in the EV-1 LTRs was a possible target for a transcriptional
activator. Duplication of this region is, in the correct context, capable of elevating the activity of
the LTR (Fig.3.5). The sequence most likely to be mediating this effect is the TATA box
proximal AP-1 site. However, this AP-1 site does not match the consensus AP-1 site found at
the same position in the 1514 LTR. In the 1514 LTR this AP-1 site has been described as one
of the principal regulatory sequences (Gdovin etal., 1992 & Shih etal., 1992). The EV-1 and
1514 sequences at this site diverge by a single base transition (G to A ). As this site differs at
only one position from the functional sequence seen in the 1514 LTR and the mutation is not
one that is known to abolish binding, it was decided to compare directly the binding
characteristics of these two sequences. A list of the oligonucleotides used in this Chapter is
given in Fig.4.1a and their position of the MVV derived sequences within the LTR in Fig.4.1b.
The variation between the EV-1 and 1514 sequence in this region may alter its
function in one of two ways. While AP-1 may still bind to the EV-1 sequence it may do so with
an altered, probably reduced, affinity. The altered AP-1 site in EV-1 may thus preferentially
bind a distinct set of AP-1 dimers. This may result in subtle alterations in the response of the
two viruses to monocyte activation and differentiation in vivo. The second possibility is that
AP-1 binding to this site has been abolished by the mutation in the recognition sequence. If
this is correct, and AP-1 is no longer binding to the EV-1 LTRs, then it raises further questions.
Primarily, given that the consensus AP-1 site appears to be required for inducibility of the
1514 LTR (Hess etal., 1989); how are the EV-1 LTRs compensating for the apparent loss of
AP-1 binding to this site?
In order to test the binding properties of the degenerate TATA box proximal AP-1 site
present in the EV-1 LTRs, double stranded oligonucleotides corresponding to the EV-1 and
1514 regions were compared in gel retardation assays. This assay takes advantage of the
stability of protein/DNA complexes under non-denaturing conditions in native polyacrylamide
gels (reviewed in Lane etal., 1992).
The protocol used for these studies was fully described in Chapter 2. Unless stated
otherwise, all experiments were performed using 5pg of nuclear protein extract prepared from
chondrocytes growing in 5% FCS. This extract was initially incubated with poly dl-dC.dl-dC to
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remove nonspecific DNA binding proteins. After this incubation competitor oligonucleotides
were added at 1000x fold excess over radiolabeled probe. Finally the radiolabeled probe was
added and the reaction incubated for a final 10 minutes prior to loading onto the gel. The
complexes formed in these reactions were resolved on 4% non-denaturing polyacrylamide
gels. Retarded probe was detected by autoradiography of dried gels.
4.2 Comparison of EV-1 and 1514 AP-1 sites
The TATA box proximal AP-1 site in MVV 1514 has been shown to bind the
transcription factor AP-1 (Shih etal., 1992, Gabuzda etal., 1989). The AP-1 sequence in the
1514 LTR fully matches the consensus site but the site at this position in the EV-1 LTRs
diverges from the consensus sequence. In order to examine whether this site was functional
in the EV-1 LTRs oligonucleotides covering this area were compared. The two sequences
used (1514 AP-1 and EV-1 AP-1) and the results of gel shift experiments using these double
stranded oligonucleotides as probes are shown in Fig.4.2a/b. It is important to state that the
sequence used here in the EV-1 AP-1 oligonucleotide is found in all the EV-1 LTR
sequences, both in vitro and in vivo. The chondrocytes used to generate the cell extracts
used in these experiments are known to express a Jun-containing AP-1 sequence binding
activity (Section 4.6.1).
A control AP-1 sequence was used to confirm that any shifts observed with the MVV
probes were due to AP-1 binding and not an additional transcription factor site in this region.
The control probe from the human collagenase promoter gives a single retarded band (lane 9
Fig.4.2a). The protein in this complex is competed by an excess of both cold control AP-1
(lane 11) and 1514 AP-1 (lane 10) oligonucleotides. No competition is seen using the EV-1
AP-1 sequence (lane 12). When using the 1514 AP-1 sequence as probe a retarded band is
observed (lane 5). The retarded complex is competed by both 1514 AP-1 and control AP-1
oligonucleotides (lanes 6 and 7 respectively). It is clear that the complex binding to the1514
AP-1 sequence is doing so with a lower affinity than that binding to the control AP-1 sequence
(lane 5 versus lane 9). This is also seen when comparing the ability of these two double
stranded oligonucleotides to compete the complex off control AP-1 probe. The 1514 AP-1
sequence does not compete the AP-1 complex off the control AP-1 sequence as well as
excess cold control oligonucleotide (lane 11 compared to lane 12). This observation can be
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Figure 4.2
Comparison of 1514 and EV-1 TATA box proximal AP-1 sites. Fig.4.2a shows an
autoradiograph from a standard (overnight) exposure, Fig 4.2b shows the same gel
autoradiographed for 4 days. The control AP-1 tracks Fig.4.2a (9-12) are not shown in
Fig.4.2b. Below the sequences of the 1514 and EV-1 oligonucleotides are shown.
1514 TGCTTGAGTCATAACC
EV-1 TGCTTAAGTCATAACC
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explained in two ways. Firstly two distinct complexes may be interacting with these two
oligonucleotides. The cross competition seen between these two sequences suggests that
this is not the case. The second possibilty is that the shorter flanking sequences around the
core recognition site on the 1514 AP-1 sequence reduce the affinity of the AP-1 complex for
this oligonucleotide when compared to the control AP-1 sequence. This second explanation
is also supported by later observations with longer oligonucleotides (Section 4.3).
Even following longer autoradiography no binding to the EV-1 AP-1 sequence is
observed (Fig.4.2b, lanes 1 to 4). This strongly suggests that AP-1 is not binding to this
sequence. The observations made on the reduced AP-1 binding seen using the 1514 AP-1
sequence when compared to the control AP-1 sequence are also relevant here. While the
results clearly show that the 1514 AP-1 sequence is capable of specific binding to a complex
recognising the AP-1 sequence the binding may be limited by the size of the oligonucleotide.
Thus, although the EV-1 AP-1 sequence may be capable of binding no interaction may be
seen using this oligonucleotide due to the short flanking sequences. In order to ascertain if
the absence of a specific shift on the EV-1 AP-1 sequence was due to the absence of
sufficient flanking sequence, longer oligonucleotides were compared by gel shift analysis.
From the data presented in this section it is not possible to state categoricaly that AP-1 is not
interacting with the EV-1 sequence. However, it is clear that the EV-1 sequence is not
functionaly identical to the 1514 sequence.
4.3 A second transcription factor site in close proximity to the AP-1 site
In the previous section, gel retardation experiments with oligonucleotides covering
the AP-1 region of the EV-1 and 1514 LTRs showed distinct AP-1 binding patterns. This data
could not be extended to exclude the possibility of AP-1 binding to the EV-1 AP-1 sequence
because of potential problems caused by the size of the oligonucleotides.
In order to test more fully the ability of AP-1 to bind the EV-1 sequence,
oligonucleotides with extended flanking sequences either side of the core AP-1 recognition
site were obtained. Initially two oligonucleotides were prepared corresponding to the
sequences of EV-1 LTR-1 and 1514. These two sequences differ at two positions, the
mutation in the AP-1 site and also a second G to A transition. These two oligonucleotides and
the results of gel retardation experiments using them as probes are shown in Fig.4.3.
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Figure 4.3
A gel shift using the oligonucleotides EV-1 ex vitro (EV-1) and 1514 is shown. Two specific
retarded complexes are seen using the 1514 sequence (Lane 5 vs. 8). The EV-1 ex-v
sequence shows a very weak shift corresponding to the lower band seen with the 1514
sequence. The two sequences are shown below.
1514 TGATGCTTGAGTCATAACCGCA
EV-1 TGATGCTTAAGTCATAACCACA
In addition to the alteration in the AP-1 site these sequences also differ due to a second G to A
conversion downstream (towards the TATA box) from the AP-1 site.
FIGURE 4.3
1 2 3 4 5 6 7 8
PROBE - LANES 1-4 EV-1 ex-vitro
5-8 1514
COMPETITORS - LANES 1/5
" 2/6 EV-1 ex-vitro
3/7 1514
4/7 AP-1
The results from Fig.4.3, where the EV-1 sequence was used as probe (lanes 1 to 4),
show that even when the flanking sequence is extended there is no evidence of AP-1
binding. Weak bands were observed in lanes 1 and 4 with the EV-1 probe. The lengthened
1514 sequence generates, in addition to the AP-1 shift, a second retarded complex. The
upper band is seen to be competed by both the 1514 (lane 7) and control AP-1 (lane 8)
sequence confirming it as the same complex observed in Fig.4.3. The control AP-1
sequence, unlike the 1514 oligo, cannot compete the lower band. Suggesting that the lower
complex is recognising a sequence distinct from the AP-1 consensus site. This second, non-
AP-1 complex, is competed by the EV-1 sequence even though this oligonucleotide cannot
compete the complex recognising the AP-1 site (lane 6). The weak bands seen in lanes 1 and
4 where the EV-1 sequence was used as the probe suggest that the EV-1 sequence has a low
affinity binding site for this factor.
The EV-1 and 1514 oligonucleotides described above differ at two positions, one in
the AP-1 region the other outside the AP-1 site (Fig.4.3). As the second factor does not
appear to be recognising the AP-1 site it appeared likely that this G to A conversion outside
the AP-1 recognition site was responsible for the reduced affinity of the EV-1 oligonucleotide
for this sequence. In the EV-1 LTRs the second, non-AP-1 mutation, is not found in all LTR
sequences. In the ex-v/Vo LTRs, and a subpopulation of theex-v/froLTRs, the 1514 sequence
is found.
In order to test whether this second factor was binding differently to the two EV-1
sequences, the corresponding region of the ex-vivo EV-1 LTRs (EV-1ex-v) was compared to
the EV-1 and 1514 sequences in gel retardation experiments Fig.4.4. Using the EV-1ex
oligonucleotide as a probe did not generate an AP-1 specific shift (lanes 11 to 15), confirming
the results with the EV-1 sequence and demonstrating that the base change outside the core
AP-1 recognition site does not affect AP-1 binding. While the EV-1 ex-v sequence does not
bind an AP-1 complex it does bind to the second factor with an affinity apparently equivalent to
that for the 1514 sequence (lane 15 compared to lane 10). This confirms that the recognition
site for this factor is distinct from the AP-1 recognition site and lies in the 3' flanking region of
the oligonucleotide.
In order to test this more fully, an oligonucleotide covering the 3' region of the 1514
and EV-1 ex-v oligonucleotides was generated. This sequence was designated VSS (Visna
specific sequence). When this oligonucleotide is used as a probe (Fig.4.5) it generates a
77
Figure 4.4
The three oligonucleotides EV-1, 1514 and EV-1 ex-v (the sequence from the ex vivo EV-1
LTRs) are compared in a gel shift assay. The bands for the EV-1 and 1514 sequences are as in
Fig.4.3. The EV-1 ex-v sequence shows a single shifted band corresponding to the lower
band seen with the 1514 oligonucleotide. This band is of higher intensity with the EV-1 ex-v




The varying bases are again shown in bold. The EV-1 sequence differs from both the EV-1ex-
v and 1514 due to the G to A conversion outside the AP-1 site.
FIGURE 4,4













The oligonucleotide VSS is generates a single non-AP-1 shift (Lanes 1 and 4). The additional




The VSS oligonucleotide corresponds to the 3' half of the 1514 sequence and does not
contain the AP-1 site.
FIGURE 4,5
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sequence specific retarded complex (lane 1). The complex binding to this oligonucleotide is
not competed by excess oligonucleotide containing only the AP-1 site (lane 4). This, together
with the lack of a consensus AP-1 sequence on the VSS oligonucleotide, provides strong
evidence that this shift is not related to the complex binding the AP-1 site. The OCT-1
sequence (lane 5) was used as a competitor as comparison of the oligonucleotide sequence
with known consensus sequences (Faisst & Meyer 1992) suggested that the recognition site
bore closest similarity to the OCT recognition site.
Using this VSS oligonucleotide as a competitor, Fig.4.6, it can be seen this sequence
will compete for the unknown complex without interfering with the AP-1 complex (lane 5). This
gel also illustrates the independence of these two factors in relation to their ability to bind
DNA. Both can be competed without affecting the binding of the other. This appears to rule
out synergistic binding when both sites are present, as in the 1514 LTR. A second point is
whether both factors are capable of binding to this region simultaneously.
Binding of both factors to the 1514 region should result in the generation of a third
retarded complex migrating above the shifts caused by the single protein complexes. In no
experiment using the 1514 sequence as a probe was this third complex seen. This may reflect
the fact that in these experiments the probe was not saturated. This may have prevented the
formation of the two protein complex. Experiments were performed to attempt to saturate the
1514 probe using reduced probe concentrations and varying the quantity of nuclear extract
used. Despite varying NaCI concentration over the range of 50-130mM it was not possible to
saturate the probe. However, up to 50% of the probe was present in the retarded bands (as
determined by liquid scintillation counting). This would give an expected approximatly 5% of
probe in the double complex, assuming no interference between the factors. A band of this
intensity should have been readily visible on the autoradiographs but was never observed.
4.4 The upstream region of the MVV LTR contains a second copy
of the VSS Sequence
Many promoters both viral and cellular contain multiple recognition sites for the same
factor. In light of this the LTR was checked for any additional sequences with homolgy to the
VSS sequence. This search revealed a possible additional site for this factor, position 85 in
both the 1514 and EV-1 LTRs (Fig3.4). This sequence underlies the footprint observed by
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FIGURE 4.6
The AP-1 site and the VSS sequence are independent sites within the 1514 LTR. Using the
1514 oligonucleotide as a probe it can be seen that the AP-1 and VSS bands may be
independently competed (lanes 3 and 4).
FIGURE 4.6










Gabuzda etal. (1989). This region of the EV-1 and 1514 LTRs is compared in Fig.4.7.
In addition to a potential site for the unknown factor this region also contains a
degenerate AP-1 site and a consensus E-box site (CANNTG). An oligonucleotide covering
this region from the 1514 LTR was obtained and designated the USR (UpStream Region)
oligonucleotide (Fig.4.8). When used in gel retardation experiments this sequence showed a
single retarded band. This retarded band has the same sequence recognition as the protein
responsible for the shift seen with the VSS oligonucleotide (lane 3). Specific competition of
this protein with the VSS oligonucleotide does not reveal any additional transcription factor
binding sites in this region of the LTR. This would suggest the AP-1 site in this region is non
functional. The presence of E-box binding proteins was not assayed in the extracts used for
these experiments, so it cannot be concluded that this site is non-functional in the MVV LTR.
The conservation of the USR sequence between the 1514 and EV-1 LTRs shows the
importance of this region in both sets of LTRs and points to its functionality in the EV-1
sequences.
The presence of two sites for this factor in the MVV LTR may be important for the
regulation of transcription by the LTR. It also raises questions regarding differential regulation
of the 1514 and EV-1 viruses. The structure of DNA at the promoter is not believed to be
linear; rather the binding of transcription factors results in bending of the DNA. This effect
allows transcription factors to interact directly even if they are separated by long sequences.
Transcription factors such as Sp1 can directly mediate DNA bending (Su et al., 1991). One
possibility is that the two sites for the non-AP-1 factor in the MVV LTR are involved in the
generation of higher order promoter structures. As there appears to be a difference in the
transcription factors binding to the 1514 and EV-1 LTRs it is interesting to speculate how
distinct the mechanisms of transcriptional regulation are in these two viruses. This will be
discussed in greater detail in Section 5.5. Having identified a novel transcription factor site in
the 1514 and EV-1 LTRs it was decided to examine the factor binding to the VSS region in
more detail.
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Sequences from the various LTRs are aligned with the upstream region footprinted in
the 1514 LTR. The region which footprints in the 1514 LTR is underlined. This region also
contains putative AP-1 and E-Box sites. In EV-1 LTRs 1,19,28 and 30 the 90 to 97 is no
longer conserved as these sequences lack the position 90 insert. The sequence of the VSS
oligonucleotide is shown below these upstream sequences and the sequence conserved
compared to the 1514 footprint is underlined.
FIGURE 4.8
The sequence of the USR oligonucleotide is shown above the autoradiograph. Putative AP-
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4.5 The VSS Binding Protein also Interacts with the
TCR Alpha Gene Enhancer
The sequence boundary of the non-AP-1 factor in the MVV LTRs is not listed as being
recognised by any characterised transcription factor (Faisst & Meyer 1992). While there has
been no characterisation of the VSS binding protein, a closely related sequence has been
footprinted within the TCR alpha gene enhancer (Ho efa/., 1989 & 1990). This footprinted
region, over box 4 (Ta4) in the enhancer, when aligned with the sequence present in the
MVV LTRs (Fig.4.9) shows a conserved sequence. The Ta4 sequence was used in gel shift
experiments in comparison with the MVV sequences (Fig.4.10a/b). Cross competition shows
that the binding specificity of these sequences is the same despite the divergence between
the TCR enhancer and MVV sequences. Alignment of these sequences which bind this factor
gives a consensus binding site for this unknown protein of "^/qAACC^VqCA. The divergence
from this sequence in LTR 1 at the TATA box proximal site, within the VSS sequence, appears
to result in reduced binding activity following the G to A conversion at position six. Having
identified the recognition sequence of this factor it was decided to look at other characteristics
of the protein. Studies on the TCRa gene enhancer revealed that the factor binding box 4
required other sequences within the enhancer to function (boxes 1 and 2) and deletion only
had a minor effect on enhancer activity (Ho efa/., 1989). This data suggest that the VSS
sequence is not capable of functioning as an enhancer element and so must be positioned at
the promoter either indirectly, by proximity to a factor which can remodel chromatin structure
and bring it into contact with the promoter element or by being present within the promoter
sequence itself. The possible function of this sequence in relation to a basal promoter has not
been tested, only its inability to function as an enhancer element has been shown. This
question of whether the VSS sequence can function as a transcriptional activator is addressed
in Chapter 5.
As it appears that in the MVV LTR the same factor is binding the upstream and
downstream sites the footprinted regions for these two sites were compared (Fig.4.11).
Comparison of the area protected from DNase footprinting suggests that at the down stream
site the VSS site is not occupied. This provides some additional indirect evidence to suggest
that these sites may not be occupied simultaneously and that these two factors AP-1 and the
VSS binding protein, are competing to bind to tnis region of the 1514 LTR.
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FIGURE 4.9 Comparison of Ta4 with the MVV VSS
Ta4 Footprint CCCCCAACCGCAGGTGC
1514 Footprint (USR) AAATGTAACCGCAAGTTCT
1514 TATA box proximal TGAGTCATAACCGCAGATGT
EV-1 TATA box proximal (LTR 1) TAAGTCATAACCACAATTGT
VSS oligo GAGTCATAACCGCA
The underlined sequence represents a putative core recognition site for the factor
binding this sequence. From this comparison the core recognition sequence appears to be
non-palindromic. The sequences denoted as footprint' are those regions which are protected
from DNAse I digestion
FIGURE 4.10
Comparison of the oligonucleotides VSS and Ta4 by gel shift. Fig.4.10a shows that when the
VSS oligonucleotide is used as a probe the specific band is competed by both the MVV LTR
sequences and the Ta4 sequence (Lane 2). The reciprocal experiment is shown in Fig.4.10b.
FIGURE 4.10a
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COMPETITOR - LANE 1 -
" 2 Taipha 4
" 3 VSS
" 4 1 514
" 5 USR
" 6 Control AP-1
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FIGURE 4.11 The TATA box proximal VSS/AP-1 element in the 1514 LTR
The 1514 oligo covering this region binds these two factors in an apparently
independent manner. This would suggest that only one or other of these two sites may be
occupied. Below the footprinted region is highlighted in bold type and the VSS and AP-1





This data on footprints is taken from the paper by Gabuzda et al (1989). In both cases
the two footprints are assumed to be caused by single factors. The gel retardation data using
the USR oligonucleotide suggests that the footprint in this region is caused by the same factor
as binds in the TATA box proximal region. Taking these two assumptions this then several
conclusions follow. Firstly that the VSS protein was saturating in the system (the USR
footprint). Secondly, in the TATA box proximal region the footprint does not cover the whole
VSS 'core'. Thirdly the VSS factor protects regions outside its 'core sequence (upstream
footprint).
From these observations together with the experimental data presented previously in
the gel shift experiments it appears unlikely that these two factors are binding simultaneously.
4.6 Partial Characterisation of the VSS binding protein
4.6.1 The VSS binding factor is antigenically distinct from the
complex binding the AP-1 site
The relationship between the factors binding to the VSS and AP-1 sequences in the
LTR has so far been described solely in terms of the sequence recognition of these two
factors, which appear distinct and unrelated. By cross competition experiments in gel shift
assays it is clear that the two transcription factors recognise distinct sequences. However, in
both of the sequences tested from the MVV LTR the VSS sequence appears near a
conserved (1514, TATA box proximal site) or degenerate (EV-1 TATA box proximal site and
USR site in 1514 and EV-1) AP-1 site. The Jun family of proteins are known to interact with
transcription factors other than those produced by the c-fos gene family. One well
characterised example is the NF-AT complex generated in activated T cells (reviewed by Rao
1994). The interaction of Jun with the EV-1 LTRs, in the absence of an AP-1 site, would allow
the same general mechanism of Tat transactivation and LTR induction in the EV-1 and 1514
viruses. If Jun is not interacting with the EV-1 LTRs at any position then it is possible that this
virus is using a distinct system to control its induction and possibly Tat responsiveness.
In order to test for the presence of the Jun protein in the VSS binding complex an
anti-Jun polyclonal antibody was used in gel supershift experiments. This antibody binds all
identified members of the c-jun gene family; Jun, Jun B and Jun D. The antibody was raised
against a peptide from the DNA binding domain of the mouse Jun protein and is cross reactive
with the human, chicken and rat proteins. When antibody is added to the gel retardation
reactions prior to loading onto the gel it can stably bind protein/DNA complexes. This
generates a band which migrates above the normal complex. This technique can therefore be
used to identify components of the retarded complex. In Fig.4.12 the anti-Jun antibody
generates a supershift on the 1514 AP-1 oligonucleotide but no supershift when the VSS
oligonucleotide is used as a probe. This data does not exclude the possibility of a Jun family
protein being present in the VSS binding complex but does illustrate that if present it is not in
the same conformation as in AP-1. These data together with the work on identifying the core
region of the VSS strongly suggests that this factor is distinct from AP-1. It also demonstrates
that this reagent is cross reactive with the ovine Jun proteins.
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FIGURE 4.12
The 1514 AP-1 and VSS oligonucleotides were used as probes. The specific retarded band
generated by the 1514 oligonucleotide can be seen to contain a Jun family protein as
demonstrated by the specific supershift, obtained after incubation with a rabbit anti-Jun
antisera, (Lane 4) which is marked by an arrow. No supershifted band is observed with the VSS
specific complex (Lane 7).
FIGURE 4.12
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PROBE - LANES 1-4 1514 AP-1
- " " 5-6 VSS
ANTISERUM - LANES 1/5 -
" 2/6 Control IgG
" 3/7 anti-Jun IgG
LANE 4 - 1000x AP-1
LANE 8 - 1000x VSS
4.6.2 UV crossiinking to the VSS sequence
A technique which has been used in several systems for the identification of proteins
binding to an oligonucleotide is to covalently link the protein to the DNA via a UV excitable
group incorporated into the recognition sequence. As three distinct sequences which bind
the non-AP-1 complex have been identified it was possible to generate an oligonucleotide
with a BrdU substitution in the putative recognition site.
The cross linking assay was performed as described in Chapter 2. Complexes were
formed as in the gel retardation experiments (Section 4.1) with the exception being the use of
the BrdU substituted oligonucleotide being used as the probe. These reactions were placed
on ice, to avoid evaporation and over heating of the sample, and placed in a commercial UV
cross linker for the period of time indicated in each experiment.
The first step in this process was the calculation of the optimum exposure to UV
required for the generation of a detectable crosslinked complex. The results of a
representative time course are shown in Fig.4.13. This Figure shows a gradual accumulation
of the covalently linked retarded complex as the length of exposure to UV is extended. From
this experiment an exposure time of 1 hour was used. In lanes 4 and 5, 1000x fold cold VSS
oligonucleotide was present. The comparison between the bands seen in these lanes and
those where no competitor was present suggests the band seen at 40-46kD is specific for the
BrdU substituted VSS oligonucleotide. This 40-46kD band appears to contain two distinct
species with closely related molecular weights.
Non-specific competitor may interfere with specific complexes if it is present at
excessive concentrations. The level of poly dl-dC.dl-dC used in standard gel retardation
experiments was 5pg per reaction. This level was determined empirically for the standard gel
retardation assay and may not be optimum for the cross linking assay. In order to determine
whether the ideal level of non-specific competitor was different for these assays in comparison
to the standard gel retardation protocol, a titration of poly dl-dC.dl-dC was performed
(Fig.4.14). In the absence of competitor four bands appear. As the level of non-specific
competitor increases all the complexes other than that at 40-46kD are strongly competed. The
40-46kD complex is only reduced at high levels of non-specific competitor suggesting it
represents the only specific complex formed on the BrdU VSS oligonucleotide. From these
experiments it appears that the 5pig of poly dl-dC.dl-dC used in the gel retardation
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FIGURE 4.13
Cross linking timecourse using the BrdU substituted VSS oligonucleotide as a probe. The
figures on the left denote molecular weight in kDa. The strong band at the bottom of the gel is
the probe migrating with the dye front.
FIGURE 4.1 3
PROBE - X-LINK VSS
COMPETITOR - LANE 1/2/3 -
" 4/5 VSS
UV EXPOSURE - LANE 1 10 minutes
" 2/4 30 minutes
" 3/5 60 minutes
FIGURE 4.14
Titration of the non-specific competitor poly dl.dC-dl.dC. for the UV crosslinking experiments.
Non-specific competitor was titrated over the range 1-1 Opg.
FIGURE 4,14
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experiments is also suitable for this protocol. Levels below this generate quite high
backgrounds and at 10pg there is interference with specific bands.
Having calculated the optimal incubation time and non-specific competitor levels
experiments using specific competitors were performed. The results of the competition
experiments are shown in Fig.4.15. In the presence of specific competitor, only the 40-46kD
complex is competed. All VSS containing sequences show competition against this complex
but no effect is seen with the oligonucleotide containing the AP-1 sequence. The incomplete
competition levels seen with the VSS and 1514 oligonucleotides, versus the USR sequence,
is readily explained by the observation that in the VSS and 1514 sequences the binding site is
at the extreme end of the oligonucleotide. The final base pair of the putative binding site is the
last base pair of the oligonucleotide. In contrast the USR sequence contains long flanking
sequences either side of the recognition sequence. This is likely to reduce the affinity of
binding and increase the on off rate of the factor on the VSS and 1514 sequences in
comparison with the USR sequence. In the gel shift assay this effect was less noticable as the
system was in equilibrium. In the cross linking experiments any complex forming with the VSS
probe has a possibilty of becoming covalently linked thus even a slight reduction of
competition efficiency will result in the presence of a detectable band and incomplete
competition.
The complex seen at 40-46kD in the cross linking experiments corresponds to a
protein of approximate MWT of 34-40kD after subtraction of the oligonucleotide MWT. The
suggestion that this complex consists of two distinct bands may reflect some heterogeniety in
the composition of the VSS binding complex.
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FIGURE 4.15
Use of specific competitors in UV crossiinking. The specific competitors listed were used to
demonstrate a specific interaction between the 36kDa band and the BrdU substituted VSS
probe.
FIGURE 4.15












4.7 The VSS binding activity and AP-1 are Differentially Induced
by PMA or TNFa
The results discussed in sections 4.2 & 3 suggest that the transcription factor AP-1
does not interact with the EV-1 LTRs at the TATA box proximal AP-1 site. One possibilty is that
the second factor which binds in this region may be compensating for the lack of AP-1 binding
in this region of the EV-1 LTRs. As the AP-1 complex interacting with the downstream site in
1514 has been described as the major regulator of inducible viral gene expression (Hess et
at., 1989) it is possible that this second factor was playing a similar role in EV-1. The presence
of two sites for this factor in the LTR suggest it may play a major role in the induction of viral
transcription following cellular activation. This hypothesis was initially tested by examining the
response of the VSS binding protein to cellular mitogens.
The transcription factor AP-1 is induced by a large number of stimuli including cellular
activation by cytokines and mitogens (reviewed by Herschman 1991, Nathans & Ryder 1988).
The induction potential of the VSS binding protein was assayed in comparison to AP-1 activity
in response to two distinct activation stimuli, PMA and ovine TNFa. Both of these stimuli are
known to elevate the activity of AP-1 (Hanazawa et at., 1993, Hass et at., 1991 ). For these
experiments cells were grown in serum free media for 24 hrs in order to stop cell growth and
reduce levels of inducible factors to an absolute minimum. The half lives of the various Fos
and Jun proteins is reported to range between one and four hours (Carillo S. etal., 1994,
Gruda et at., 1994). During this incubation there were no obvious gross alterations in cell
morphology or viabilty. This is important as removal of growth factors has been reported to
cause apoptosis and the activation of the c-fos and c-jun genes in some cell systems (Colotta
etal., 1992). This effect was not observed in the chondrocytes used in these studies.
Chondrocytes appeared able to tolerate over 48 hrs in serum free media without serious loss
of viability. The level of AP-1 in extracts did not appear to be greatly affected by extending the
serum withdrawal from 24 to 48 hours. The 24hr period was chosen as it should provide a
suitable length of time to reduce inducible transcription factor levels without stressing the
cells.
After this 24hr incubation the media on the cells was supplemented with serum free
media containing the relevant mitogen. The concentration of mitogens used was 100ng/ml for
both PMA and recombinant ovine TNFa (Green etal., 1993, provided by B. Ebrahimi).
84
The results of these stimulation experiments are shown in Fig.4.16 and Fig.4.17, for
PMA and TNFa respectively. For these experiments equivalent quantities of protein were
used from each nuclear extract. Stimulation of AP-1 binding activity is seen following both
stimuli. The main problem encountered during these experiments was the level of AP-1
activity seen in unstimulated cells. This would suggest that the chondrocytes used in this
study express the jun genes, and probably the fos genes, at relatively high levels. From
these studies it was not possible to describe which members of the jun and fos families were
induced by these stimuli. From Fig.4.16 it can be seen that 5% serum, as expected, also
elevates AP-1.
While the AP-1 complex shows the expected induction with these mitogens there
was no consistent evidence for an induction of the VSS binding protein. This provides a
second piece of indirect evidence against the VSS binding activity being related to AP-1 or its
constituent proteins. VSS levels remain constant despite stimulation of cells with PMA, ovine
TNFa or 5% serum. While the VSS binding factor appears to be constitutive, and uninduced
by these stimuli, this does not mean that it is unable to mediate inducible transcription. This
could occur either by a modification of the DNA binding complex itself or the recruitment of
inducible factors by this protein once it has bound DNA. So it appears that the role of this
protein in LTR induction, if it has one, is at best secondary. A further point is that the
chondrocytes may not be in resting state at the t=0 time point, as seen by the strong AP-1
activity found in the cells. It is therefore possible that the factor binding the VSS is already
maximaly induced in this cell type. One system which should be examined for induction of this
would be monocyte to macrophage differentiation, as this appears to be the trigger in vivo for
viral replication.
4.8 Discussion
In the in vitro gel retardation assays described in this chapter no evidence was found
for the interaction of AP-1 with the degenerate TATA box proximal site in the EV-1 LTRs. This
site has been described as the main target for the regulation of inducible viral gene expression
in the 1514 virus (Hess etal., 1989). It has also been claimed that in 1514 Tat transactivation is
absolutely dependent on the expression of c-jun (Neuveut etal., 1993). The failure to
observe AP-1 binding does not appear to be due to a limitation of the protocol used here as
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FIGURE 4.16
Timecourse for PMA stimulation. The induction of the VSS binding protein and AP-1 by PMA
and serum was examined. The AP-1 probe is used in the top panel and the VSS probe the
bottom panel.
Lanes 1/2 - Unstimulated
Lanes 3/4 - 1 hours post PMA
Lanes 5/6 - 2 hours
Lanes 7/8 - 4 hours
Lanes 9/10-6 hours
Lanes 11/12 - 5% FCS (12hours)
Even numbered lanes contain 1000x specific competitor. For this experiment induction was
quantitated by cutting out the retarded band and counting by liquid scintillation. The values
below are for three independent experiments.
AP-1 VSS
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FIGURE 4.17
protein by ovine TNFa. Chondrocytes were stimulated
for the AP-1 probe and the bottom panel for the VSS
Lane 1/2 - Unstimulated
Lane 3/4 -1 hour post TNFa
Lane 5/6 - 2 hours
Lane 7/8 - 4 hours
Lane 9/10-6 hours
Induction of AP-1 and the VSS binding
with 100ng/ml TNFa. The top panel is
probe.
Even numbered lanes contain 10OOx excess specific competitor.
1 23 456 7 89 10
strong AP-1 binding to the 1514 TATA box proximal site was observed. As was discussed in
Chapter 3, this TATA box proximal site represents the best match to the consensus AP-1
sequence in the EV-1 LTR (Fig.3.7). As AP-1 has been described a major regulator of MVV
LTR activity how does the EV-1 virus compensate? While there is no evidence of AP-1 binding
to the TATA box site it is possible that one of the other sites is indeed functional. DNase
footprinting experiments (Gabuzda et al., 1989) and comparison of the degenerate
sequences within the LTR (Section 3.4) with the AP-1 consensus site argues strongly against
this.
Leaving aside the possibility of one of the degenerate AP-1 sites being functional
then two distinct models could be invoked. Firstly the Jun protein may interact with the LTR, at
a site distinct from the TATA box proximal site, as a subunit of a transcription factor recognising
a non-AP-1 site. This would still be consistent with the requirement of c-jun expression for Tat
action. The second model would involve EV-1 Tat transactivating through distinct cis -acting
sequences in the LTR. This would remove the requirement for AP-1 or Jun interaction with the
LTR. As the functional domains of MVV Tat have only been partially characterised (Carruth et al
1994) the feasibility of this system is not clear. One final point is that Tat may interact with the
AP-1 complex (via Jun) to target its transactivation domain to the MVV LTR. It is still unknown
whether this Tat/AP-1 interaction could modify the recognition activity of the AP-1 complex.
The experiments in this chapter concentrated on the binding of AP-1 to the EV-1 LTR.
The TATA box proximal AP-1 site in the MVV LTRs is in close proximity to a degenerate AP-4
site (Fig.3.5). AP-4/AP-1 interactions at promoters have been described in a number of
cellular and viral systems (Mermod etal., 1988, Comb etal., 1988). These two factors act in a
synergistic manner when they bind in proximity to each other in promoter and enhancer
sequences. The role of AP-4 in the control of the MVV LTR, if it has one, is unknown. DNase
footprinting on the 1514 LTR only shows protection over the AP-1 site in this region. Neither
the AP-4 nor the VSS sequence are protected (Gabuzda et al., 1989). Further, using a
synthetic oligonucleotide covering the AP-4/AP-1 region of the 1514 LTR Neuveut et al.
(1993) failed to observe an AP-4 specific shift. This suggests that 1514 AP-4 site is non¬
functional or of low affinity and the requirement for both the AP-4 and AP-1 sequences in Tat
transactivation is independent of AP-4 binding. There is the possibility of a non-AP-4, Jun
containing, factor recognising this region (Neuveut etal. 1993). One problem with the study
by Neuveut et al. is the short oligonucleotides used as specific competitors. For the AP-4
86
experiment a 9bp sequence was used and for AP-1 a 12bp sequence. Given the potential
problems of using short oligonucleotides in gel shift assays (Section 4.2) and the failure of
these workers to show that their 'AP-4' and 'AP-1' sequences did indeed bind these factors
this work should be taken as inconclusive. In the EV-1 and SA-OMVV viruses, which have lost
their consensus AP-1 sites, the AP-4 site has moved closer to consensus when compared to
the 1514 virus (Fig.3.6). The ability of these two viruses to bind AP-4 has not been tested but
this may represent a second distinction between the 1514 type viruses (1514 and 1772) and
EV-1 and SA-OMVV. While AP-4 and AP-1 can act in a synergistic manner the binding of these
two factors to closely positioned sites is independent (Mermod etal., 1988). Thus changes in
the recognition sequences should be considered independently rather than as a single unit
where the binding of one protein enhances the binding of the second. It appears possible
that the interaction of the transcription factor AP-4 may represents another divergence
between the 1514 and EV-1 viruses in relation to the mechanisms of transcriptional control.
AP-4/AP-1 interactions have also been proposed to regulated FIV transcription (Thompson
etal., 1994, Miyazawa etal., 1993). Deletion of this region reduces LTR activity in transfected
cells but does not affect the growth of virus in vitro. The ability of these deleted viruses to grow
in vivo has not been reported so it is still possible that this deletion blocks the infective
process in vivo. This data from MVV together with the observed variation in activity of the MVV
LTR variants described in Chapter 3 supports the idea of multiple regulatory elements capable
of partially compensating for the loss of any individual sequence. It is also possible that viral
transactivators play a role in maximising transcription when the promoter sequence is damaged
(Thompson et al., 1994). The possible significance of the variation in transcription factor
binding for LTR function will be discussed in Section 5.6.
The gel retardation experiments described in this Chapter provide strong evidence
against the interaction of AP-1 with the EV-1 LTRs. The identification of a second, apparently
constitutive, DNA binding protein which interacts with the 1514 and EV-1 LTRs sheds more
light on regulation of MVV replication. In the course of infection most infected cells will not be
in an activated state, and so will be depleted for transcription factors such as AP-1.
Lentiviruses present in these cells are believed to be in a state of 'restricted replication' where
only the products of spliced transcripts are present and little or no infectious virus is produced
(Brahic et al., 1981). The identification of this apparently constitutive factor suggests a
mechanism for viral transcription in resting cells.
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Gel retardation assays give no information on the function of a DNA binding protein in
the context of an active promoter. In order to address this question the recognition sequence
for a given factor must be inserted in a vector containing a basal promoter and any cis -
activating ability assesed. This is important information as different members of the same
transcription factor family can regulate transcription in different ways (Majello etal., 1994, Chiu
etal., 1989). In order to test the sequences used in these gel retardation assays vectors were
generated to examine there ability to upregulate transcription from a basal promoter. These




The data presented in Chapter 4 demonstrated differences in the binding of
transcription factors to the 1514 and EV-1 LTRs. As the identification of binding proteins by
the gel shift technique is dependent upon the transcription factors and complexes being
stable under assay conditions it is desirable to assess the functionality of these sequences in
the context of a basal promoter. This technique demonstrates whether the results observed
using the sequences in gel retardation experiments also hold true in the context of a
functional promoter. As the sequences under investigation here are believed to interact with
transcriptional activators, the assay vector chosen was a minimal promoter, rather than a more
extended sequence with a higher basal activity. Such vectors are more suited for testing of
'enhancer' or 'silencer' activities.The vector used for these studies was A56. This plasmid
contains the CAT gene and the TATA box region of the c-fos gene. The presence of a TATA
box allows assembly of the basal transcription complex and initiation of transcription at a low
rate. Insertion of sequences of interest upstream of this region, using a Sal 1 site, allows them
to be tested for any cis regulatory function, i.e. do transcriptional activators bind to them. As
the basal promoter has a very low background activity any upregulation of transcription is easily
detected by reporter gene assays. In order to facilitate cloning into A56, the oligonucleotides
used in the gel retardation were designed with Sail ends, with the exception of the short AP-
1 oligonucleotides. The vectors used in the following experiments are outlined in Fig.5.1.
In relation to the factors seen to bind to the MVV LTR there were two points to
address. The first was to show that the lack of AP-1 binding to the EV-1 TATA box proximal AP-
1 site was a genuine observation and not an artifact of the gel retardation assay. The second
was in relation to the second transcription factor seen to interact with the MVV LTR; the VSS
binding protein. Is this factor able to function as a transcriptional activator? Comparison of the
vectors outlined in Fig.5.1 by transfection into chondrocytes addressess these two questions
and tests whether or not the observations made using the gel retardation assay can be
extended to transcription processes within the cell. In experiments using the A56 vector
activity of the oligonucleotide containing vectors is expressed as fold increase over the basic
vector (xA56).
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Figure 5.1 Orientation of oligos in A56 Vectors
1 514/EV-1 /EV-1 ex-v (2X)
VSS
USR/1 514/EV-1 ex-v (1 x)
The arrows denote the orientation of the oligonucleotides relative to the
basal promoter. Each arrow represents one copy of the test sequence.
5.2 Comparison of EV-1 and 1514 TATA Box Proximal Regions
The initial experiments focused on whether the differences seen in the gel shift
experiments using the long oligonucleotides [1514, EV-1 and EV-1ex-v (Fig.4.1a)] had any
bearing on the ability of these sequences to function as cis -activators of a heterologous
promoter. The differences observed in the gel shift experiment do appear to be reflected in
the results of these transfection experiments (Fig.5.2).
These data demonstrate that the 1514 sequence shows the greatest activity whether
present in one (Fig.5.2a) or two (Fig5.2b) copies. Where two copies of the 1514 sequence
are present an activity 7-8 times that of the EV-1ex-v vectors is seen. These differences are
maintained regardless of whether the cells are stimulated by either 5% FCS or PMA
(100ng/ml). For the PMA induction experiments cells were cultured in media containing 0.5%
FCS. Three hours before harvesting this was replaced by serum free media containing
100ng/ml PMA.
The reduced activity of the EV-1ex-v sequence may be accounted for in one of two
ways. If the AP-1 site is responsible for the activity seen then either the AP-1 site is of a lower
affinity than the 1514 site, and so less active, or interacting with a different, less
transcriptionally active AP-1 complex. The second possibilty is that the AP-1 site within the EV-
1ex-v sequence is indeed inactive, confirming the results of the gel shift assays (Chapter 4),
and the activity of the vector is accounted for by the factor responsible for the non-AP-1 shift
in the gel retardation experiments. Comparison of the activity of the EV-1 and EV-1 ex-v
sequences (Fig.5.2.) gives some support to the idea that the non-AP-1 factor is responsible
for the activity of the EV-1 vectors. Although the difference is not as marked as seen in the gel
shift experiments, the EV-1 sequence does appear to show a reduced activity in relation to the
EV-1 ex-v sequence. As these two sequences differ only outside the AP-1 site and within the
VSS sequence, it appears likely that this region is responsible for the activity observed.
Where only a single copy of the oligonucleotide is present, the 1514 sequence again
shows an elevated activity in comparison to the EV-1ex-v sequence. However, in these single
copy vectors, the difference in activity is less marked suggesting that while multiple AP-1
binding elements function synergistically multiple copies of the EV-1ex-v sequence show only
an additive effect.
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FIGURE 5.2 Comparison of A56 vectors
The relative activity of A56 vectors is compared. All experiments show the results from
4 independent transfections with the exception of EV-1 (2x) in Fig.5.2c which is for three
independent transfections. Graphs show:
a) one copy vectors in 5% FCS stimulated chondrocytes.
b) two copy vectors in 5% FCS stimulated chondrocytes.
c) two copy vectors in PMA (100ng/ml) stimulated chondrocytes.
The activity of vectors (xA56) represents the increase in activity of the MVV A56













These results are compatible with the observations made in Chapter 4 where each of
these 3 sequences showed distinct characteristics in the gel retardation assays. While the
experiments described above provide indirect evidence for the VSS sequence binding a
transcriptional activator, the question can only be answered using vectors containing the VSS
sequence in the absence of an AP-1 site.
5.3 The Factor Which Binds the VSS is a Transcriptional Activator
As analysis of the long oligonucleotides is complicated by the possible presence of
two transcription factor binding sites. The oligonucleotide VSS, which has been shown to only
interact with a non-AP-1 factor (Fig.4.5), was used to test whether this factor was indeed a
transcriptional activator.
The results of transfections experiments using this vector are shown in Fig.5.3. These
data indicate that this sequence is indeed capable of driving transcription from a basal
promoter. Again, as for the vectors containing both the AP-1 and VSS elements, the activity is
comparable following serum or PMA stimulation. This would support the idea that in the EV-1
viruses the TATA box proximal AP-1 site is non-functional and that transcriptional activation
caused by this area of the LTR is due, at least in part, to the binding of a factor to the VSS
sequence. The apparent failure of AP-1 to bind to this EV-1 sequence and the lack of a
consensus AP-1 site elsewhere within the EV-1 LTRs, raises questions about the studies on
the 1514 LTR and Tat function. Studies on the regulation of transcription in 1514 have
repeatedly highlighted the importance of AP-1 binding for induction of transcription and
transactivation by Tat (Gabuzda et al., 1989, Hess et al., 1989, Shih etal., 1992, Gdovin &
Clements 1992, Neuveut etal., 1993).
As the oligonucleotide carrying solely the VSS sequence was capable of driving
transcription and the results from the the gel shift experiments suggested a lower affinity for
the EV-1 VSS site when compared to the EV-1ex-v and 1514 sequences, the activity of this
sequence in the context of the LTR was examined. EV-1 LTRs no.1 and 48 differ in that LTR




0 2 4 6 8 10 12 14 16 18
XA56
The VSS-1 vector transfected chondrocytes were stimulated with either 5% FCS or PMA
(100ng/ml). Activity is the increase over the A56 vector without any insert. Data is the mean of
5 (5% FCS) or 4 (PMA) independent transfections.
Figure 5.3
In order to test the activity of this region, in the absence of upstream regulatory
elements, a sequence from position 120 was amplified by PCR and cloned into pCAT 12.
Transcription from these two vectors was assessed. The results of these experiments are
summarised in Fig.5.4. These two sequences show identical activity demonstrating that in the
context of the LTR the G to A conversion within the VSS probably does not signficantly
reduce the rate of transcription from the LTR. Comparing the activity of these two vectors with
the full length sequences from which they are derived it is clear that the TATA proximal AP-
1/VSS element is not causing the reduced activity of LTR 48 in comparison to LTR 1 (Fig.5.4).
This would suggest that the difference in activity seen between LTRs 1 and 48 is caused by
differences in upstream elements. These two LTRs differ at a number of positions in the
upstream sequence due to point mutations (see Fig.3.4). However, the more significant
difference between these two sequences is probably the insert at position 90 in LTR 48 (see
Fig.3.8). In Section 3.3.2 it was demonstrated that this sequence determined the ability of
repeats to act as upregulators or inhibitors of LTR activity. One possible explanation is that this
sequence, or a factor which may bind to it interferes with the ability of upstream sequences to
contribute to transcriptional activation. It may, in a sense, function as an isolator element
preventing sequences upstream contributing fully to promoter activity. Duplications
downstream of this site are not effected by the sequence and so allow transactivation (LTRs
18 and 44 compared to LTR 48, Fig.3.5). When this sequence is removed, upstream
elements (Section 5.4) can interact more fully with the transcription complex assembling over
the TATA box and so upregulate transcription. The presence of repeats, when the position 90
insert is not present, may now interfere with promoter architecture, perhaps by blocking
upstream sites, and so lead to a reduction in LTR activity. In this case the repeat is functioning
as an analogue of the position 90 insert (LTRs 19 and 30 compared to LTR 1 and also LTR 48).
This mode of action is of course highly speculative but does provide one possible explanation
for the experimental observations.
In the previous chapter the issue of whether or not both the AP-1 site and VSS could
be occupied simultaneously was discussed. While it was not possible to give a definitive
answer to this question it appeared unlikely that both sites could be occupied at once.
Bringing this observation together with the data on the activities of the various oligonucleotide
A56 vectors it appears that AP-1 may be capable of displacing the VSS binding protein. This is























Activity of truncated LTRs. Vectors containing LTRs 1 and 48 with the upstream sequences
deleted were compared by transfection into chondrocytes growing in 5% FCS. Activity is
compared to the full length LTR 1 (100). In contrast to the full length LTRs these 3' sequences
show comparable activity. The activity of the pCAT12 vector with no LTR sequences was >1.
Data is the mean of four independent transfections.
/
show the highest activities. In the gel shift experiments the VSS binding protein interacted
with both the 1514 and EV-1ex-v with an apparently equal affinity. Yet the 1514 sequence is
more active in transfection experiments, suggesting that AP-1 binding to 1514 accounts for
the higher activity. This AP-1 interaction with the 1514 LTR is probably at the expense of the
VSS binding protein. Further experiments are required to answer this question fully; for
example, would mutation of the VSS in the 1514 oligonucleotide reduce its activity in A56 in
comparison to the wildtype sequence? While some questions remain about the interaction of
these two factor binding sites in this short sequence it appears that in 1514 at least the ratio of
these two factors in the nucleus may play a pivitol role in setting the rate of viral transcription.
5.4 The USR Sequence From MVV 1514 can also Activate Transcription
The upstream region of MVV 1514 was also inserted into A56 as a single copy in the
same orientation as present in the viral LTR. This sequence was shown in gel shift
experiments to contain a single copy of the VSS. In transfection experiments this sequence is
able to activate transcription but shows a distinct activity in comparison to other regions
containing only a single copy of the VSS (Fig.5.5). The activity of the USR region is elevated
when compared to a single copy of the EV-1ex-v sequence and is equal to that shown by the
1514 sequence which contains a functional AP-1 site. The single copy of the USR sequence
appears to drive transcription as well as three copies of the VSS oligonucleotide.
This difference in activity between the USR and EV-1ex-v sequences, which in gel
shift analysis appeared to bind the same factor, may be explained in two ways. Firstly, the USR
sequence may contain sites for factors not observed in the gel shift analysis, the consensus
E-box site being a candidate. Alternatively, the context of the VSS core sequences in these
two regions results in the USR site having a greater activity. In terms of context the sequences
flanking the VSS are likely to be critical. These do differ between the two VSS sites in 1514
LTR (Fig.4.9). It is of course possible for both of these mechanisms to be functioning.
The data from experiments performed on the VSS and USR sequences argues that
the factor observed to bind this region (Chapter 4) is indeed a transcriptional activator. In
Chapter 4 the relationship between the VSS in the MVV LTRs and the box 4 footprint in the
TCR alpha gene enhancer (Ta4) was discussed. The Ta4 sequence has been shown to
footprint but does not appear able to act as an enhancer element (Ho et al., 1989, Ho &
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Figure 5.5
Activity of the USR sequence in the vector A56.
Transfections were performed on chondrocytes growing in 5% FCS. The USR activity is the
mean of 8 independent transfections. The EV-1ex-v and 1514 data is the mean of 4
independent transfections.
Leiden 1991). The data presented here show that a factor which interacts with this sequence
can mediate the activation of transcription. These two observations are not contradictory. As
enhancers are positioned at remote points from the promoter they must act at a distance
(Chapter 1.7). This action will to some degree depend on the factors ability to remodel
chromatin structure. The factor(s) may be acting either indirectly to alter conformation and
structure of the chromatin and so allow other factors access to the promoter or directly by
bringing enhancer elements into contact with the promoter, via DNA bending or looping.
There is experimental evidence to support the idea that not all transcription factors are capable
of functioning as enhancers and that this effect is in part mediated by the activation domain
(Seipel efa/., 1992).
5.5 Serum Induction of A56 Vectors
In Section 3.6 serum induction of full length LTRs was described. These experiments
showed a uniform (2 fold) induction. The results on induction of AP-1 and the VSS binding
factor (Section 4.7) showed that unlike AP-1 the factor binding to the VSS did not appear to
be inducible. As there will be multiple transcription factor binding sites within the LTR it was
decided to repeat these serum induction experiments using the A56 vectors. These
experiments were performed using the vectors 1514 (2x), VSS-1 and USR (1x) and the
protocol described in Section 3.6. The results from these induction experiments are shown in
Fig.5.6. As in the previous attempt (Chapter 3) to show serum induction all three vectors show
an equivalent response.
In the gel retardation experiments (Chapter 4) AP-1 activity was present at easily
detectable levels in serum starved cells. Thus it is possible that in the system used, AP-1
concentrations do not become limiting and there is a sufficient pool of the factor to activate
AP-1 sites within promoters, such as the 1514 LTR or sequences derived from it. It therefore
seems likely that the induction observed is not due to specific transcription factors but a
general increase in transcription triggered by the elevated serum. In this case factors, such as











1514 (2x) VSS-1 USR (1x)
Serum Induction of A56 vectors.
The increase in activity of vectors in cells growing in 5% FCS versus 0.5%. In each case the
induction was performed in three independent transfections.
5.6 Discussion
The data presented here strongly argues that studies on the regulation of
transcription in MVV strain 1514 cannot be extrapolated to describe the the regulation of
transcription in MVV strain EV-1 (and by extension possibly SA-OMVV).
The data presented in this Section taken together with the previous studies on AP-1
binding to the MVV LTR (Chapter 4) and the degenerate nature of the AP-1 sites in the EV-1
LTRs, would argue against functional AP-1 sites in the EV-1 LTRs derived ex vitro or ex vivo.
As AP-1 has been proposed as the main regulator of inducible transcription from the MVV LTR
and the principle target for Tat transactivation, this result was surprising. As all the remaining
AP-1 sites within the EV-1 site are highly degenerate with only limited homology to the
consensus sequence, it appears likely that transcription from the EV-1 LTRs is regulated by a
system distinct from that used by the 1514 LTRs. The identification of a second factor binding
in this region of the LTR in both EV-1 and 1514 viruses suggested a possible mechanism for
the replacement of AP-1. However, from the data presented here it appears that this second
factor is not related to AP-1 and shows a weaker transactivation function. One problem with
the system used here was the failure to show induction of transfected AP-1 sites by serum
(Fig.5.6). From the data presented in Chapter 3 this may reflect the 'activated' nature of
chondrocytes in this culture system. The data on the truncated LTRs (Fig.5.4) are in
approximate agreement with the observations of Hess et al. (1989) at least for the LTR 1
sequence, in that deletion of the upstream sequences results in a sharp drop in LTR activity. In
contrast LTR 48 appears to suggest that the upstream elements are redundant. This is unlikely
to be true and probably reflects the experimental system used. One experiment which
remains to be performed is a comparison of the truncated 1514 sequence with the LTR 1 and
LTR 48 sequences. This would show the effect of the consensus AP-1 site in the context of
LTR sequences.
If these observations are valid in other systems and the VSS binding factor is
constitutive then this raises two distinct questions; how do the EV-1 LTRs regulate inducible
expression and what is the function of this second factor if it does not confer inducibility on the
MVV LTR? If the observations for the induction experiments in chondrocytes hold true for the
more relevant case of cells of the monocyte/macrophage lineage then it is possible that the
VSS binding factor may drive low level transcription and play a role in restricted replication.
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The VSS binding factor(s) may be capable of driving low level transcription from the LTR so
building up a pool of Tat and Rev protein. This may provide a mechanism for gearing the
infected cell up for high level replication following cellular activation; both Tat and Rev would
be at optimal or near optimal concentrations allowing immediate high level production of
transcripts for structural proteins. It is likely that there will be a number of other regulatory
factors interacting with the LTR and controling its activity. A fuller understanding of the control
mechanisms of the MVV LTR will depend on the identification of such elements.
Considering the entire structure of the MVV LTR then it becomes apparent that there
is some plasticity in LTR structure. Comparing the MVV LTRs, both variation in transcription
factor binding (1514 compared to EV-1) and alterations in the positions of transcription factor
binding sites (1514 compared to 1772) are seen. These three LTR types appear likely to
possess distinct LTR structures due to variations in transcription factor binding. Possible
promoter/transcription factor complexes are outlined in Fig.5.7. It appears a strong possibility
that MVV strains are able to alter their transcriptional control mechanisms without greatly
altering the in vivo infectious process. What does this say regarding the importance and
significance of this variation in promoter structure? The main conclusion would appear to be
that the exact organisation of the promoter is not under selective pressure. Rather any
sequence and architecture which allows the correct rate of transcription for the infective
process is tolerated. This lack of constraint on LTR structure is illustrated by the observation
that the LTR appears to be as variable as the env gene and more variable than the gag gene
(R. Zanoni pers. communication). Both Env and Gag are under strong selective pressure from
the immune system so variation is being driven rather than drifting, as in the LTR. However, the
plasticity of LTR structure probably has defined limits. This appeared to be the case in the
types of LTR selected from the infecting population (Chapter 3); not all LTR types appear
capable of supporting in vivo infection. Secondly, the data on the transcription rates of the
various EV-1 LTR variants (Chapter 3) showed that context was important. Similar observations
have been made in other systems. Attempts to modify the FIV promoter by the insertion of 4
additional AP-1 sites into a wild type LTR revealed some constraints on promoter structure
(Miyazawa etal., 1994b). Insertion of these AP-1 sites elevated transcription when measured
by CAT assay. However, when this modified LTR was introduced into an FIV molecular clone
the virus had a reduced rate of replication and after several rounds of infection the AP-1 sites
were removed by deletion and a virus with wild type characteristics was regenerated. This
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FIGURE 5.7 Transcription binding to MVV LTR types
A schematic representation of transcription factor binding to the MVV LTR is shown.
Sequence variation will apparently lead to distinct transcription factor binding patterns in the
three LTR types shown. For a comparison of the sequence in AP-1/AP-4/AP-1 regions of the
viruses shown see Fig.4.6. In the EV-1 viruses the position 90 insert is shown as a
transcription factor binding region given a) its homology to the region footprinted in the 1514
LTR and b) the observations on the LTR variants in Chapter 3 which suggests it modulates LTR
activity.
As can be seen from this Figure the four LTRs show distinct transcription factor
binding properties. In the 1514 LTR it is still unclear whether both AP-1 and the VSS binding
protein can bind simultaneously. However in 1772, with the movement of the AP-1 site, the
sites are sufficiently distant (Fig.3.6) to suppose there could be no direct interference, or site
competition, between the factors in relation to DNA binding. If there is competition between
these sites in 1514 then it appears that the VSS binding protein is displaced by AP-1.
Duplication of the AP-1/AP-4/AP-1 region in some of the EV-1 LTRs generates two sites for
the VSS binding protein. This duplication approximately doubles LTR activity (Fig.3.5.). The
significance of this duplication for virus replication in vivo is unclear as both repeatless and
















1514 Footprint Factor (within position 90 insert)
would suggest that the LTR has already evolved to its optimum form and attempts to enhance
artificially its activity may disrupt the 'stereospecific ' complex which normally forms at the
promoter (Chapter 1.7). Together with the observations presented here on the variation in
MVV LTR structure it would appear that promoter plasticity only occurs within fixed limits. The
boundaries being set by the nature of the interacting factors in a given promoter and there
dependency on a given structure.
One further sequence which should be compared between the various MVV LTRs is
the TATA box itself (Fig.5.8). In HIV-1 TATA box mutants have been identified as second site
revertants which compensate for the loss of upstream Sp1 sites (Kashanchi etal., 1994).
Variation in TATA box sequences may also modify the Tat responsiveness of the HIV-1 LTR
(Berkhout & Jeang 1992). The TATA box sequences of the various MVV isolates from Fig.5.7
are compared in Fig.5.8. From this comparison it is clear that these sequences are varying
between MVV isolates. The significance of this variation is unknown but the point should be
made that there may well a relationship between alterations in transcription factor sites in the
promoter/enhancer proper and the 'basal' component represented by the TATA box
sequence.
The interactions between transcriptional control systems can result in a potentiation or
inhibition of transcription. In the 1514 virus the overlapping AP-1 site/VSS represents a target
for two distinct sets of factors. Composite elements have been observed in a number of
promoters (Diamond etal., 1990, Rahuel etal., 1992, Tan etal., 1992, Treisman 1992, Grazia
etal., 1994). The serum response element of the c-fos gene represents an extreme example
where 7 distinct factors, including the serum response factor, may interact with a 22bp region
of DNA (Treisman etal., 1992). Factors interacting with a composite element my compete for
binding resulting in a suppression or activation of transcription (Rahuel etal., 1992, Tan etal.,
1992, Grazia etal., 1994). Alternatively factors may interact co-operatively to upregulate their
binding and so synergisticly activate transcription. In the case of the Interleukin 2 enhancer
both these effects are seen (Grazia etai, 1994). Co-operartive binding of AP-1 and Oct-2
results in the activation of transcription. However, the retenoic acid receptor (RRR) binds to the
same region of the enhancer and this interaction disrupts the AP-1/OCT complex and inhibits
transcription. The effect of factor binding may also depend on the composition of the factor
interacting with the site. As has been stated before the factor AP-1 factor may be composed of
numerous combinations of the Fos and Jun proteins depending on cell lineage and activation
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Figure 5.8 Comparison of TATA box sequences from MVV isolates
1514 GCCTATATAAGCCG
SA-OMVV GCCTATAAAAGCTG
EV-1 ex vivo GCCTATAAAAGCTG
EV-1 ex vitro GCCTATAAAAGCTG
The TATA box sequences of 1514 type viruses (Sonigo etal., 1985, Staskus etal., 1991) and
the viruses SA-OMVV (Querat etal., 1990) and EV-1 (Chapter 3) are compared. The notable
feature of these sequences is the T to A conversion (in bold type) in the viruses which appear
to lack TATA box proximal AP-1 sites (EV-1 and SA-OMVV).
state. While this will effect the transcriptional activation potential of the AP-1 protein it will also
determine the interaction of AP-1 with other transcription factors (Miner & Yamamoto 1992).
Comparison of the plfG element from the proliferin gene promoter binds both AP-1 and the
GR. The compostion of the AP-1 complex effects the activity of this sequence; while Fos
containing AP-1 complexes repress, complexes containing Fra-1 activate transcription from
the element. This effect was not mediated by the activation domain but the DNA binding
domain. Thus this interaction is similar to that observed in the HIV LTR between Nf-kB and Sp1
(Perkins etal., 1994). This crosstalk between the AP-1 and hormone receptors has been
examined by other groups (Yang-Yeng etal., 1990, Doucas etal., 1991, Grazia etal., 1994).
This suggests that these two sets of factors are involved in a complex crosstalk system which
is modulated by the set of fosand jun family members expressed in the responding cell.
Cross talk between different signalling pathways may thus occur at composite
elements. Such sequences may represent crucial elements in the control of gene expression.
In the 1514 virus there was no evidence in vitro for simultaneous binding of AP-1 and the VSS
binding protein to the closely positioned TATA box proximal sites. From the transfection data it
appeared that the VSS binding factor was being displaced by AP-1. It also appears that the
VSS binding factor is unable to recruit AP-1 to the non-consensus AP-1 site present in the
EV-1 oligonucleotides. This data strongly suggest that in this region of the LTR there is
competition for DNA binding between these two factors, in this regard a comparison of the AP-
1/AP-4/AP-1 regions from the 1514 and 1772 viruses would be interesting as in the 1772 LTR
the AP-1 site has been repositioned due to point mutations in the LTR. This results in a





In vivo the activation of transcription from the MVV LTR appears constrained by cell
type and differentiation state (Chapter 1). Within cells of the monocyte lineage differentiation
into macrophages, and macrophage activation, is required for the efficient expression of
transcripts driven by the MVV LTR. For MVV strain 1514 the transcription factor AP-1 has been
proposed as a major regulator of LTR activation. In cells of the monocyte/macrophage lineage
differentiation and activation leads to the expression of the fos and jun gene families (Matsui
et at., 1990, Redner et al., 1992). These factors are positive regulators of monocyte
differentiation (Lord etal., 1993). Studies on monocytes, and other cell lineages, illustrate the
differential regulation of the various fosand yunfamily members. Thus, during the timecourse
of activation the composition of the AP-1 dimers present within the cell will change. This
alteration of dimer composition will have effects on the activation of genes, due to changes in
site affinity and activation potential, and also modulate the crosstalk between AP-1 and other
transcription factor families.
6.2 Crosstalk and Transcriptional Regulation
Crosstalk between different transcription factor families can obviously occur between
independent sites in the target promoter and also by competition or cooperation at composite
elements (Section 5.6). In addition to these two mechanisms there is also the possibility of
direct protein-protein interactions between members of different families and the competition
of different transcripion factor complexes for the same DNA sequence, as opposed to
interference at composite elements where two distinct recognition sites are involved.
Competition for a single site is observed between a number of factors as well as within
families (i.e. the varying site affinities and activities of different AP-1 forms). Cross family
competition is observed at AP-1 and CRE (cAMP response element) sites. The recognition
sites of these factors are closely related and allows these two factors to recognise reciprocally
each others consensus sites, but with distinct affinities (Galien et al., 1994, Ryseck & Bravo
1991). Further, the affinity of AP-1 for the CRE is dependent on the composition of the AP-1
dimer. These two factors may show distinct effects on promoters containing an AP-1 site or
CRE; CREB potently inhibits the Ras driven activation of the collagenase TRE (TPA response
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element, a consensus AP-1 site) (Galien et at., 1994). Thus an AP-1 site (or CRE) may be
targeted by members of both the Fos and Jun families (AP-1) and CREB (a member of the
ATF-CREB familiy) and the consequences in terms of transcriptional regulation will be
dependent on which factor binds the site. The consensus AP-1 site, and CRE, may also be
targeted by NF-IL6 (C/EBP6) a member of the C/EBP family (Klampfer et at., 1994, Tsukada
etal., 1994). At a single CRE site within the prointerleukin-1 gene 3 distinct factors are seen to
bind; NF-IL6 dimers, CREB dimers and NF-IL6/CREB heterodimers. NF-IL6 is present in a
preexisting inactive form and is activated by stimuli such as LPS and IL-6. Activation triggers
translocation to the nuclei and activation of target genes, including IL-6 and c-fos(Akira etal.,
1990, Metz & Ziff 1991). NF-IL6 is composed of positive and inhibitory isoforms which are
translated from the same RNA species from separate in frame AUGs (Descombes & Schibler
1991, Hsu et at., 1994). The inhibitory isoform is capable of binding to some AP-1 sites so
blocking AP-1 binding and inhibiting gene transcription (Klampfer et at., 1994). This
recognition is not fully reciprocal as AP-1 (Fos/Jun) will not bind most NF-IL6 sites. In addition
to this promiscuous site recognition there is the phenomenon of cross family dimerisation.
6.2.1 Interactions between members of different transcription
factor families
The example of cross dimerisation between CREB and NF-IL6 has already been
mentioned. This is not a unique example. Members of the three transcription factor families
Fos/Jun, ATF-CREB and C/EBP all contain a leucine zipper domain which mediates the
dimerisation of these factors (Hai & Curran 1991, Lamb & McKnight 1991, Johnson &
McKnight 1989). Members of these families are able to cross dimerise selectively with
members of the other groups. The basis for this selective cross dimerisation is unclear but the
composite factors show distinct site recognition (Hai & Curran 1991, Hsu etal., 1994). Cross
dimerisation is limited between families. For example, while ATF-4 will dimerise with Jun, Fos
and Fra-1, ATF-1 will not dimerise with any of these proteins and ATF-2 and ATF-3 will only
dimerise with Jun (Hai & Curran 1991). These heterodimers show distinct binding specificity
depending on their compostion. While an ATF-3/Jun complex will recognise both the CRE
and AP-1 sites an ATF-4/Jun complex binds the CRE but not AP-1 sites.
The examples discussed above are from what may be described as a transcription
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factor super family (Hai & Curran 1991); all these factors dimerise via a leucine zipper domain.
The formation of cross family heterodimers is not dependent on this sharing of a common
dimerisation domain as is demonstrated by the cross dimerisation between the Fos/Jun
proteins and NF-kB p65 (Stein et al., 1993). This dimerisation is mediated by an interaction
between the bZIP domain of Fos and Jun and the Rel homology domain of p65. The
interaction of Fos and Jun with NF-kB appears to enhance the binding of these factors to their
recognition site in vitro. Indirect evidence for these dimers existing in vivo comes from data
where expression of antisense jun or fos inhibits the transcription from an artificial promoter
driven by mutiple NF-kB sites (Stein et al., 1993). Overexpression of Jun or Fos (but not Jun B
or Jun D) potentiated transcription from the same artificial promoter or a truncated HIV-1 LTR
(deleted for sequences upstream of the NF-kB sites). Such transfection studies cannot rule
out indirect effects but together with the in vitro data support the idea of the formation
heterodimeric species. Using immunoprecipitation NF-kB p50 has been shown to be able to
interact with NF-IL6 apparently also via the Rel and bZIP domains (LeClair etal., 1992). In this
case there was no examination of the functional consequences of this association.
This cross dimerisation allows changes in both sequence specificity and the
transactivation domains targeted to a given promoter. It provides a mechanism whereby
distinct signal transduction pathways may interact. The common occurance of cross
dimerisation between transcription families, generating novel activities, and competition of
various factors for the binding to the same region of DNA results in a huge number of possible
factor combinations at a promoter. During cellular activation there will be a flux in the
concentration and types of transcription factors available to interact and regulate transcription.
It is therefore likely that over the course of the activation process the composition of the
promoter complex will alter as factors are displaced by others with higher affinity for that region
of the promoter. In this respect the transcription of the MVV LTR induced by macrophage
activation is likely to be dependent on multiple interacting factors. These factors may be
interacting at the promoter itself or prior to promoter binding. It will be of interest to determine
whether their is direct protein-protein interaction between the factors interacting with the MVV
LTR. The work of Neuveut et al. (1993) suggests that in 1514 the c-Jun protein may be a
component of a non-AP-1 factor interacting with the LTR.
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6.3 Summary and Concluding Remarks
The data presented in this thesis argues that different MVV isolates show modified
mechanisms of transcriptional regulation. This conclusion is based on the observation that the
EV-1 LTRs lack a consensus AP-1 site and that the positions of transcription factor sites are
not fixed between the EV-1, 1514 or 1772 viruses. Both 1514, and its derivative 1772,
contain a consensus AP-1 site and in the case of 1514 this sequence has been demonstrated
to bind AP-1. The sequence within the EV-1 LTRs with closest homology to the consensus
AP-1 sequence did not bind AP-1 in vitro and did not appear to do so in vivo. It was not
possible to conclude for certain that this sequence was non-functional in vivo due to the
presence of a second transcription factor site in this region of the LTR. This factor, which binds
the same sequence in the 1514 and EV-1 viruses, shows a transactivating activity. This activity
was lower than that seen for the AP-1 complex present within these cells. There appear to be
two sites for this factor within the MVV LTR, one proximal to the TATA box the other at an
upstream site. This factor appears to be distinct from AP-1 both on the basis of site recognition
and the failure to observe binding of an anti-Jun antibody in gel supershift experiments. UV
crosslinking experiments identified a protein of approximately 34-40kD which interacts with
the recognition site. A full characterisation of this factor, and other cellular factors with which it
interacts, will allow further dissection of the mechanism by which MVV controls its transcription
rate.
Various questions need to be addressed regarding the nature of the VSS binding
protein. The simplest involves determining the tissue distribution of this factor; is there any
evidence for tissue specific expression? A second related question is whether this factor is a
component of a multi member family; do the family members show tissue specific expression?
In relation to MVV the key question is the expression of this factor during
monocyte/macrophage differentiation and activation. The transcription factor AP-1 is activated
during this process and it is important to determine if the factor which binds the VSS is under
similar control.
An analysis of the expression of transcription factors involved in the regulation of
MVV during monocyte/macrophage differentiation may also explain the restriction/latency of
MVV in the majority of infected cells in vivo. In vitro the MVV LTR has been shown to be a
strong promoter which is active in a variety of different cell types. This is in marked contrast to
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the observations of in vivo infection where viral transcription appears under tight control. The
basis of this in vivo restriction is unclear. It is possible that the VSS binding protein is involved
in this process, however, nothing is known about its expression in vivo. In addition to these
two factors, AP-1 and the VSS binding protein, the nature of other factors interacting with the
LTR remains to be defined. It is possible that neither of these two factors is critical for the
regulation of MVV transcription and some additional factor is required.
One important question raised in this thesis which needs to be fully resolved is the
apparent variation between the EV-1 and 1514 viruses in relation to AP-1 binding. Sequence
comparison suggested that none of the non-consensus AP-1 sites within the EV-1 LTR would
be able to bind AP-1 but this still requires formal proof. The EV-1 TATA box proximal AP-1 site
was shown to be unable to bind AP-1 in vitro. From the data using the gel shift
oligonucleotides in a CAT reporter vector it was not possible to completely rule out AP-1
binding to the EV-1 sequence in vivo due to the presence of the VSS binding site. However,
this data does indicate that even if AP-1 is binding to the EV-1 sequence it is binding with a
much lower affinity than in 1514.
In relation to other factors which interact with the LTR the nature of the factor
interacting with the sequence at position 90 remains to be defined. From the data on the EV-1
LTR variants this factor appears to be playing a role in determining the activity of duplications of
c/s-regulatory sequences in the LTR. The effect of this sequence illustrates the
codependence of the factors driving transcription from the LTR. As has been discussed
crosstalk can involve direct protein-protein interactions or occur indirectly through effects on
DNA conformation and the factors which are recruited to the basal transcription complex
assembled on the TATA box. One factor which may be affecting LTR activity is integration
state. To date studies on the MVV LTR have all made use of transient transfection assays
where the DNA is present in a non-integrated form. In contrast during infection the viral
genome will be integrated into the hosts DNA. It is possible that this integrated state may affect
viral transcription and play a role in latency. Viral latency in vivo is likely to be the product of
several interacting regulatory pathways. A comparison of the factors interacting with the LTR
during latency and active transcription will be required.
In Chapter 3 it was seen that alterations in the structure, and sequence, of the MVV
LTR modified its transcription rate. This data illustrated the interaction between various
sequences within the LTR and the variability of the LTR sequence within the EV-1 virus
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population. Comparisons of the LTRs from the 3 viruses 1514, 1772 and EV-1 suggests that
alterations in LTR architecture are tolerated. These three viruses appear to have transcription
factors binding in distinct locations in the LTR. A question which remains to be answered is
whether such alterations in LTR structure alter the process of viral pathogenesis in vivo. The 3
strains do differ in the pathology they induce; EV-1 the British isolate causes predominatly
Maedi disease, in contrast the 1514 and 1772 viruses cause primarily Visna disease, with the
1772 virus being selected in vivo by serial passage for increased neuropathogenesis. Of
course, these viruses do not solely differ in their LTR sequences so the importance of this
variation to the distinct pathologies induced remains unclear. Comparing the 1514 and 1772
LTRs then it could be suggested that the separation of the VSS and the AP-1 site may result
in an elevated transcription, and replication rate, so accelerating the disease course. This
separation of these two binding sites also raises the question of synergistic interaction
between the two factors. It is still unclear whether both these factors interact simultaneoulsy at
the TATA box proximal site in 1514. This could be addressed using a A56 vector containing
the AP-1/VSS region but with mutations in the VSS region. The activity of this sequence
could then be compared with the 1514 and EV-1ex-v (AP-1 mutant) vectors. Such a
comparison should identify any interaction between AP-1 and the VSS binding protein which
modifies the transcription rate.
One method for determining the role of the LTR in determining the disease course
would be by constructing chimeric molecular clones differing only in the LTR sequence. Such
constructs could then be introduced directly into animals by DNA injection. The data on the
EV-1 LTR population within the infected animal and the comparison of these sequences with
those seen in the infecting population strongly suggests that the LTR is under selective
pressure in vivo. This selection appears to limit the number of LTR types capable of
establishing infection. Dissection of the interactions involved in the regulation of transcription
from these promoters will depend on targeted disruption of transcription factor binding sites
and the manipulation of sites by altering orientation and spacing. While these studies may be
performed using isolated LTRs and reporter gene assays, in order to shed light on the LTRs
role in disease, it will also be neccessary to perform such experiments using infectious
molecular clones. This will allow the effect of alterations of LTR structure on viral replication to
be monitored.
One aspect of the regulatory process not touched on in this work is the activity and
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targets of the MVV Tat protein, it appears that the MVV Tat protein does possess a potent
transcriptional activation domain (Carruth et at., 1994). The absence of a TAR region in the
MVV viruses has led to the proposal that the Tat protein is interacting with cellular factors and is
activating transcription via this route. A second observation on the MVV Tat protein, that it only
weakly transactivates the MVV LTR, has been used to suggest that Tat may be primarily
targeting cellular genes so maintaining the cell in an activated state and disrupting normal
homeostasis. This mechanism of action is consistent with observations that MVV Tat is not
required for in vitro replication. It is possible that it is more important for the successful
maintenance of infection in vivo, and may be involved in the generation of pathology. This
remains to be tested by experimental infection with Tat deleted virus.
Due to the apparent requirement for integration in the lentiviral lifecycle these viruses
behave essentially as cellular genes. However they have the great advantage of containing all
their regulatory elements within a defined sequence of DNA which can be readily manipulated
in vitro. In contrast, cellular genes contain widely dispersed regulatory elements and these
elements cannot be easily manipulated in their normal context. Analysis of the molecular basis
of replication in MVV, and other lentiviruses, will shed light on the mechanisms by which these
pathogens maintain infection and evade the host immune response. Further, a fuller
understanding of the mechanisms involved in the control of lentiviral transcription is useful in
the dissection of cellular transcriptional control mechanisms.
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